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 Abstract 
Endurance exercise typically leads to beneficial cardiac adaptations manifested as increased 
cardiac mass, higher cardiac function and lower central hemodynamic load (blood pressure, 
aortic stiffness and wave reflections). However, studies in male marathoners suggest detrimental 
cardiac remodeling, such that larger cardiac mass is associated with reduced cardiac function and 
higher central hemodynamic load. There are well-established sex differences in cardiac 
adaptations to endurance exercise and central hemodynamics across the lifespan. Whether there 
are sex differences in cardiovascular adaptations in marathoners requires further scrutiny. We 
examined sex differences in 1) Left ventricle (LV) structure, 2) LV function 3) 24-hour central 
hemodynamic load and 4) ventricular-vascular coupling in marathon runners and recreationally 
active adults. LV structure and function were measured using 3-dimensional echocardiography 
(3DE). LV mass index (LVMI) was used as an index of LV structure. LV longitudinal (LS) 
circumferential (CS), area (AS), and radial strain (RS) were used as indices of LV function. An 
ambulatory oscillometric blood pressure (BP) cuff was used to measure 24-hour hemodynamic 
load after a non-exercise control day and following a 30-minute run/walk. 24-hour hemodynamic 
load was comprised of brachial and aortic BP, aortic stiffness measured as pulse-wave velocity 
(PWV) and pressure from wave reflections. Measures from central hemodynamics and 3DE were 
combined to derive the ratio of arterial elastance (Ea) to ventricular elastance (Elv) as a global 
measure of ventricular-vascular coupling. Our findings suggest that although female marathoners 
had larger LVMI they did not have LV dysfunction or increased central hemodynamic load and 
had better overall ventricular-vascular coupling. Furthermore, chronic marathon training and 
racing does not appear to be associated with LV dysfunction, or increased central hemodynamic 
load in otherwise healthy middle-aged men and women.  
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Key Concepts 
Endurance Exercise. Aerobic exercise that includes activities such as, walking, 
jogging/running, cycling, swimming, dancing, tennis, basketball, soccer, racquetball. Endurance 
exercise constitutes activity that increases your breathing and heart rate for greater than 10 
minutes at a time. The American College of Sports Medicine recommends 150 minutes of 
moderate aerobic exercise or 75 minutes of vigorous aerobic exercise a week.  
Recreationally-Active. An individual is defined as recreationally active by the American 
College of Sports Medicine as performing exercise on less than or equal to 2 days a week for 80 
minutes (total of 2 hours and 40 minutes a week). For the purpose of this study our participants 
fell into the recreationally active group if they completed <3 hours a week of exercise.  
Inactive. An individual is defined as inactive if they are not doing enough physical activity, 
defined as not meeting the recommended daily amount of physical activity established by the 
American College of Sports Medicine (150 minutes of moderate aerobic exercise or 75 minutes 
of vigorous aerobic exercise a week).  
Sedentary. An individual is defined as sedentary if they self-report or are objectively measured 
to spend a significant time during their day sitting and/or lying down.  
Marathon Race.  
A marathon running event is a 26.2 mile road race. Any distance beyond 26.2 miles is known as 
an ultra-marathon. Individuals between the ages of 35-50 years old, finish a marathon event on 
average between 4 hours and 22 minutes and 4 hours and 47 minutes. Competitive-age group 
individuals (35-50 yrs), for instance those who might qualify for the Boston Marathon, complete 
the marathon event between 3 hours and 40 minutes and 3 hours and 55 minutes for women, and 
between 3 hours and 10 minutes and 3 hours and 25 minutes for men. For this study, we 
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examined marathon runners between the ages of 35-50 yrs who on average completed a 
marathon in 3 hours and 45 minutes for men and 4 hours for women.  
Arterial Stiffness.  
Arterial stiffness is a term referring to the material 
properties of the blood vessels that carry blood away from 
the heart (i.e. arteries). Arteries are naturally elastic and 
stretch when the heart ejects blood into the vessel. With 
age and disease,the arteries lose elasticity (i.e. increase in stiffness) and affect how blood flow 
is delivered to tissuesand organs and thus, transmitted throughout the body. This study 
examined large artery stiffness, particularlyat the level of the aorta. 
Hemodynamics (aortic and brachial). 
Hemodynamics is an encompassing term used to describe the movement of both blood pressure 
and blood flow throughout the body. Central hemodynamics is referred to as aortic 
hemodynamics and peripheral hemodynamics might be referred to as brachial hemodynamics. In 
regards to hemodynamics, blood pressure and blood flow represent two separate forces. Blood 
pressure and blood flow travel at different speeds throughout the body and are altered by 
different factors. When the heart contracts, the pressure created is what propels the blood 
forward throughout the periphery of the body. However, contrary to intuition, blood pressure and 
blood flow do not travel in one direction; blood pressure and blood flow can move forward and 
backward (forward and backward wave reflections). In some settings, backward traveling blood 
pressure and blood flow can be detrimental to health. In the current study, we examine both 
resting and 24-hour aortic and brachial hemodynamics.  
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Left Ventricle.  
The heart has four main chambers that allow 
the heart to properly relax and contract to 
receive and deliver blood flow from and to the 
body. The four chambers include: right 
ventricle, left ventricle, right atrium and left 
atrium. The left ventricle is the largest chamber and the most muscular part of the heart tissue. 
The left ventricle receives oxygenated blood from the lungs and then ejects the blood into the 
main artery off of the heart, the aorta, which transmits blood out to the body to be delivered to 
the working muscles, tissues and organs. High blood pressure, or atherosclerosis can increase the 
stress and pressure that the left ventricle must work against to eject blood. Thus, the health of the 
arteries throughout the body readily impact left ventricle function. This study will examine the 
size of the left ventricle and how well it is contracting and whether these indices are associated 
with the overall health of the systemic arteries.  
Left Ventricle Systolic vs. Diastolic Function. The cardiac cycle is comprised of one-third time 
spent in systole and two-thirds time spent in diastole. Diastole is considered the filling or 
relaxing phase of the cardiac cycle, in which, the left ventricle fills with blood. Systole is 
considered the emptying or contracting phase of the cardiac cycle. Thus, diastolic dysfunction is 
defined as a condition in which the filling of the left ventricle is impaired, while systolic 
dysfunction may result from impaired ventricular contraction. For the purposes of this study, we 
focus on left ventricle systolic function and measure it via echocardiography and strain analysis. 
viii 
 
Echocardiography.  
Echocardiography also called an echo test, or heart 
ultrasound is a clinical test that takes “moving 
pictures” of the heart with sounds waves. A trained 
sonographer uses ultrasound technology to capture 
the heart’s movements. Ultra-high frequency sound 
waves pick up the images of the heart with the help of clear ultrasound gel. Echocardiography 
does not use X-ray technology. Echocardiography can give lots of information regarding heart 
size and function. For the purposes of this study we will use 3-dimensional Echocardiography to 
quantify heart size and function of the left ventricle.  
Left Ventricle Strain and Deformation.  
Left ventricle strain is an index of left ventricle function and how well the heart muscle is 
moving with each heart contraction (beat). The ventricle wall motion is detected via 
displacement of the heart muscle, while wall deformation is detected via strain analysis. 
Displacement is the difference between the position of a given point of the ventricle wall during 
the cardiac cycle and the position of the wall at the onset of the cycle (L-L0) (at QRS complex) 
[1]. Deformation is measured by strain, which evaluates the degree of deformation in a particular 
wall segment in relation to its initial dimension (E= L-L0/L0) [1]. L = the length of the muscle 
fiber at the end of contraction, L0 = the initial length of the heart muscle fiber. Conventionally, 
lengthening/thickening or stretching is indicated by positive strain values while 
shortening/thinning is indicated by negative strain values.  A higher strain value indicates 
optimal left ventricle function (strain, deformation) while a lower strain value indicates lower left 
ventricle function (strain, deformation). Measuring strain allows us to examine the multi-
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directional nature of how the heart truly contracts (longitudinal, radial, circumferential 
directions). For the purpose of this study, we will measure LV function using LV longitudinal, 
area, radial and circumferential strain.  
Ventricular-vascular Coupling.  
The interaction between the left ventricle and the arterial system is typically described as 
ventricular-vascular coupling. Ventricular-vascular coupling is a measure of cardiovascular 
performance. The cardiovascular system is designed to provide adequate blood flow and pressure 
to the body’s tissues both at rest and during exercise. In order to determine the efficiency of the 
cardiovascular system, it is necessary to study the left ventricle (heart) properties (Elv) and also 
the arterial system which provides blood directly to the left ventricle (Ea). For the purpose of this 
study, we will measure ventricular-vascular coupling using the ratio of Ea:Elv.  
Physiological Adaptations. Physiological adaptations are defined as healthy, normal 
adaptations. For the purpose of this study we are interested in physiological cardiovascular 
adaptations to endurance exercise of the left ventricle (structure and function) and of the 
vasculature (blood pressure and arterial stiffness). For this study, physiological cardiovascular 
adaptations will be defined as left ventricle size on average <95g/m2 or >95g/m2 in females, and 
<115 g/m2 or >115 g/m2 in males. If left ventricle relative wall thickness is 0.42 mm with a left 
ventricle size of <95g/m2 and <115g/m2 this will be defined as a physiological adaptation as 
well. Blood pressure values of <140/90 mmHg and arterial (aortic) stiffness values of <7.2 m/s 
will be considered physiological in the current study.  
Pathological Adaptations. Pathological adaptations are defined as abnormal and unhealthy, 
typically due to disease. For the purpose of the current study, pathological cardiovascular 
adaptations will be defined as left ventricle size >95g/m2 in females and >115g/m2 in males 
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combined with a left ventricle relative wall thickness of >0.42 mm. Blood pressure values of 
>140/90 mmHg and arterial (aortic) stiffness values of >7.2 m/s will be considered pathological 
in the current study.  
Non-Technical Summary 
What is known?  
 Over the past few decades there has been increased participation in endurance events, 
such as marathons. In particular, the number of female marathon participants has increased, such 
that there is almost the same number of female as male marathoners. The impact of aerobic 
exercise on risk for cardiovascular disease (CVD) is well-established as beneficial for the 
cardiovascular system. However, there is some debate as to whether excessive endurance 
exercise, such as completing multiple marathons, is detrimental to the cardiovascular system. 
Some studies in male marathoners note adverse cardiac structural remodeling (i.e. enlarged 
heart), ventricular contractile abnormalities [2, 3] coronary artery calcification and fibrosis [2, 3]. 
Additionally, studies report increased aortic stiffness and blood pressure in endurance trained 
men compared to controls. Despite, well-established sex differences in cardiovascular risk and 
physiology across the lifespan, no studies have examined the impact of chronic endurance 
exercise on the cardiovascular system in female marathoners. Thus, our study examined sex 
differences in cardiovascular structure, function and vascular hemodynamics in male and female 
marathon runners and recreationally active adults. 
What is new and noteworthy from our results? 
Aim 1: Surprisingly, when left ventricle mass was adjusted for differences in body size between 
male and females, female marathoners had a larger left ventricle compared to both their 
recreationally active female and male counterparts. We suggest in our sample, that female 
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marathoners have a larger left ventricle, that is not associated with increased blood pressure, 
aortic stiffness or cardiac dysfunction and is actually associated with increased cardiac efficiency 
(as measured by ventricular-vascular coupling).  
Aim 2: Left ventricle function was similar between all groups, both men and women, and 
marathoners and controls. This is the first study to examine sex differences in left ventricle 
function in marathoners. Also, this it the first study to do so, utilizing three-dimensional 
echocardiography strain analysis. We found no sex or training differences in left ventricle 
function.  
Aim 3: There were sex differences, but no training differences in 24-hour ambulatory 
hemodynamics following non-exercise control and post-exercise conditions. As expected women 
had lower resting 24-hour hemodynamics (arterial stiffness, and blood pressure) compared to 
men, irrespective of training status. Similarly, women had lower 24-hour hemodynamics 
following acute exercise. There were also no differences between resting and post-exercise 24-
hour hemodynamics.  
Lastly, we assessed overall ventricular-vascular coupling, a measure of the interaction 
between the left ventricle and the arterial system to determine cardiac performance and 
energetics, we found that female marathoners had better overall ventricular vascular coupling 
compared to both recreationally active controls and male counterparts. Adequate coupling 
between the heart and the arterial system is important as it results in optimal transfer of blood 
from the heart to the periphery without excessive changes in pressure [4]. Thus, our findings 
suggest that female marathoners have a larger heart, with preserved function, and lower central 
hemodynamic load, that might contribute to better observed ventricular-vascular coupling.  
Implications  
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In our study, women irrespective of training status had lower blood pressure and aortic stiffness 
compared to men.  Thus, sex differences in cardiovascular system are present in both the 
recreationally active and marathon runner population. This finding emphasizes the importance of 
examining sex differences in how endurance exercise affects the cardiovascular system. Previous 
studies that examine male marathoners with similar cardiac adaptations show that a larger 
ventricle is associated with reduced function, and higher hemodynamic load. The results of our 
study suggest that although female marathoners had a larger heart, they had preserved function, 
lower central hemodynamic load and optimal ventricular-vascular coupling. Thus, female sex 
may confer a level of cardio-protection from possible cardiac mal-adaptations with habitual 
endurance exercise training.  Understanding the cardiovascular response to regular endurance 
exercise may also have important clinical implications for women as cardiovascular risk with age 
in women has been linked to greater risk of heart failure than men. Endurance exercise may offer 
an important therapeutic strategy to mitigate CVD risk in women.  
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Chapter I: Introduction 
  Over the past three decades there has been an unprecedented number of athletes training 
for and racing at distances up to and exceeding the marathon. The number of marathon finishers 
has increased from 25,000 in 1976 to 550,636 in 2015 [5]. The percentage of female marathon 
finishers has reached an all-time high (43%) and is almost as high as the number of male 
marathon finishers [5]. Although exercise is generally viewed as beneficial for the heart [6], 
there are controversial reports of adverse cardiac structural remodeling, ventricular contractile 
abnormalities [2, 3] and fibrosis [2, 3] in long-distance runners.  As such, new questions have 
surfaced concerning the effects of long-term endurance exercise on the cardiovascular system. 
Endurance training results in myocardial structural adaptations such as increases in wall 
thickness [7-10] and increases in cardiac mass [11]. Historically these physiological adaptations 
are viewed as benign and considered a phenotypic expression of the “athlete’s heart” [12-14]. 
Recent studies have suggested that exercise-induced cardiac remodeling can progress to 
myocardial fibrosis in a subset of the athletic population. This is of concern as fibrosis is a 
pathological substrate for lethal arrhythmogenesis and sudden cardiac death [15]. Increases in 
cardiac mass are associated with myocardial dysfunction [16], which may play a role in the 
development of myocardial fibrosis [16]. Myocardial contractile dysfunction may precede the 
development of ventricular enlargement and subsequently myocardial fibrosis. Therefore, 
myocardial dysfunction may be a marker for myocardial damage and risk in endurance athletes 
[16].  
Ventricular structural adaptations to endurance exercise are less pronounced in women 
compared to men [17-24]. Female athletes display smaller left ventricular (LV) mass and 
volumes compared to male athletes [21] even after adjusting for body size and lean body mass 
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[22, 25, 26]. Whether there are sex differences in cardiac functional changes with endurance 
exercise is less explored as the majority of studies to date have examined men only [15, 27-29].  
Women may have higher myocardial contractile function when compared to men of the same age 
[30]. It is possible that endurance-trained women may have better myocardial function than men, 
which may lead to a lesser degree of training-induced ventricular remodeling. The relationship 
between myocardial function and ventricular remodeling in female endurance athletes has yet to 
be examined.   
Reasons for potential sex differences in myocardial function and ventricular remodeling 
with endurance training are unknown but may be related to differences in underlying central 
hemodynamics at rest and in response to exercise. Specifically, there are known sex differences 
in resting central hemodynamics (blood pressure, arterial stiffness and wave reflections) [31-33]. 
Studies show that men have higher arterial stiffness and blood pressure when compared to 
women while women have higher pressure from wave reflections than men [31, 34]. Increased 
blood pressure, arterial stiffness and pressure from wave reflections leads to increased afterload 
and is associated with increased LV mass [35]. Increased arterial stiffness and pressure from 
wave reflections have also been linked to reduced myocardial contractile function [36] and 
myocardial fibrosis [37].  
Generally, regular endurance exercise training leads to reductions in blood pressure, 
arterial stiffness and wave reflections [38, 39]. Studies in men suggest that strenuous endurance 
exercise may lead to increased blood pressure and arterial stiffness with no change in wave 
reflections [40, 41]. Conversely, women experience reductions in blood pressure, arterial 
stiffness and wave reflections following strenuous endurance exercise [34, 42-48]. Differential 
acute hemodynamic responses to endurance exercise compounded over years of training may 
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give rise to chronic sex differences in central hemodynamic load. Sex differences in central 
hemodynamic load may lead to differences in LV afterload and ultimately explain differences in 
the magnitude of myocardial contractile function and myocardial remodeling.  
Conventionally, 2-dimensional echocardiography (2DE) has been used to characterize the 
“athlete’s heart” by assessing LV mass (LVM), dimensions and function in athletes [49]. Recent 
advances in 3D echocardiography (3DE) have allowed researchers to more accurately and 
expansively assess cardiac structure and contractile function. 3D speckle tracking 
echocardiography (3DSTE) assesses LV contractile function using strain analysis. Increased 
strain or a higher strain rate indicates optimal contractile function whereas decreased strain or a 
lower strain rate indicates contractile dysfunction [50]. Few cross-sectional studies in athletes 
have used strain analysis to characterize myocardial functional adaptations to exercise training 
found differences in cardiac function between strength and endurance-trained athletes [51-53]. 
Unlike the well-established literature surrounding cardiac enlargement with endurance training, 
disparities exist with regards to whether endurance-trained runners have higher cardiac function 
[3] or lower cardiac function [54] compared to sedentary individuals. Myocardial strain also may 
be transiently reduced immediately after endurance events (i.e. marathons, ultra-marathons), 
which suggests myocardial dysfunction or “cardiac fatigue” [2, 55, 56]. Previous studies that 
examined cardiac function in endurance-trained runners used 2DE not 3DE [3, 54]. We wish to 
use 3DE and 3DSTE to explore the impact of sex on cardiac structural and functional adaptations 
to habitual endurance exercise.   
   Despite increased female participation in competitive endurance events, minimal 
advances have been made to examine the cardiovascular adaptations to prolonged endurance 
exercise in women. Pre-menopausal women may never approach pathological thresholds of 
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ventricular remodeling and subsequently, may be cardio-protected with regards to possible 
adverse cardiac remodeling, cardiac dysfunction and risk for fibrosis. Understanding the 
ventricular-vascular responses to habitual endurance exercise training in lifelong male and 
female endurance athletes may give insight into sex differences in cardiac remodeling, function 
and future cardiovascular risk.  
Specific Aims 
Aim1: To compare LV structure (i.e. LV mass) in marathoners and recreationally active women 
and men using 3DE imaging.  
Hypothesis 1:  Female marathoners will have lower LV mass (adjusted for body surface area and 
body composition) compared to male marathoners and higher LV mass compared to 
recreationally active women. Male marathoners will have higher LV mass compared to 
recreationally active men.  
Aim 2: To examine LV function (i.e. strain analysis) in marathoners and recreationally active 
women and men using 3D STE. 
Hypothesis 2: Female marathoners will have higher function (i.e. higher strain) compared to 
male marathoners and recreationally active women. Male marathoners will have lower function 
compared to recreationally active men.  
Aim 3: To examine 24-hour central hemodynamic load (blood pressure, arterial stiffness, 
pressure from wave reflections) at rest and after acute exercise in marathoners and recreationally 
active women and men.  
Hypothesis3a:  Female marathoners will have a lower 24-hour central hemodynamic load (blood 
pressure, arterial stiffness, pressure from wave reflections) at rest and following exercise 
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compared to male marathoners and recreationally active women. Male marathoners will have 
higher 24-hour central hemodynamic load compared to recreationally active men.  
Hypothesis 3b: Higher 24-hour central hemodynamic load (blood pressure, arterial stiffness, 
pressure from wave reflections) will be associated with larger LV structure (LVM) and lower LV 
function (LV strain) in marathoners and recreationally active men and women.  
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Chapter II: Review of the Literature 
 
I. The Effect of Physical Activity and Exercise on CVD Mortality and Morbidity 
“All parts of the body, if used in moderation and exercised in labors to which each is 
accustomed, become thereby healthy and well developed and age slowly; but if they are un-tuned 
and left idle they become liable to disease, defective in growth and age quickly” (Greek 
physician, Hippocrates, 460-375 B.C). 
Over 2000 years ago, the Greek Physician Hippocrates dictated the importance of 
physical activity to overall health. Thousands of years later, in the 21st Century, evidence 
suggests that a sedentary lifestyle may be an adversary to optimal health [57]. An exemplar study 
in the field of physical activity epidemiology, performed by Morris et al. compared coronary 
heart disease (CHD) mortality rates of London double decker bus conductors who stood, walked, 
and climbed bus stairs for hours a day to the CHD mortality rates of London bus drivers who 
spent their day sitting [58]. This study found that the bus conductors had 50% lower CHD 
mortality rates compared to the bus drivers. The researchers attributed lower rates of CHD to 
increased daily physical activity performed by the bus conductors. The London bus conductor 
study had an immediate impact on physical activity epidemiology and emphasized the beneficial 
role of physical activity on several chronic diseases.  
In accordance with Morris et al. several large epidemiological studies have determined 
that there is an inverse relationship between physical activity and cardiovascular events and 
mortality [59-62]. Highly active people have lower rates of cardiovascular disease (CVD) than 
inactive individuals [63-65]. The large body of evidence surrounding the association of physical 
activity and CVD led the federal government in 2008 to issue the first issue of physical activity 
guidelines for Americans [63]. The 2008 guidelines comprehensively reviewed several studies 
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and found that active men and women had an approximately 30-35% reduction in risk for 
developing CVD compared to inactive individuals. More importantly, the 2008 US federal 
physical activity guidelines drafted by The American College of Sports Medicine (ACSM) and 
American Heart Association (AHA) recommend that adults perform 150 min/week of moderate-
intensity or 75 min/week of vigorous intensity physical activity [63, 66]. Since then, several 
epidemiological studies have determined that 15 minutes of exercise per day (~105 minutes) [67, 
68] is the minimum dose of moderate intensity exercise that is associated with reduced CVD risk 
[61, 67]. Even individuals who perform the minimum level of physical activity have a reduced 
risk of CVD over a 15-year period compared to sedentary individuals [68, 69].   
Gender and Relationship of PA and CVD  
The inverse relationship between physical activity and risk of developing CVD is 
reported in both men and women [70]. It appears from several studies that more physical activity 
is associated with a reduced risk of CVD in both men and women, respectively [69, 71-79]. 
Interestingly, this relationship may be more pronounced in women than in men as the average 
relative risk reduction in active women was 40% [70] when compared to inactive women while 
the average risk reduction in men was 30% when compared to inactive men [70]. Even though 
the association may be stronger in women compared to men there are few studies that include 
gender comparisons because different studies use a variety of questionnaires to assess physical 
activity and categorize physical activity differently (intensity, duration, frequency, energy 
expenditure). Indeed, not only does sex impact the association between physical activity and 
CVD but also intensity, duration, frequency and energy expenditure of the physical activity 
performed may have a profound influence the association of physical activity and risk for CVD. 
Dose-Response Relationship between PA Energy Expenditure and Risk for CVD 
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The inverse relationship between physical activity and CVD is well established however; the 
dose of physical activity is not well defined. The 2008 Guidelines of Physical Activity concluded 
that “greater amounts of activity appear to provide greater benefit but the shapes of any dose-
response relations have not been well-defined” [63]. In order to explore this point two-hallmark 
studies will be discussed: The Harvard Alumni study and The Women’s Health Study.  The 
Harvard Alumni Study, a large epidemiological study, determined the relationship between 
volume, intensity, and duration of physical activity and risk for CVD and mortality [61]. 
Approximately 7,000 male alumni were followed for 6 years to examine levels of daily physical 
activity. From this data, energy expenditure was calculated and men were placed into categories 
based on total energy expenditure per week (Figure 1). In men, the relationship between energy 
expenditure and levels of physical activity and risk for CVD was curvilinear where higher total 
physical activity was correlated with lower CVD risk but at approximately 3000 kcal/week and 
greater the risk reductions were of 
smaller and smaller magnitude 
(Figure 1)[61]. This suggests that 
there is a point at which higher 
volume of physical activity may 
not confer additional 
benefits [59].  
 A similar relationship 
between physical activity and risk for CVD has been established in women.  The Women’s 
Health Study, a randomized trial of the effects of aspirin and vitamin E in the prevention of CVD 
and cancer in healthy women, assessed physical activity, energy expenditure and risk for CVD in 
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Figure 2.1: The relationship between PA and CVD in men, 
Modified from Paffenbarger et al. [57]. 
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approximately 27,000 women throughout 10 years [77].  Similar to the Harvard alumni study, 
women in this study were categorized based on their total weekly energy expenditure (Figure 2). 
 
Contrastingly, the relationship between physical activity and CVD risk appears to be 
more linear in women. However, this relationship might be due to the lower weekly energy 
expenditure in women (200-1500 kcal/week) compared to men (1000-4000 Kcal/week) and the 
relationship in women (Figure 2) represents the beginning or lower end of the dose-response 
curve. It is evident from these studies that physical activity is associated with low mortality rates 
[70, 80]. However, it is currently unclear whether high/excessive volumes of physical activity are 
associated with additional risk reductions in CVD in both men and women [6, 70, 81]. Future 
studies need to examine the dose response of physical activity and risk for CVD in men and 
women matched for energy expenditure.  
Dose-Response Relationship between PA Intensity and Risk for CVD 
The dose response relationship between moderate and vigorous intensity physical activity 
and cardiovascular mortality appear to be different [67, 68, 82]. In contrast to the well-
Figure 2.2: The relationship between PA and CVD in women 
Modified from Mora et al. [75]. 
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established dose-response relationship of moderate intensity physical activity and CVD, there are 
discrepancies in the literature regarding the relationship between vigorous intensity activity and 
CVD. Some studies suggest a linear relationship between vigorous activity and risk for CVD, 
like moderate intensity physical activity [69, 75]. For instance, Lee et al. examined the 
association of vigorous and non-vigorous intensity physical activity with CVD mortality and 
found an inverse relationship between amount of vigorous physical activity and mortality but not 
between non-vigorous physical activity and mortality [83]. Similarly, Sesso et al. found that the 
total volume of physical activity and amount of vigorous intensity physical activity were 
significant predictors of reduced risk for CVD [75]. Thus, these studies suggest that vigorous 
activity is associated with the largest reductions in risk for CVD.  
 In contrast, other studies suggest that vigorous intensity activity yields a maximum risk 
reduction at lower exercise volumes than moderate intensity exercise [67, 68] suggesting that 
high volumes of vigorous exercise, above the ACSM/AHA recommendations (75 minutes), may 
not be reduce risk for CVD. In a prospective study, Wen et al. studied 416, 175 Taiwanese adults 
for 13 years and found that individuals who performed 15 minutes of physical activity per day 
had significant reductions in risk for CVD and all-cause mortality compared to those who are 
inactive. After the 15 minutes per day of exercise, every additional 15 minutes of daily moderate 
intensity exercise was associated with greater reductions in risk for mortality (Black Line, Figure 
3). However, this pattern only continued until 100 minutes per day of moderate intensity 
exercise, at which this study found no additional reductions in risk for CVD. More importantly, 
this study also found that there was no additional reductions in mortality risk in individuals who 
performed more than 50 minutes per day of vigorous activity (Red Line, Figure 3) [67].  
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Similarly, Mons et al. showed that individuals who expended over 14,700 kcals per week 
via vigorous activity had an increased risk for CVD [84]. This study found the highest hazard 
ratios for adverse cardiovascular outcomes in the least active patient group and the lowest in 
those who exercised moderately at 2-4 times per week. A higher rate of CV events was also 
found in daily exercisers compared to the moderate exercisers but not as high as that found in the 
least active group.  These results suggest a reverse J-shaped curve describing the association of 
physical activity levels and CVD mortality [84]. Typically, high levels of moderate and vigorous 
intensity exercise are associated with larger reductions in CVD mortality however; there may be 
a threshold of physical activity in which there are no additional reductions in CVD mortality [67, 
68, 82].   
0
5
10
15
20
25
30
35
40
45
50
10 20 30 40 50 60 70 80 90 100
M
or
ta
lit
y 
R
is
k 
R
ed
uc
tio
n 
(%
)
Amount of Physical Activity/week (minutes) 
Vigorous
Moderate
Total
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A recent retrospective study examined the dose response relationship between leisure 
time physical activity and CVD mortality to determine whether there is an upper limit of 
physical activity in which additional physical activity does not confer further reductions in CVD 
risk. In a pooled analysis of 6 populations from the National Cancer Institute Cohort Consortium, 
a total sample of 661,137 people and 116, 686 deaths were studied [68]. Arem et al. found that 
the individuals who performed just below the daily recommendations of physical activity had a 
20% lower risk of CVD mortality, individuals who performed 1-2 times the recommended daily 
dose of activity had a 31% reduction in risk, individuals who performed 2-3 times the 
recommended daily amount of activity had a 37% reduction in risk and those who engaged in 3-
10 times the recommended daily amount of activity had 39% lower risk reduction, while people 
Figure 4: The relationship between Leisure Time Physical Activity and 
Mortality Risk Modified from Arem et al. . 
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Figure 2.4: The Relationship between Leisure time activity and Mortality 
risk, Modified from Arem et al. [66]. 
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who exercised >10 times the recommended amount only had a 31% lower CVD mortality risk 
which is the same amount as those individuals who performed just below the daily recommended 
dose (Figure 4). Thus, individuals who perform 10 times the recommended amount of physical 
activity had no additional reductions in risk. However, similar to the findings of Mons et al., 
because their risk was not significantly higher than those who performed less activity, the 
authors concluded that this level of activity does not lead to increased risk for cardiovascular 
mortality. These studies extend previous findings by Wen et al. that only examined the dose 
response relationship between physical activity and CVD mortality up to 40 MET-h/week or 5 
times the recommended daily activity. Arem et al. found that beyond 40 MET-h/week there were 
no further reductions in mortality risk (Figure 4). Future studies need to examine the relationship 
between high volumes of moderate and vigorous physical activity and risk for CVD to confirm 
and extend these findings.  
II. Endurance Exercise CVD Risk and Mortality  
 Long-distance/Endurance Running and Risk for CVD and Mortality  
There are an unprecedented number of individuals training for and competing in 
strenuous endurance events such as marathon races [5]. Thus, an increasing number of 
individuals are exercising at volumes of physical activity that exceed the current physical activity 
guidelines. Running is an attractive form of aerobic exercise and has been regarded as a popular 
and practical form of high intensity vigorous aerobic exercise [85]. The effect of high volumes of 
strenuous aerobic exercise such as running on risk for CVD is currently debated. Some studies 
suggest that higher volumes of running are associated with lower risk of CVD and mortality [86-
89]. While other studies suggest a U-shaped curve or reverse J-shaped curve between the amount 
of running and risk for CVD [85, 90-92]. The U-shaped relationship implies that sedentary or 
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inactive individuals and extremely/excessively runners have similar risk of CVD while the 
reverse J-shaped curve suggests that extreme endurance runners have significantly higher risk for 
CVD compared to those who exercise at moderate levels, respectively [84, 85, 89-92]. 
 The National Runners’ Health Study examined the dose response relationship between 
CVD risk factors and vigorous exercise in 8,283 male recreational runners. As shown in Figure 
5, the estimated 10-year CVD risk for events, determined by the Framingham study, decreased 
with more miles run per week, 9.3 (15k) miles to approximately 49-50 miles (80km) a week [87, 
89]. However, there were no additional reductions in risk for CVD events in individuals who ran 
>50 miles (80km) a week. 
 
 Another study by the same research group, examined the dose response relationship 
between exercise energy expenditure (Metabolic Equivalents, MET-hours per day) and CVD 
related mortality in myocardial infarction survivors and observed a J-shaped relationship 
between risk for CV mortality and exercise energy expenditure [89]. As can been seen in Figure 
Figure 2.5: National Runner’s Study amount of distance run and 10-Year CVD risk in 
men, Modified from Williams et al. [85]. 
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6, those who expended 3.6 to 5.4 MET hours per day  (15-23 miles per week) had a 50 % lower 
risk of CVD than those who exercised <1.07 MET h/d and those who exercised at 5.4-7.2 MET 
hours per day (23-30 miles per week) were at a 63% lower risk, and those individuals who 
exercised > 7.2 MET-hours per day (>30 miles per week) had only a 12% lower risk. This study 
found higher energy expenditure from walking or running was associated with lower risk for 
CVD mortality until 7.2 MET-hours per day (>30 miles per week), which is equivalent to 
running 30 miles per week or briskly walking 46 miles/week [89, 93]. The results of this study 
suggest that the benefits of running or walking may not accrue indefinitely. In MI survivors, 
there was a significant increase in cardiovascular mortality in both walkers and runners who 
exercised more than 30 miles a week compared to those who exercised anywhere between 15-30 
miles per week [89].  Increased cardiovascular mortality in the most active cohort is unclear and 
needs to be further examined, especially considering that this cohort also had lower CVD risk 
factors. However, this study was conducted in MI survivors so the results cannot be generalized 
to entire exercise population. 
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Figure 2.6: National Runner’s Study amount of energy expenditure from walking or 
running and CVD risk in men, Modified by Williams et al. [87].  
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Additionally, The Coppehagen City Heart Study, a prospective observational study of men and 
women joggers (1,100 joggers) and non-joggers (4,000), examined whether running was 
associated with all-cause mortality and cardiovascular mortality in healthy men and women [92]. 
In this study, running frequency, distance and speed were examined and the joggers were divided 
into 3 groups: low, moderate and strenuous/high intensity joggers (Figure 7). Researchers found 
that as expected, jogging was associated with lower mortality rates compared to non-jogging. 
The age adjusted increase in longevity for those who regularly jogged was 6.2 years for men and 
5.6 years for women [92] 
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Interestingly this study also found that up to 2.5 hours (150 minutes) of moderate intensity 
jogging per week (5-6 miles per week for ≤ 3 times per week) was associated with the lowest 
mortality rates (Figure 7). However, strenuous jogging ≥4 times per week at ≥ 7miles per hour 
appeared to increase risk for mortality. Thus, this study observed an unexpected U shaped 
curve/relationship with volume, frequency and intensity of jogging and mortality [91, 92]. As 
can be seen in Figure 7, this study found that the lowest CVD and all-cause mortality was among 
the low intensity joggers in relation to duration per week, frequency per week, and speed of 
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jogging. Moderate intensity joggers had a significantly higher cardiovascular mortality rate 
compared with low intensity joggers but still lower than sedentary individuals. Conversely, 
strenuous intensity joggers (≥7miles per hour) had a cardiovascular mortality rate that was not 
statistically different from that of non-joggers [91]. Thus, researchers suggest that strenuous/high 
intensity runners see no additional cardiovascular benefits compared to their sedentary 
counterparts.  
In support of the previous controversial findings, a recent study examined 55,000 adults 
between 18-100 years of age and followed them for 15 years. Analyses revealed that runners had 
a 30-45% lower overall risk of all-cause mortality, cardiovascular mortality and a higher life 
expectancy by 3 years compared to non-runners, even after controlling for age and gender. 
Additionally, running 50-120 min, ≤ 3 times per week at a modest pace of 6-7 miles per hour 
conferred the highest reductions in cardiovascular risk. However, similar to The Coppenhagen 
City Heart Study, higher doses of running (≥4 times per week) were associated with 33-50% 
higher risk for cardiovascular mortality compared to that seen with moderate doses of running 
[85].  
 In summary, there are limited studies examining the effects of high volumes of frequent 
vigorous aerobic exercise on risk for CVD in highly competitive endurance trained individuals. 
High volumes of strenuous endurance exercise may accelerate risk for CVD. The benefits of 
regular physical activity are well-established but long-term training for and competing in 
strenuous endurance events may predispose or accelerate cardiovascular issues that may not be 
seen at more moderate intensity physical activity [28, 29, 94, 95]. The literature appears to 
conclude that highest reductions in cardiovascular mortality rates is at ≤ 30 miles per week, < 4 
times per week, at 5-6 miles per hour of running or ≤ 46 miles of walking.  Typically, avid 
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marathon runners report weekly exercise in excess of 30 miles/week, 6-15 hours per week, >100 
METS per week, 6-7 days per week [96]. The number of people participating in marathons and 
multiple marathons a year is increasing yet there is scarce epidemiological data advising these 
populations on health benefits or the potential consequences of habitual strenuous exercise on 
cardiovascular health. A growing body of literature suggests that too much exercise may be 
detrimental for CVD risk. Moreover, the attenuation and potential reversal of the beneficial 
effects of exercise on CVD risk may be related to the underlying physiological cardiovascular 
responses to repeated exposure to vigorous endurance exercise.  
III. Cardiovascular Adaptations to Endurance Exercise: The “Athlete’s Heart” 
 Exercise and LV Remodeling  
 Endurance athletes engage in prolonged daily exercise thereby eliciting repeated 
increases in heart rate, blood pressure, stroke volume and cardiac output that consequently lead 
to increases cardiac mass and dimensions [97]. Endurance training places increased 
hemodynamic demand on the heart, that when repeated chronically throughout life acts as a 
physiological stimulus for cardiac adaptations [98]. The frequent increased blood flow generated 
by endurance training places a volume load on the ventricles which contributes to significant 
cardiac remodeling [82]. There are established upper limits of normal cardiac remodeling 
associated with “athlete’s heart” that are necessary to distinguish physiological from pathological 
adaptations. The magnitude of cardiac structural changes detected in athletes is large and if 
detected in the general population would indicate clinical cardiac abnormalities.   
 Previous studies utilizing echocardiography have clearly established a link between 
training and LV enlargement (9, 22). Conventionally, 2DE M-mode echocardiography was used 
to determine LV hypertrophy and dilation (23). Numerous cross sectional studies have examined 
20 
 
LV remodeling in endurance and strength trained athletes [99-106]. Overwhelmingly these 
studies found that LVM is significantly higher in athletes compared to controls [99-106]. 
Moreover, the data show that the highest degree of LV hypertrophy occurs in athletes with the 
largest body size and in those athletes participating in endurance sports. Hence, more recent 
studies control for body surface area, body fat percentage and/or lean body mass.  
Endurance and resistance exercise are associated with distinctly different LV structural 
adaptations. Cardiac adaptations to endurance exercise training and strength training are largely 
defined based on volume and pressure overload, respectively. Morganroth et al. first used 
echocardiography to image and define the athlete’s heart and stated that cardiac remodeling is 
specific to each training modality [99]. According to the “Morganroth Hypothesis” typically, 
endurance athletes engaging in continuous dynamic exercise (i.e. running), experience prolonged 
elevations in cardiac output (increases from 6 L/min to 40 L/min during intense exercise) [107], 
presenting the heart with a volume load. This stimulates eccentric cardiac hypertrophy, 
manifesting as an increase in LV internal dimension and mass with minor changes in LV wall 
thickness [8, 99]. Contrastingly, strength athletes (i.e. weight lifters) engaging in predominately 
static or isometric exercise, experience increases in blood pressure as high as approximately 
320/250 mmHg [108, 109], presenting the heart with a pressure load. This stimulates concentric 
LV hypertrophy, whereby LV wall thickness and mass increase, with little to no change in LV 
wall dimensions [12]. Athletes that incorporate both dynamic and static components (i.e. rowers 
and cyclists) exhibit a significant increase in LV wall thickness and even larger increase in LV 
internal dimensions. These athletes experience extreme pressure and volume loads on the 
myocardium. 
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 Additional aspects of myocardial remodeling in athletes include right ventricular chamber 
enlargement [110], atrial dilation [10] and mild aortic remodeling. Remodeling, specifically 
enlargement of the athlete’s LV, is beneficial in providing the ability for the heart to pump more 
blood with greater contractile force. However, a larger myocardium requires more oxygen 
consumption and energy and thus has greater metabolic requirements compared to a smaller 
myocardium. If increases in myocardial oxygen demand are not met, myocardial ischemia occurs 
and fibrosis can develop. Thus, LV hypertrophy is associated with myocardial fibrosis or 
scarring, which is a pathological substrate for arrhythmias and increased risk for SCD. Indeed, 
LV hypertrophy in endurance athletes may be of pathological concern. Recent studies have 
examined LV function in athletes at rest using cross-sectional designs [111]. Conventionally, 
ejection fraction has been used to measure LV function and this has been determined to be 
relatively normal in athletes except for a few studies [111]. Recent advances in functional 
cardiac imaging including LV strain measured by STE has also suggested that endurance training 
may lead to beneficial changes in LV function [112, 113] or in some cases diminished LV 
function at rest, that cannot be detected using LV ejection fraction. This paradox in the literature 
regarding LV function in athletes needs to be explored further.  
The athlete’s heart provokes controversial discussions with respect to its cardiovascular 
health implications and predispositions to disease. Traditionally, LV remodeling and hypertrophy 
in endurance athletes have been primarily attributed to volume overload placed on the heart 
chambers. Cardiac functional parameters may give better insight into LV structural adaptations 
and future risk for pathological adaptations in endurance-trained athletes. Additionally, evidence 
suggests increased chronic hemodynamic (arterial) load (i.e blood pressure, arterial stiffness and 
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wave reflections) may help to partially explain LV remodeling in response to long-term 
endurance training.  
Imaging of the Endurance Athlete’s Heart  
 Echocardiographic and MRI studies demonstrate that athletes have larger hearts [7, 12]. 
Recent developments in imaging technology enable researchers to assess in depth myocardial 
morphology and function. Conventional echocardiography techniques to measure structure and 
function include, M-mode, Tissue Doppler imaging (TDI) and 2-dimensional echocardiography 
(2DE), however these technique have limitations (Table 1). Recent developments in 3-
dimensional echocardiography (3DE) have helped provide more detailed morphological and 
functional myocardial measurements. [114]. 3DE offers more comprehensive details of LV 
remodeling as it can distinguish differences in length, shape of LV chamber, geometry, function 
and synchronicity of contraction between different populations, including athletes [49, 114]. 3DE 
evaluation of cardiac chamber volumes and mass avoids geometric assumptions made by 2DE 
acquisition and has the capability to assess regional LV wall motion and strain. As a novel 
imaging technique, 3DE is able to detect cardiac structure and function in a similar way to 
cardiac magnetic resonance imaging (CMRI). 3DE is as accurate as cardiac magnetic resonance 
imaging (considered the gold standard for assessing cardiac structure/function) for quantifying 
myocardial structure and function. 3DE has ideal image spatial resolution and quality that is not 
influenced by body size allowing for precise cardiac chamber size, mass and function 
measurements. Moreover, when 3DE is compared to CMRI in the assessment of ventricular 
morphology optimal intra-observer and inter-observer reliability is observed compared with 
other standard imaging techniques [49, 114, 115]. Therefore, 3DE is a reliable, accurate, novel 
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imaging technique that may provide novel insight into pathological versus physiological cardiac 
structural and functional adaptations in athletes.  
IV. LV Wall (Function) Mechanics and Strain Analysis  
LV wall function measured by Myocardial Strain 
Conventional cardiac imaging techniques only provide one-dimensional (linear motion) and two-
dimensional (horizontal and vertical components) quantifications of cardiac structure and 
function. Thus, these conventional techniques merely assume the actual geometric dimensions of 
the myocardium.  Physiologically, myocardial contraction occurs in three planes of motion as 
seen in Figure 8: longitudinal (base to apex) shortening, radial (endo- to epicardial) thickening 
and circumferential shortening (Figure 10). In simpler terms, an object may undergo motion 
and/or deformation. The motion of an object is determined by both 1) the distance it travels 
(displacement) and 2) by the time it takes for that object to arrive at its destination (velocity). 
However, not all objects that move undergo deformation or change shape. For instance, a stiff 
object that does not stretched readily may move but not change shape and thus, this moving 
object does not undergo deformation (as long as every part of the object moves at the same 
velocity). Thus this object has purely linear or translational velocity but the shape of the object 
remains the same. On the contrary, if different parts of the object have different velocities the 
object has to change shape, as different components of that object are being stretched to move at 
different times during its movement. This is exemplified in Figure 8, as the box is being 
deformed and stretched and compressed in different directions causing it to change shape. As 
compression/shortening occurs in one direction stretching or expansion in other directions 
balances this deformation. Thus, deformation is analogous to differential motion and local 
(regional) deformation is a proxy for global (total) deformation. The concepts of deformation and 
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motion can be applied to the heart, which has a stationary apex but mobile base. As the apex is 
stationary, the base moves toward the apex in systole (when the heart is contracting) and away 
from the apex in diastole. Thus, deformation of the heart is between zero (at the apex) and is at 
its maximum at the base. During the cardiac cycle as the heart contracts (is stretched) and relaxes 
the cardiac myofibers undergo motion, displacement and deformation. The magnitude of 
regional myocardial contraction is dependent on the local arrangement of myofibers within the 
myocardial wall at an angle of inclination with respect to the longitudinal axis of the ventricle 
[1]. 
 
 
 
 
 The segmental/regional function and the global function are of equal importance. Both regional 
and global functional components can be obtained from wall motion and deformation 
measurements. Wall motion is detected via displacement of the myofibers while wall 
Figure 2.8: Three planes of myocardial contractile motion and deformation: 
longitudinal, radial, circumferential, modified from Shiota et al. [114] 
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deformation is detected via strain analysis which is calculated as the initial length of the 
myofiber subtracted from the length of the myofiber at the end of contraction or relaxation 
divided by the initial length of the myofiber. Figure 11 represents the calculation of displacement 
and deformation of a single myofiber. As can be seen in Figure 11, Displacement is the 
difference between the position of a given point of the myocardial wall during the cardiac cycle 
and the position of the wall at the onset of the cycle (L-L0) (at QRS complex) [1]. Also 
represented in Figure 9, Deformation is the percentage of wall displacement during a point in the 
cardiac cycle from the onset of the cardiac cycle (E= L-L0/L0).  Deformation is measured by 
strain, which evaluates the degree of deformation in a particular wall segment in relation to its 
initial dimension (E= L-L0/L0) [1]. Systole would be met with longitudinal shortening, 
circumferential shortening and radial thickening. Conventionally, lengthening/thickening or 
stretching is indicated by positive strain values while shortening/thinning is indicated by negative 
strain values.  A higher strain value indicates optimal myocardial contractile 
function/deformation while a lower strain value indicates lower myocardial contractile function.   
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Speckle Tracking Echocardiography (STE) 
Advances in the field of echocardiography have allowed for an estimation of strain using speckle 
tracking technology (STE). STE is a novel method that estimates tissue velocities from grey 
scale imaging with high reproducibility of results and no angle dependence. STE is a pattern 
recognition software that tracks the speckle pattern throughout the cardiac cycle. These speckles 
are known as kernels that are placed on the myocardial wall during the analysis to track wall 
motion and calculate deformation. The kernel allows for identification of a specific area on the 
wall and then tracks it by identifying the kernel in the next frame. STE is a technique that is 
based on analysis of many of these speckles or kernels throughout the cardiac cycle. Changes in 
the speckle patterns can be assessed to determine the motion and deformation of the myocardial 
wall. Speckle tracking algorithms are used to track local tissue wall patterns of patches, which 
Figure 2.9: Standard calculation 
of 1D and 3D Myocardial 
Strain/deformation. 
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contain numerous speckles. The displacement of a single patch between two consecutive frames 
during the cardiac cycle corresponds to myocardial motion.  
 Older methods used to assess wall strain include Tissue Doppler Imaging (TDI) and 2DE 
[1]. Comparisons of the three methods of measuring myocardial function via strain are provided 
in Table 1. TDI generates detailed information regarding tissue velocities at any location in one 
dimension. TDI is a relatively easy method and can also estimate wall deformation and 
mechanics. However, TDI is limited to one dimension, is angle dependent and the wall mechanic 
measurements are noisy[1]. TDI velocities may also be heavily influenced by global heart 
translational movement and by blood flow. These issues cannot be fixed but may be reduced by 
having the patient hold their breath for several heart beats.  2DE strain is an approach for 
quantification of strain, strain rate, tissue velocity and displacement. However, this approach has 
limitations, principally due to the use of geometric assumptions, high inter-observer variability, 
probe positioning issues [1, 50]. 2DE is the most used technique however; the use of 3DE STE 
represents a further advancement in the field of STE that can overcome conventional limitations 
of the 2D STE irregular tracking.  
 Novel technology includes 3D strain analysis, which is ideal for evaluating the 
deformation of the 3D LV cavity. 3D strain properties include measurements in the longitudinal, 
circumferential, and radial planes of motion. 3D STE Strain analysis has the ability to link the 
cardiac contractile mechanics with the underlying cardiac structure and fiber arrangement. This 
improves the physiological understanding of the myocardial contraction. Future studies are 
necessary that utilize the capabilities of 3D STE to establish normative values and improve the 
accuracy of myocardial strain values.  
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Myocardial Strain Norms and Relationship to Disease States  
 Conventionally, myocardial function is measured by ejection fraction (i.e. the amount of 
blood pumped out of the heart); however, strain values may provide additional insight into LV 
Table 2.1: Strengths and Limitations of Echocardiography Techniques to 
Measure Myocardial Strain 
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systolic function. Longitudinal strain is associated with LV ejection fraction [116] and has 
proven useful in differentiating between different clinical and athletic populations [111, 117]. 
Strain is additionally sensitive enough to characterize differences between athletes, athletes with 
LVH and patients with HCM [118, 119].  
 Abnormalities in myocardial strain have been seen in early development of chronic 
diseases. Impaired longitudinal strain has been implicated in diabetes patients [120, 121], 
coronary artery disease [122], valvular disease [123], heart failure [124], and cardiomyopathies 
[125]. Studies have also determined that longitudinal strain is a predictor of LV remodeling and 
adverse events such as congestive heart failure and death [126]. Thus, impaired myocardial strain 
may be a marker for pathological adaptations.  
STE allows for novel comprehensive assessment of myocardial function across 
physiologic and pathologic states beyond traditional echocardiographic techniques. Strain 
parameters are influenced by age, gender, race, ethnicity, anthropometrics, heart rate, blood 
pressure, LV size and wall thickness. However, due to the novelty of STE, few studies have 
established how these variables might influence myocardial strain. However, normative values of 
deformation indices have been published from 2D TDI in healthy individuals [127-129].  
Kuznetsova et al. determined LV strain and strain rates in the general population (18-89 years 
old). Their study is the first comprehensive study to determine that longitudinal strain was 
similar in 480 men and women. Normative values of longitudinal strain were -22% (strain rate, 
1.31 s-1) and radial strain of -59.2% (strain rate, 3.40s-1). The mean range is 15-25% and 50-
70% for longitudinal and radial strain respectively [127]. Low longitudinal strain was reported to 
be 18.4% and low radial strain 44.3% with cut off values as normal is above 18.5% and 44.5%. 
Marwick et al. examined longitudinal strain in 242 individuals with an average age of 51 years 
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(44% men, 56% women) and found the average strain value to be -18.6% [129]. However, this 
study did not examine differences in strain values with age or sex.  
 Dalen et al. also performed a study that examined longitudinal strain to determine the 
global and segmental strain/strain rates according to sex and age in individuals with no known 
CVD [30]. This study included 1266 people (673 females, 623 males) of Norwegian descent in 
the HUNT (Norwegian Helseundersokelsen I Nord-trondelag) study using 2DE. Similar to 
Kuznetsova et al. with increased age strain is significantly reduced and strain values were 
significantly higher in women across all age groups [127]. The normative average values Dalen 
et al reported for global strain were -17.4% (strain rate, 1.05s-1) and -15.9% (strain rate -1.01 s-
1) in women and men respectively [30]. Thus, both gender and age were significant predictors of 
strain. Due to the novelty of 3DE there are no established normative values for 3DE and it is 
well-established that strain methodology is not interchangeable[1].  
Myocardial Strain in Athletes 
Cross sectional studies using both 2DE and 3DE have compared myocardial function, 
assessed by regional strain measurements, in various exercise-trained individuals [51-53]. Monte 
et al. compared myocardial performance using 3D STE in male strength trained, endurance 
trained (cyclists, swimmers) and sedentary individuals. They found that the strength-trained 
group had a significantly reduced longitudinal, circumferential, and radial strain. Even though 
both the endurance trained and strength trained athletes had similar increases in LVM, the 
reduction in LV function in strength-trained athletes was suggested to be due to reports of 
increased aortic stiffness and blood pressure in the strength athlete population [51].  In contrast, 
Poulsen et al. examined longitudinal strain using 2D STE in male non-competitive endurance-
trained, strength-trained and sedentary controls and found that the average strain was 
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significantly higher in strength athletes compared to both endurance athletes and controls [52]. 
Similarly, Demirelli et al. used 2D echocardiography to examine LV strain rates in retired male 
wrestlers (strength trained), marathoners and healthy controls and determined that after 10 years 
of cessation of organized exercise training, wrestlers had higher overall strain rate compared to 
both marathoners and controls [53]. The disagreement in these studies might be reflective of 
samples that include mixed athletic populations, varying years of training experience, which 
might influence values of strain.  
Myocardial Strain in Runners 
 In addition, cross-sectional studies have examined myocardial function in endurance 
trained individuals, specifically, marathon runners and there is some debate as to whether 
runners have higher or lower overall LV strain [3, 54, 130]. Szauder et al. compared 2DE LV 
strain in male ultra-marathon and marathon runners, body builders and controls. This study 
found similar morphological/structural changes (i.e. LV mass) in runners and body builders 
however, they observed that runners had the lowest global longitudinal strain which was 
inversely associated with increased LV-EDV, LV mass and BSA [3]. In contrast, Schattke et al. 
used 2DE to examine resting LV strain rate in amateur male and female marathon runners and 
compared these values to normative control values established in the literature by Dalen et al. [3, 
30]. This study observed higher strain rates in the marathoners compared to the reported strain 
rates in the general population. Thus, it was concluded that runners have higher myocardial 
performance compared to un-trained individuals.  
 These studies do not provide convincing data that endurance-trained runners have better 
or worse LV function when compared to their counterparts. Not only is there a lack of studies 
that examine LV function in endurance-trained athletes but also there are key methodological 
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differences in the current studies discussed. For instance, studies include mixed gender and 
inconsistent definitions of training status. The study performed by Schattke et al. examined 
amateur marathoners (20-30 miles/week) who may not be exposed to similar magnitude of long 
term strenuous high intensity exercise as more experienced competitive marathoners such as 
observed in the study by Szauder et al. (individuals who had trained for 5 or more years at 40-50 
miles/week). Additionally, longitudinal studies might be necessary to discern exercise-induced 
functional adaptations to the myocardium.  
Myocardial Strain in Response to Acute Exercise 
 Recent acute longitudinal studies have examined LV function following acute prolonged 
endurance exercise. Acute exercise studies have examined the effect of endurance exercise on 
measures of strain and strain rate by measuring LV function before and after marathons or ultra-
marathon races with some studies suggesting no change in LV function while others indicate a 
reduction LV function [2, 54-56]. Some data note temporary reductions in LV strain values in 
the longitudinal, radial and circumferential axis following prolonged exercise >180 minutes [2, 
131, 132]. Although transient, acute reductions in myocardial strain may compound over years of 
repeated exposure to high intensity endurance exercise and may thereby negatively impact LV 
function among life-long endurance athletes. However, there is currently no data that examines 
the effects of years of endurance training/competitions (i.e. marathon racing >3hours) on LV 
strain. Reductions in acute LV strain could predispose these well-trained individuals for the 
development of fibrosis and arrhythmias and ultimately, sudden cardiac death.  
 Both Table 2.2 and Table 2.3 summarize the studies that examine LV strain in athletes, 
and endurance athletes along with studies that have previously examined the impact of life-long 
endurance exercise on cardiovascular risk and adaptations. This area of research has a lot of 
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disagreement and it is important to highlight reasons for these discrepancies which might be 
related to lack of consistency with regards to age group studied, mixed gender samples, 
inconsistent definitions of training status, varying years of experience of the athletes in the 
studies. Ultimately, there are a lack of studies that have examined the impact of lifelong 
endurance exercise on risk for cardiovascular disease. Table 2.2 and Table 2.3 highlight some of 
these differences.  
 
Table 2.2: Summary of Studies  
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Table 2.3: Summary of studies examining impact of lifelong endurance exercise on risk for cardiovascular disease 
and cardiovascular adaptations.  
 
 
V. Central Hemodynamics: Arterial Stiffness, Wave Reflections  
Although the exact mechanism behind the documented reductions in LV strain among endurance 
athletes is unknown central hemodynamics may provide insight into reasons for reductions in LV 
strain with endurance exercise.  
Arterial Stiffness   
 Arterial stiffness refers to the material structural properties of the arterial wall and 
ultimately, influences the functional properties of the arterial wall as it affects blood pressure, 
blood flow and arterial diameter with each cardiac cycle [133]. Arterial stiffness can be 
measured in both peripheral muscular arteries and large/central elastic arteries. The elasticity of 
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the arteries depends on the properties of the arterial wall including elastin, collagen and smooth 
muscle. The peripheral muscular arteries (i.e. brachial) modulate vascular conductance (i.e. 
blood flow as it related to mean pressure) and have more smooth muscle content and collagen 
while the central elastic arteries contain more elastin [134, 135]. Large elastic arteries such as the 
aorta and the carotid arteries, modulate blood pressure and peripheral blood flow. These arteries 
passively transfer oxygenated blood from the heart to the peripheral arteries and tissues and 
actively buffer or dampen the hemodynamic impact of LV stroke volume that occurs with each 
heart contraction [136]. As can be seen in Figure 2.10, in a healthy elastic artery, as blood is 
ejected from the LV, the artery expands and contracts in response to blood flow and the blood 
travels slowly down the arterial tree.  
 
 During LV contraction, the large arteries act 
to dampen the pulsatile output of the LV 
changing the flow from rhythmic to 
continuous [133]. Interestingly, during systole, 
some of the blood pumped out of the LV is 
also stored in the large arteries and thus, the 
aorta acts as a reservoir. In a healthy vessel 
during systole, only a percentage of the stroke 
volume from the LV is ejected to the periphery 
while the rest is stored in the aorta. This stored potential energy helps to push the blood to the 
periphery. The continuous flow of blood from the aorta occurs due to the healthy elastic 
properties of the large arteries. Therefore, the arteries respond to the hemodynamic impact of the 
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LV stroke volume by expanding and storing the blood and recoiling during diastole, propelling 
the remaining blood forward, providing energy to drive the continuous blood flow throughout the 
arterial tree to the peripheral organs and tissues.  
 With age and in the absence of disease, the large arteries stiffen [34, 137]. Hypertension, 
inflammation, metabolic alterations and other diseases can change the structure and function of 
the arteries by degrading the elastin content and promoting collagen content resulting in the 
acceleration of increased arterial stiffness [135]. Increased arterial stiffness predicts adverse CV 
events independent of traditional risk factors, thus consideration of arterial stiffness may be 
useful in identifying individuals at intermediate risk for CVD [136, 138, 139]. In stiffer arteries 
the stroke volume that is stored during systole decreases, the energy stored in diastole decreases, 
and consequently, diastolic pressure decreases and more stroke volume is ejected to the 
periphery [140]. Increased arterial stiffness leads to increases in systolic blood pressure, 
decreases in diastolic blood pressure and ultimately, increases in pulse pressure. Increases in 
arterial stiffness reduce the buffering capacity of the large arteries and are more likely to transfer 
this pulsatile flow downstream causing damage to the vessels in other organs [141]. As can be 
seen in Figure 2.11, in a stiffer artery that is less elastic, as blood is ejected from the LV, the 
artery does not expand and contract readily to blood flow and blood travels much faster down the 
arterial tree.  
 
 
 
 
 
37 
 
Wave Reflections 
The relationship between LV and arterial stiffness is also influenced by wave reflections. 
As blood is ejected from the LV a blood pressure waveform is generated and is comprised of a 
forward and backward travelling wave [142]. Blood pressure is modulated by the elastic 
properties of the aorta/large arteries. When the blood pressure wave is generated by the LV a 
forward wave travels down the arterial tree. When this forward wave encounters various 
reflections sites, such as bifurcations or branches in the smaller arteries/vessels, areas of systemic 
vascular resistance or impedance (resistance to flow) the wave is reflected back towards the 
heart. This reflected wave is superimposed on the forward pressure wave and creates the blood 
pressure waveform that impacts cardiovascular function. The magnitude and speed of the 
reflected wave is dependent on the distance to the bifurcations, aortic stiffness and vasomotor 
function [143]. The timing and magnitude of these waves may ultimately impact cardiac 
function. Thus, wave reflections characterize the interaction between the heart and arterial load.  
 In healthy arteries, the forward pressure wave arrives towards the end of systole and then 
the superimposition of the backward and forward waves occurs during diastole. Thus, under 
optimal conditions the forward wave largely establishes systolic blood pressure, while the 
backward wave maintains or increases diastolic blood pressure [134]. In a healthy elastic artery, 
there is optimal continuous flow and no unnecessary increases in LV afterload or load at against 
which the ventricular contracts to eject blood. In stiffer arteries, the forward and backward waves 
travel faster along the arterial tree. Thus, increased arterial stiffness causes the backward wave to 
arrive in early systole, augmenting systolic pressure [134, 135]. This augmented pressure from 
wave reflections increases systolic pressure and subsequently, increases afterload. Additionally, 
there is less pressure arriving in diastole so there is a reduction in both diastolic pressure and the 
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pressure gradient driving coronary perfusion.  Increased arterial stiffness may lead to increases in 
systolic blood pressure and decreases in diastolic blood pressure through increases in wave 
reflections. These alterations to the arterial load, increases LV afterload and myocardial work, 
leading to reductions in coronary perfusion, ultimately influencing the magnitude of LV function 
and structural remodeling.  
Arterial Stiffness, Wave Reflections and LV Structure and Function  
 Adequate coupling between the left ventricle and the arterial system results in optimal 
transfer of blood from the LV to the periphery (optimal efficiency) without excessive changes in 
pressure [4]. Thus, increased arterial stiffness may negatively affect cardiac function through this 
relationship. Increases in arterial stiffness with age are coupled with an increase in ventricular 
stiffness most likely as a means to maintain the ventricular-vascular coupling. Although acutely 
this coupling may indicate enhanced contractility, chronically this adaptation can reflect 
structural adaptations in the myocardium which ultimately, reduce contractility [36]. Increased 
arterial stiffness and pressure due to wave reflections can increase LV systolic load, which may 
lead to ventricular remodeling and cardiac dysfunction. 
 LV remodeling may result in a dilated ventricle leading to an increase in myocardial 
oxygen demand [144] and consequently a reduction in diastolic coronary perfusion as systolic 
pressure increases and diastolic pressure decreases [36]. Increased arterial stiffness can lead to 
LV diastolic dysfunction, which increases cardiac filling pressure (preload) and limits coronary 
perfusion [145, 146].  LV remodeling and increases in LV mass can occur due to wall thickening 
in response to pressure overload or from chamber dilation due to volume overload. Therefore, 
ventricular enlargement may be due to increased arterial stiffness, which increases both 
myocardial oxygen demand and pressure load from the peripheral arteries (i.e. vascular 
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afterload). Lastly, increased arterial stiffness may also influence myocardial function [35]. In 
hypertensive individuals, increased arterial stiffness contributes to altered LV function 
manifested as a reduction in LV strain (150). Increased arterial stiffness coupled with increases 
in wave reflections may potentiate the development of LV dysfunction and ultimately LV 
hypertrophy.   
VI. Arterial Stiffness, Wave Reflections, and Endurance Exercise  
 Generally, endurance exercise reduces arterial stiffness and pressure from wave 
reflections [147-152]. Endurance athletes generally exhibit lower arterial stiffness and wave 
reflections compared to their sedentary or recreationally active counterparts [153, 154]. 
However, some studies suggest that strenuous long-term endurance exercise training and acute 
endurance exercise may increase arterial stiffness and wave reflections [41, 148, 153] [40].  
 Recent cross-sectional studies have observed higher arterial stiffness in marathon [40], 
and ultra-marathon [41] runners, suggesting that repetitive high intensity exercise may lead to 
increased arterial stiffness [95, 155-157]. Vlachopoulos et al. examined 49 endurance trained 
men and found that marathoners had increased arterial stiffness and blood pressure but similar 
wave reflections when compared to sedentary controls [40]. More importantly, in this study 
exercise volume was a predictor of increased arterial stiffness in marathon runners who trained 
for over 11 years. In another study, Burr et al. studied 18 veteran ultra-marathon runners and 
found that the ultra-runners had increased arterial stiffness compared to age-matched untrained 
controls [41]. These studies suggest that high volumes of strenuous endurance exercise may lead 
to increased arterial stiffness in relatively healthy adults.  
 In contrast, additional cross-sectional studies note no differences in arterial stiffness [148] 
or lower stiffness [158] in marathon runners compared to controls. Nualnim et al. showed a 
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lower arterial stiffness in runners and swimmers compared to sedentary controls [148]. Similarly, 
Radtke et al. examined arterial stiffness in 51 non-elite middle-aged male marathons, ultra-
marathon runners and controls and found that there were no differences between the three 
groups. Thus, they concluded that strenuous endurance exercise did not have a negative impact 
on indices of arterial stiffness; however, their recreationally active controls performed the same 
volume of exercise per week as the marathon runners and had previously run marathons. Thus, 
the recreationally active group may not have been a true control group, which leaves the 
conclusions of this study questionable. Furthermore, the studies that found lower arterial stiffness 
in endurance athletes did not examine veteran athletes who have years of training/racing 
experience.  
In addition to cross-sectional studies, acute exercise studies in men demonstrate that 
following acute strenuous prolonged exercise (i.e. marathon race, ultra-race) runners have 
increased arterial stiffness with no change in wave reflections [40, 41, 159]. For instance, Burr et 
al. suggest that arterial stiffness is transiently increased following an ultra-marathon race while 
Muller et al. showed that arterial stiffness is increased during an acute bout of strenuous aerobic 
exercise [41, 159]. These studies undermine the question of whether these acute increases in 
arterial stiffness due to strenuous endurance exercise sessions may lead to chronic increased 
arterial stiffness. This hypothesis might be more readily examined in individuals who engage in 
repeated bouts of strenuous endurance exercise over years of training.  
 Traditionally, regular aerobic exercise induces repetitive bouts of augmented blood flow 
that may modulate decreases in arterial stiffness that is observed with most exercise training 
[160]. Contrastingly, prolonged habitual vigorous exercise such as marathon running may 
increase arterial stiffness over time by increasing inflammation [161], increasing catecholamines, 
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producing excessive oxidative stress and vasoconstrictor substances [162]. Additionally, 
increased arterial stiffness resulting from high intensity endurance training may be due to 
reductions in vasodilator capacity [162-165]. Based on these mechanisms and in accordance with 
conclusions made by several epidemiological studies on physical activity levels and risk for 
CVD, habitual strenuous exercise such as marathon running may result in a U-shaped curve with 
arterial stiffness; no exercise leads to high arterial stiffness while some exercise is associated 
with the low arterial stiffness and high/excessive amounts of endurance exercise is associated 
with high arterial stiffness and comparable levels to those who do not exercise.  
 Future studies are warranted to examine whether excessive endurance exercise may lead 
to increased arterial stiffness and wave reflections in endurance-trained athletes. The current 
disparities in studies investigating arterial stiffness in endurance athletes may be due to the study 
of only male athletes, inclusion of athletes from different training modalities/histories, and a lack 
of consistent control group (active vs. sedentary). Future studies should follow these 
considerations to help determine the effect of lifelong endurance exercise on central 
hemodynamics.   
VII. Sex Differences in LV Structure, LV Function and Central Hemodynamics  
Origins of sex differences in cardiovascular physiology 
 There are notable sex differences in risk for CVD throughout the lifespan. Sex 
differences in risk for CVD primarily stem from the influence of menstrual cycle hormones on 
female cardiovascular physiology. Increased age in women is accompanied by reductions in 
estrogen concentrations. Indeed, after menopause the risk for CVD is greater in women than in 
men. The role of estrogen in cardiac physiology remains to be examined, as it is known that 
cardiac myocytes have functional estrogen receptors such that estrogen may attenuate cardiac 
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hypertrophy [17].  Estrogen has been implicated in the slowed progression of heart failure and 
may also be protective in the development of LVH. Additionally, estrogen receptors are located 
on the vascular wall and estrogen is a potent vasodilator. Arterial stiffness is modulated by 
estrogen concentrations, as low estrogen levels in post-menopausal women are associated with 
increases in arterial stiffness [166]. Thus, the disparity in risk for CVD between men and women 
may be partially explained by consequential sex differences in cardiac and arterial function and 
structure.  
Sex differences in LV Structural Adaptations to Endurance Exercise  
 There are profound sex differences in ventricular adaptations to endurance exercise. 
Ventricular adaptations to endurance exercise are less pronounced in women compared to men 
[17-24]. Cross sectional studies reveal that female athletes display smaller LV mass and volumes 
compared to male athletes [21] even after adjusting for body size and lean body mass [22, 25, 
26]. Pelliccia et al. reported 2DE characteristics of 600 Olympic female athletes by sport to 
determine the normal structural LV adaptations in female athletes. Additionally, this study 
compared the 600 female athletes to 738 elite male athletes of similar age, ethnicity, intensity of 
training and competition, and level of achievement. LVM was significantly higher in male 
athletes compared to female athletes. Interestingly, LVM was still 31% lower in female athletes 
(80 g/m2) compared to male athletes (105 g/m2) indexed for body surface area [19]. George et al. 
examined 10 university female endurance athletes and found that mean LVM expressed to fat 
free mass to be significantly lower than male athletes [18]. However, Morales et al. found no 
significant sex differences in LVM in training-matched distance runners when expressed for 
FFM or BSA [24] while Rowland et al. found that when training volume, body size and 
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composition are considered male endurance athletes have greater cardiac dimensions and mass 
compared to their female counterparts [22].   
 Additional cross sectional studies compared LVM in male and female cross-country 
skiers and distance runners and found a 25% greater relative LVM in trained males compared to 
trained females but found no difference between untrained males and females [18]. In long 
distance runners, Mumford et al. observed not only a 34% greater relative LVM in trained males 
compared to trained females but also reported 20% greater LVM in untrained males compared to 
untrained females [20]. Similarly, Smith et al. examined sex differences in LVM in highly 
trained athletes and normally active individuals LVM in trained males was higher compared to 
trained female athletes and reported a similar magnitude of difference between LVM in 
untrained males and females. These studies suggest that there are physiological sex differences in 
untrained individuals and sex differences in training adaptations. 
 Longitudinal studies suggest that sex differences may not be solely due to inherent 
biological differences but also due to difference in the response to endurance exercise training 
[17, 20, 167]. These studies report significant sex differences in LV adaptations to endurance 
training [17]. Recently, Arbab-Zadeh et al. demonstrated that sedentary individuals who 
underwent 1 year of intensive endurance training had increases in cardiac mass to levels similar 
to that observed in elite endurance athletes [168]. In a second study, researchers examined 
whether males or females experienced similar cardiovascular adaptations to 1 year of endurance 
training when matched for volume and intensity. Twelve previously sedentary males and females 
underwent an intensive endurance-training program for 1 year. Both females and males 
experienced significant increases in LVM but males had a greater increase in LVM compared to 
females. The results of the study indicated that males had a more pronounced LV hypertrophy 
44 
 
adaptation throughout the 1-year program while females reached the maximal LVM after 3 
months of training. This data indicates clear sex differences in the cardiac response to endurance 
training even when males and females were subjected to the same training stimulus and volume 
[17]. Contrastingly, previous studies have observed no significant differences in the 
cardiovascular response in males and females to 90 days of intense endurance training [169], 
which is a much shorter training duration than 1 year. Sex differences may only be apparent in 
response to long-term training. Future studies need to examine sex differences in response life-
long endurance-training men and women. However, before a longitudinal study is completed 
cross sectional studies are necessary to determine possible reasons for the sex differences in LV 
adaptations. Sex differences in structural cardiac adaptations to endurance training may be 
related to sex differences in LV function.  
Sex Differences in LV Function in Response to Endurance Exercise 
 There is limited data regarding sex differences in LV function/strain in endurance 
athletes. Nonetheless there are a few studies that examine LV function in response to acute 
endurance exercise. A study by Scott et al. found sex differences in LV function in amateur 
triathletes following a half-ironman triathlon race performed at 80% of their maximum heart rate. 
This study examined 9 males triathletes and 8 female triathletes who had 2 years of training 
experience. The main findings of this study suggest that LV function decreased to a greater 
extent in males compared to females following prolonged exercise [170]. Similarly, Cote et al. 
performed an additional study that examined ventricular strain in endurance-trained and 
normally active males (11 males) and females (9 females) following high-intensity bout of 
cycling exercise of approximately 45 minutes of exercise. This study found that men had 
significantly reduced strain following a bout of high intensity cycling compared to females [171]. 
45 
 
MacGavock et al. examined LV function at rest and in response to prolonged strenuous exercise 
in female triathletes. Participants performed a 40km cycling time trial followed by a 10km run at 
approximately 90% of their maximum heart rate. Contrary to the hypothesis that prolonged 
exercise would elicit a reduction in LV function, this study found an enhanced LV function 
following 2 hours of strenuous exercise in female triathletes [172]. These studies suggest there 
might be sex differences in cardiac function in response to acute strenuous endurance exercise.  
 In contrast, Cote et al. found that women and men had similar exercise induced LV 
dysfunction following an ultra-marathon race. This study used 2DE to examine 34 athletes (21 
males, 13 females) with an average of 14 lifetime ultra-marathons each over an average of a 5-
year period had their LV function and structure measured before and after an ultra-endurance 
race [173]. Sex differences in acute LV dysfunction following prolonged endurance exercise 
may become chronic sex differences LV function as endurance athletes engage in daily exercise 
sessions and compete in multiple endurance events. There are limited studies that examine sex 
differences in LV function in endurance-trained athletes and the current studies available use 
different methodologies (TDI, 2DE, vs. 3DE) making it difficult to compare results.  Future 
studies need to examine sex differences in LV function and how it relates to LV structure to 
determine whether sex differences in LV function might explain sex differences in LV structure. 
The underlying mechanisms and reasons for sex differences in LV structural adaptations to 
endurance exercise are unknown, however numerous factors may be at play. 
Possible Mechanisms for Sex differences in LV Structural Adaptations to Endurance Exercise  
 Current potential mechanisms that might help to explain sex differences in LV 
adaptations with endurance exercise might be differences in sympathetic nervous system 
function [170, 171] and androgenous hormones. Women have a greater parasympathetic 
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predominance both at rest and in response to exercise while men have a greater sympathetic 
activation [170, 171]. Increased sympathetic activation is associated with increased myocardial 
contractility, subsequently leading to higher SV and cardiac output and thus, larger LVM. 
Increased sympathetic activity in males may explain sex differences in LV adaptations with 
exercise. Studies suggest that the relationship between muscle sympathetic nerve activity 
(MSNA) and wave reflections is dependent on sex [174] [175]. Increased MSNA is associated 
with increased wave reflections in men, however increased MSNA is associated with a decrease 
in wave reflections in women [174, 175].  Thus, the sympathetic beta-adrenergic receptor 
activity in women may be unregulated or more sensitive than that in men [174, 175]. In addition, 
the role of estrogen in cardiac physiology remains to be examined, as it is known that cardiac 
myocytes have functional estrogen receptors such that estrogen may modulate cardiac 
hypertrophy. High estrogen concentrations may also be associated with slower progression of 
heart failure. High estrogen concentrations in pre-menopausal women may give insight into why 
females may have attenuated cardiac structural hypertrophy compared to males in response to 
endurance training. More importantly, considering the influence of estrogen on the vasculature, 
sex differences in arterial stiffness and wave reflections may also provide a novel insight into 
differential LV remodeling in endurance athletes.  
Sex differences in Central Hemodynamics at Rest 
 Numerous studies have noted sex differences in resting arterial stiffness and wave 
reflections [31-33]. Men are reported to have higher arterial stiffness when compared to 
premenopausal women until the age of 60 years when women enter menopause and 
subsequently, have higher arterial stiffness compared to men [45]. Interestingly, the association 
between arterial stiffness, wave reflections and LV mass is greater in women than in men [146]. 
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Women have a larger reflected wave magnitude then men, which may be due to a smaller stature 
and shorter height of women. Such biological characteristics are associated with a reduced 
distance between the heart and the peripheral reflecting sites [34] and greater taper of the arteries 
between the aorta and the periphery [46]. However, one study examined prepubescent children 
and showed that girls had significantly higher augmentation index even when compared to boys 
of the same age and height [176]. Thus, body height may not account for all sex differences in 
wave reflections [176]. Given that women have greater wave reflections compared to men and 
there are known differences in arterial stiffness, sex differences in central hemodynamic load 
may influence LV afterload, function and structural remodeling [47, 48, 176].  
Sex differences in central hemodynamics in response to acute exercise  
 In addition to sex differences in central hemodynamics at rest there are also sex 
differences in central hemodynamics in response to acute exercise. Studies in men suggest that 
strenuous high intensity exercise may lead to increased arterial stiffness with no change in wave 
reflections [40, 41]. Conversely, women experience reductions in large artery stiffness and wave 
reflections following acute high intensity/high volume exercise [34, 42-48]. Few studies have 
examined sex differences in central hemodynamic load in response to prolonged exercise. 
Nieman et al. examined arterial stiffness in 16 runners (8 males, 8 females) before and after a 2-
hour intense run on a treadmill. This study noted a significant decrease in arterial stiffness, blood 
pressure and augmentation index following the prolonged run in females but noted no change in 
arterial stiffness and augmentation index and a significant increase in blood pressure following 
the 2-hour run in males. Thus this study concluded that there seems to be a sex difference in the 
recovery pattern of central hemodynamics following prolonged exercise [43]. However, this 
study had a small sample size and did not measure cardiac mass or function to determine whether 
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the relationship between central hemodynamics, LV mass and function in endurance-trained 
individuals explains the sex difference in LV adaptation to endurance exercise.  
 Cote et al. found similar exercise induced cardiac fatigue in men and women following 
an ultra-marathon but interestingly found that individuals with lower baseline arterial stiffness 
had less cardiac fatigue following the ultra-marathon race. This novel finding suggests there is a 
relationship between arterial stiffness and altered ventricular function. The relationship between 
ventricular function and arterial function is well recognized and a central determinant of 
cardiovascular performance and function [177]. This novel finding suggests there may be a 
relationship between arterial stiffness and altered ventricular function.  
 Additionally, differences in resting and exercise blood pressure might explain sex 
differences in LV mass in endurance athletes. Women are reported to have lower resting blood 
pressure and peak exercise blood pressure compared to men [42, 178, 179]. There is a well-
established relationship between LVM, LVH and resting and exercise brachial blood pressure. 
Studies suggest that even in the absence of hypertension exaggerated blood pressure during 
exercise is related to an increased prevalence of LVH [180-182]. Thus, a greater blood pressure 
during exercise could be a reflection of similar blood pressure responses throughout the day to 
various physical and emotional stimuli [183].  
 The differential central hemodynamics at rest, during and in response to acute strenuous 
endurance exercise likely suggests day-to-day variation in central hemodynamic load that may 
differ by sex. The day-to-day variation may subsequently lead to different cumulative central 
hemodynamic load, which may likely influence LV structural adaptations. This is important 
because endurance athletes train daily for years and complete numerous endurance races thus, 
are repeatedly exposed to this underlying central hemodynamic load. Thus, sex differences in 24-
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hour (daily) cumulative hemodynamic load may explain sex differences in LV adaptations to 
endurance training.  
Sex Differences in Central Hemodynamic Load/Central Hemodynamic load in athletes 
 Central hemodynamic load is defined as the cumulative effects of arterial load overtime: 
arterial stiffness, blood pressure and wave reflections. Central hemodynamic load may mediate 
LV remodeling and subsequently explain magnitude of LV function and structural remodeling in 
endurance athletes. Considering the hemodynamic principles and the diurnal variability in blood 
pressure [184, 185] and hemodynamics examination of 24-hour central hemodynamic load may 
provide a mechanism for LV adaptation.  
 Studies have examined the association of increased blood pressure and incidence of 
hypertension and end target organ damage [186-189]. Although the traditional oscillatory blood 
pressure that is taken in clinical practice has been utilized for decades, this measurement only 
provides a single point measurement that is typically taken under conditions that influence blood 
pressure. A single clinical measurement of brachial systolic blood pressure and diastolic blood 
pressure alone provides only indirect information about the adequacy of tissue and organ 
perfusion. In order to overcome the limitations of office visit blood pressure, techniques to obtain 
automated blood pressure over a 24-hour period have been developed. In fact, underlying blood 
pressure in hypertensive individuals cannot be confirmed without an out of clinic blood pressure 
measurement such as a 24-hour ambulatory blood pressure [190].  Measurement of chronic 
hemodynamic load can thus, be achieved via 24-hour ambulatory monitoring device.  
 Only one known study has examined 24-hour blood pressure in male and female athletes 
to directly explore the sex differences in LV mass with exercise training [42]. Zemva et al. 
examined 24-hour brachial blood pressure in male and female dancers to determine whether 
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there are sex differences in 24-hour blood pressure that may give insight into apparent sex 
differences in LV mass with exercise training.  This study chose to assess dancers in their study 
since dance partners presumably are exposed to the same training stimulus. This study found 
significant differences in LVM, resting and 24-hour blood pressure between male and female 
dancers [42]. Female dancers had a lower LVM, which was related to a lower peak exercise 
blood pressure, resting blood pressure and 24 hour blood pressure compared to male dancers. 
Thus, lower LVM in female dancers could be partially explained by lower 24-hour systolic blood 
pressure. However, this study did not examine endurance athletes and only reported measures of 
24-hour brachial blood pressure and did not examine resting or 24-hour central blood pressure, 
arterial stiffness or wave reflections, which may provide more insight into sex differences in LV 
mass.  
It is well established that systolic blood pressure and pulse pressure are higher in the 
peripheral arteries compared to the central arteries. This “amplification” of pressure is largely 
due to the progressive decrease in arterial diameter and increase in arterial stiffness down the 
arterial tree [134, 135]. Thus, central pressures are more important than brachial/peripheral 
pressures in determining risk for CVD [135]. After all, it is central systolic pressure that the heart 
ejects against (afterload) and it is central pulse pressure that expands the arteries. Central systolic 
blood pressure and pulse pressure are highly associated with LVH, hypertension and end target 
organ damage in multiple populations [191, 192]. Indeed, studies show that central pressures are 
better predictors of cardiovascular outcomes than peripheral/brachial pressures [193]. For these 
reasons measurements of central pressures are advantageous.  
Therefore, to further our understanding of the central hemodynamics of the circulation, 
efforts over the last several decades have sought to noninvasively assess central blood pressure. 
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Analysis of the arterial waveform allows researchers to dissect out the relative contributions of 
LV ejection and wave reflection, and to discern the longitudinal effects of these interactions on 
the myocardium. Thus, the development of non-invasive 24-h central hemodynamic load 
provides insight into the structure and function of the LV weber [194]. Sex differences in resting 
central hemodynamics, and the hemodynamic response to acute exercise may lead to chronic 
hemodynamic differences that may lead to differential LV afterload and ultimately modulate LV 
function and structural remodeling in endurance athletes. 
VIII. Proposed Study 
The purpose of the proposed study is to examine sex differences in 1) LV structure, 2) LV 
function, and 3) 24-central hemodynamic load in endurance athletes and recreationally active 
controls.  
It is hypothesized that endurance-trained women will have lower LV mass (adjusted for body 
surface area and body composition) compared to endurance-trained men and higher LV mass 
compared to recreationally active women. Endurance-trained men will have higher LV mass 
compared to recreationally active men. Further we hypothesize that endurance-trained women 
will have higher function (i.e. higher strain) compared to endurance-trained men and 
recreationally active women. Endurance-trained men will have similar LV function compared to 
recreationally active men. Lastly, we believe that endurance-trained women will have a lower 
24-hour central hemodynamic load (blood pressure, arterial stiffness, and pressure from wave 
reflections) at rest and following exercise compared to endurance-trained men and recreationally 
active women and endurance-trained men will have a similar 24-hour central hemodynamic load 
to recreationally active (Figure 10).  
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Significance  
 CVD is the leading cause of morbidity and mortality in women in the United States 
[195]. With increasing age, risk for CVD in women exceeds that in men [196]. It is expected that 
by 2020 approximately 20% of the population of the United States will be 65 years or older 
[197]. In order to improve cardiovascular health, it is essential that implement strategies of early 
prevention in midlife, targeting at risk populations, such as women, is critical. As women age, 
they experience greater increases in artery stiffness and wave reflections which contributes to 
reduced LV function and LV mass and ultimately increased incidence of heart failure.  
Figure 2.12: Theoretical Framework  
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 Aerobic exercise is a well-established and effective lifestyle strategy to attenuate risk for 
CVD in women [198-200]. Over the past 30 years there has been a steady increase in the number 
of women racing competitive endurance events such as marathons. However, there is little 
research examining the effects of this chronic strenuous endurance exercise training on 
cardiovascular health in women. Recent research in men suggests the potential for adverse 
ventricular remodeling and myocardial fibrosis, which may lead to cardiac arrhythmias and 
sudden cardiac death [27-29]. However, there is evidence to suggest that women may actually be 
cardio-protected from this type of strenuous exercise. Pre-menopausal women are reported to 
have attenuated ventricular remodeling in response to strenuous endurance training even when 
women are subjected to the same training duration and stimulus as men [17]. Thus, pre-
menopausal women may never approach pathological thresholds of ventricular remodeling. As 
such, there may be a level of cardio-protection afforded by female sex with regards to potentially 
adverse LV functional and structural adaptations to endurance exercise, but this has yet to be 
explored. 
  Despite increased female participation in competitive endurance events, minimal 
advances have been made beyond these findings to examine the cardiovascular adaptations to 
prolonged endurance exercise in women. Future studies are necessary to discern the hypothesis 
that excessive endurance exercise may lead to fibrosis and premature death. The public impact of 
this hypothesis that high intensity-high volume exercise might promote pathologic adaptations is 
substantial for both athletes and patients with CVD [89]. This is even more relevant considering 
the recent evidence that was presented suggesting that small amounts of exercise may be more 
than ideal in preventing the development of CVD [85]. Our understanding of exercise-induced 
LV remodeling has advanced tremendously in the past decade due to developments in 
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technology and cardiac imaging. However, our understanding of how extreme exercise 
modalities, such as marathon running, positively or negatively affect risk for CVD is still 
unclear.  
Innovation 
 This study will examine whether sex differences in central hemodynamic load are related 
to sex-specific ventricular functional and structural adaptations in endurance athletes. More 
importantly, the results of the current study will provide information on cardiac adaptations in 
not only endurance-trained men but also endurance-trained women.  
      First, the proposed study is novel in how we propose to measure LV structure and function. 
Sex differences in LV morphology may be confounded by scalar variables such as body size. 
Smaller body size is associated with smaller LVM while larger body size is associated with 
larger LVM and volume.  As such, cardiac metrics are often expressed relative to body surface 
area (BSA). Typically, heart size measures (LV mass) adjust for BSA indirectly using 2D BSA, 
Currently, most clinicians use an equation to indirectly measure BSA, which was adopted in 
1916 (Dubois and Dubois, 1916). However, these conventional 2D BSA methods often 
underestimate BSA, as they cannot depict the 3D nature of the body. The 3D body scanner is a 
novel method that is able to examine body contour and definition resulting in more accurate BSA 
measurements compared to 2D methodology. 3D BSA is able to measure cross-sectional area 
and slice area in addition to surface area. Also, 3D BSA measurements allows for rotation of the 
3D image so the entire anatomic surface area can be fully captured. In the proposed study, we 
will directly measure BSA using a novel 3D body scanner and adjust our LVM measures for 3D 
BSA.  
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 We will also measure LV function using 3D STE, which is novel technology to assess 
both regional and global LV strain in endurance athletes. As previously outlined in Table 1 in 
Chapter 2, there are many limitations to assessing LV function using conventional TDI and 2DE 
techniques that are overcome by using 3DE. Similar to the benefits of using 3DE to measure LV 
structure, using 3DE to measure LV function allows for a more sensitive, comprehensive picture 
of myocardial function. 3DE STE can simultaneously provide strain values in three planes of 
motion, which may mitigate the effect of beat-to-beat variation in LV contraction on strain 
values. Only a few studies have utilized the capabilities of the 3DE STE to examine cardiac 
structure and function in athletes and no study has directly examined both LV function and 
structure in both male and female endurance-trained athletes.  
In our study, we will recruit a healthy recreationally active control group rather than an 
sedentary control group. Studies that utilize a sedentary control group are assuming that 
sedentary individuals are healthy controls. The U.S Centers of Disease Control (CDC) have 
identified that physical inactivity or sedentary behavior may be an “actual” cause of chronic 
disease [201]. Recreationally active individuals are much healthier than sedentary individuals. A 
sedentary lifestyle is not a healthy lifestyle and is extensively associated with Alzheimer’s 
Disease, Cancer, atherosclerosis, obesity, osteoporosis, Type 2 Diabetes, and sarcopenia [202]. 
Moreover, as it pertains to the proposed study, sedentary behavior is associated with increased 
arterial stiffness, augmentation index, intima media wall thickness (IMT), and thus, subclinical 
atherosclerosis [203, 204]. Therefore, if a sedentary group is used as a control group in exercise-
related studies it may perpetuate misinterpretation of results such that sedentary group is healthy 
when in reality this group is more than likely not a healthy population. It is for these reasons that 
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we propose to recruit recreationally active adults rather than sedentary adults for our control 
group.  
 Additionally, we will use a validated oscillometric 24h ambulatory device to monitor central 
hemodynamic load in endurance trained women and men. This device assesses not only 24-hour 
peripheral/brachial blood pressure but also central blood pressure, together with estimations of 
pressure from wave reflections and aortic stiffness. Only study has examined chronic 
hemodynamic load in endurance trained men and women and of those studies, brachial blood 
pressure was used as the measure of hemodynamic load [42]. However, as previously discussed 
brachial pressure is noted to be a poor surrogate for cardiovascular disease risk and central 
hemodynamic load experienced by the LV. Central blood pressure is more predictive of LV 
mass, cardiac events and prognosis [205, 206]. Additionally, consequences of increased arterial 
stiffness and wave reflections on CV mortality are well established [207]. This approach will 
allow us to directly determine whether day-to-day hemodynamic load is associated with the sex-
specific adaptations in ventricular function and remodeling in endurance-trained athletes.  
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Chapter III: Preliminary and Feasibility Data 
 Preliminary and Feasibility Data. The student principal investigator has extensive experience 
with the vascular measures and research methodology required in the proposed study and has 
personally collected all feasibility/preliminary data presented below. The PI has been involved in 
research in the Human Performance Laboratory throughout her MS/PhD and is familiar with al 
physiological measures described in the methodology and preliminary data section. The PI has 
collected data on over 400 participants (9-89 years old) in the Human Performance Laboratory in 
the past 7 years.  
Preliminary research of Principal Investigator  
Primarily my research has focused on the influence of sex on vascular adaptations to endurance 
and resistance exercise and how differential responses to exercise may explain sex differences in 
risk for cardiovascular disease. The previous work of the PI is discussed below as it relates to 
the current proposal.  
Sex differences in responses to exercise and other physiological stimuli 
 Recently in two separate studies, the student PI examined how chronic high intensity endurance 
exercise in women might influence risk for atherosclerosis in amenorrheic (i.e. hypoestrogenic) 
women [208]  and how being physically fit and centrally obese might modulate risk for 
cardiovascular disease in women [209]. We found that endurance trained women (n=28) who 
engaged in chronic strenuous endurance exercise had lower arterial stiffness (PWV, p<0.05) and 
wave reflections (AIx, p<0.05) compared to their sedentary counterparts (n=15) [208] (Table 1). 
These findings indicated that amenorrheic women have reduced vascular function but no 
structural abnormalities. Thus, they may not have increased risk for CVD. Measures of LV 
afterload and coronary perfusion were also measured. LV wasted pressure effort (LVWPE) is a 
58 
 
measure of LV afterload due to wave reflections and is associated with LV remodeling and 
hypertrophy [210]. Diastolic pressure time integral (DPTI) is an estimate of oxygen supply while 
systolic pressure time integral (SPTI) is a measure of LV work or oxygen demand [210]. The 
ratio of oxygen supply/demand is the sub-endocardial viability ratio (SEVR)[210]. We found 
that endurance-trained women had lower LV afterload (p<0.05) as indicated by a lower SPTI and 
LVWPE and greater coronary/myocardial perfusion as indicated by a higher SEVR and DPTI 
than the sedentary controls (p<0.05). Thus, the endurance-trained women displayed no mismatch 
between oxygen demand and supply suggesting the potential for attenuated ventricular 
remodeling (Table 1). These results differ from previous studies in men that suggest endurance-
trained men may have higher or similar level of arterial stiffness and wave reflections, and 
substantial LV remodeling compared to sedentary counterparts [40].  
 
 
 Additionally, the student PI performed an independent study to examine whether the 
menstrual cycle influences the vascular response to resistance exercise. This study found that the 
response to resistance exercise did not differ between menstrual cycle phases and thus estrogen 
may not modulate vascular responses to resistance exercise in women. In this study, we used the 
proposed ambulatory brachial oscillometric device (Mobil-o-graph) and applanation tonometry 
Table 3.1: Sex differences in cardiac mechanics  
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(gold standard) to measure central hemodynamics both during a rest period and immediately 
following moderate intensity resistance exercise in 18 young healthy women (28±7 years). 
Moreover, the results of this study allowed us to compare the PWV values estimated from the 
Mobil-o-graph to the gold standard measure of PWV using applanation tonometry. Using Bland-
Altman analysis, arterial stiffness (pulse wave velocity, PWV) values using the mobil-o-graph 
device were in good agreement with the gold standard measure of PWV using applanation 
tonometry at rest (Fig.1) and immediately following intense exercise (Figure. 1 and Figure 2) 
[211].  
Figure 3.1: Mobil-o-graph PWV vs. SphygmoCor PWV at rest  
Figure 3.2: Mobil-o-graph PWV vs. SphygmoCor PWV post-exercise 
 
 
Sex differences in Cerebrovascular, Cognitive function and Exercise in Older Adults 
Our laboratory also has a unique interest in how systemic vascular function and exercise may 
influence cerebrovascular function and thus cognitive function. We have the capabilities to 
examine brain blood flow as we show in a study that examined the acute effects of resistance 
exercise on cerebral blood flow. We found that even though resistance exercise increases 
cerebral artery stiffness it does not negatively impact cerebral blood flow [212]. Recently, our 
laboratory has developed a technique to examine neuro-vascular coupling, which allows us to 
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determine the matching of vascular supply to neuronal demand during a mental stress or 
cognitive engagement task. Increases in arterial stiffness may negatively impact neuro-vascular 
coupling and thus impair cognitive function and performance. This becomes an especially 
interesting model to apply to populations that may have increased arterial stiffness due to aging 
or varying disease states. Our lab has examined this model in older adults. 
 Sex differences may exist in neurovascular coupling and stimuli such a mental stress may 
give us insight into these physiological differences. Mental stress is known to increase blood 
pressure and arterial stiffness. In response to perturbations of mental stress, women have blunted 
increases in blood pressure compared to men. These differences are noted in brachial blood 
pressure and primarily premenopausal women. Thus, our lab examined whether these sex 
differences exist in postmenopausal women and older adults. We found that mental stress did not 
elicit differential cardiovascular responses in postmenopausal women and men. This finding is 
similar to observed sex differences in cardiovascular parameters with endurance exercise. In 
response to mental stress and endurance exercise training, premenopausal women appear to have 
a smaller magnitude of increase in blood pressure, arterial stiffness and cardiac remodeling 
compared to endurance-trained men (Table 2, 4). 
 
Sex Differences in Cardiovascular Parameters in Children ages 9-12 years old 
Table 3.2: Sex differences in Hemodynamics in Older Adults  
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The P.I. has also collected data on over 150 children ages 9-12 years old as a part of a larger 
grant examining the effect of lead exposure on cardiovascular and psychological parameters in 
young children. In examination of the current data even at a young age there are significant sex 
differences in cardiovascular parameters. Boys have a significantly higher pulse wave velocity, 
aortic systolic blood pressure, pulse pressure and LVM index compared to girls (Table 3). 
Previous studies have attributed these differences to a taller stature and bigger body surface area 
in boys than in girls, however, even when adjusting for body surface area in children (LVM-
index) we observe significantly higher LVM in boys compared to women. 
 
 
Sex differences in aortic stiffness following acute resistance exercise 
 
There are established sex differences in vascular structure and function and neurovascular 
blood pressure (BP) regulation at rest and in response to various stressors. Below is a summary 
of a recently published study by the P.I. that is a secondary analysis of two previously published 
studies that both used the same methods and study design. Briefly, 27 young healthy adults 
Table 3.4: Sex differences in Children Ages 9-12 years old  
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between the ages of 18-35 participated in these studies (n = 13 female). The purpose of this study 
is to examine sex differences in aortic stiffness and central BP in response to acute RE.  We 
hypothesized that women would have an attenuated increase in aortic stiffness and central BP in 
response to acute RE.  Significant group-by-time interactions were detected for heart rate, 
brachial and central pressures, and aPWV (table 2, p<0.05).  Compared to men, women had an 
attenuated hemodynamic response (lessened increases in HR and BP) to acute RE. There are sex 
differences in changes in aortic stiffness following acute RE that appear to be pressure mediated.  
Women have an attenuated increase in aortic stiffness following acute RE relating to attenuated 
central hemodynamic reactivity.  Underlying sex differences in muscular strength may affect the 
pressor response to the exercise bout, mediating functional changes in aortic stiffness.  
Figure 3.5: Sex differences in Hemodynamic Response to RE 
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Variable  Males (n=14) Females (n=13) 
Time  
Effect 
Group 
Effect Interaction 
Brachial SBP (mmHg)     0.00 0.00 0.01 
Baseline  120±10*^ 111±9  0.66 0.00 0.06 
P10  145±19*^ 115±11*     
P20  132±11*^ 114±11*     
Brachial DBP (mmHg)     0.17 0.02 0.03 
Baseline  68±6  68±7  0.17 0.32 0.06 
P10  74±7*^  63±8     
P20  66±5  64±8     
Brachial PP (mmHg)     0.00 0.00 0.09 
Baseline  52±6*^  45±9  0.22 0.13 0.24 
P10  72±17*^  52±10*     
P20  67±9*^  50±11*     
Mean Arterial Pressure (mmHg)     0.00 0.01 0.01 
Baseline  92±7  88±7  0.12 0.81 0.05 
P10  106±11*^ 87±8     
P20  96±7^  87±9     
Central SBP (mmHg)     0.00 0.00 0.01 
Baseline  109±11  107±11  0.31 0.02 0.15 
P10  140±20*^ 110±11*     
P20  127±12*^ 108±11     
Central DBP (mmHg)     0.22 0.01 0.03 
Baseline  69±6  69±6  0.57 0.00 0.12 
P10  75±8*^  64±8*     
P20  68±6  64±11*     
Central PP (mmHg)     0.00 0.00 0.15 
Baseline  40±9^  35±7  0.27 0.15 0.53 
P10  65±19*^  46±11*     
P20  59±11*^  43±12*     
*significantly different from baseline  
^significantly different than females  
P10, 10 minutes following resistance exercise protocol  
P20, 20 minutes following resistance exercise protocol  
italicized p value, Adjusted for 5RM strength  
Table 3.5: Sex differences in Hemodynamic Response to RE 
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Pilot data for the Proposed Study 
In a recent feasibility study, 4 young, normotensive participants (2F, 2M, 25±1yrs) wore the 
Mobil-o-graph device for 24h (Figure. 3) to ensure that the device meets acceptable acquisition 
guidelines for ambulatory blood pressure monitoring [213]. In this small pilot study, we were 
able to measure over 70% of planned hemodynamic measures and obtained approximately 56 
measures during daytime hours and approximately 16 during nighttime hours (guidelines, >20 
daytime, >7 nighttime) [141]. Based on our feasibility and pilot data, we are confident that the 
cuff-based method will reliably assess central hemodynamic load for 24h at rest and post-
exercise as proposed for our current study design. Taken together, our results highlight our 
ability to accurately assess central hemodynamic load over a 24-hour time period and further 
suggest that women may display some level of cardio-protection in response to strenuous 
endurance exercise training. 
 
Figure 3.3 24-hour Hemodynamics in Men and Women  
 
 
 
 
Figure 3: 24h PWV and AIx75 in males/females 
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Chapter IV: Sex Differences in Cardiovascular Adaptations to Chronic Endurance 
Exercise 
Abstract 
Endurance exercise typically leads to beneficial cardiac adaptations manifested as increased 
cardiac mass, higher cardiac function and lower central hemodynamic load (blood pressure, 
aortic stiffness and wave reflections). However, studies in male marathoners suggest detrimental 
cardiac remodeling such that larger cardiac mass is associated with reduced cardiac function and 
higher central hemodynamic load. There are well-established sex differences in cardiac 
adaptations to endurance exercise and central hemodynamics across the lifespan. Whether there 
are sex differences in cardiovascular adaptations in marathoners requires further scrutiny. 
PURPOSE: To examine sex differences in 1) Left ventricle (LV) structure, 2) LV function 3) 
24-hour central hemodynamic load and 4) ventricular-vascular coupling in marathon runners and 
recreationally active adults. METHODS: 52 marathon runners (n=28 female 41±5 yrs) and 49 
recreationally active controls (n=25 female 42±5 yrs) participated in the current study. LV 
structure and function were measured using 3-dimensional echocardiography (3DE). LV mass 
index (LVMI) was used as an index of LV structure. LV longitudinal (LS) circumferential (CS), 
area (AS), and radial strain (RS) were used as indices of LV function. An ambulatory 
oscillometric blood pressure (BP) cuff was used to measure 24-hour hemodynamic load after a 
non-exercise control day and following a 30-minute run/walk. 24-hour hemodynamic load was 
comprised of brachial and aortic BP, aortic stiffness measured as pulse-wave velocity (PWV) 
and pressure from wave reflections measured Pb. Measures from central hemodynamics and 
3DE were combined to derive the ratio of arterial elastance (Ea) to ventricular elastance (Elv) as 
a global measure of ventricular-vascular coupling.  A 2x2 ANOVA was used to detect mean 
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differences in LVMI, LV strain indices, 24-hour hemodynamic load and Ea:Elv. A 2x2 repeated 
measures ANOVA was performed to compare mean differences in resting and post-exercise 24-
hour hemodynamic load. RESULTS: Female marathoners had larger mean LVMI compared to 
both recreationally active and male counterparts (Sex effect, p=0.00; Training effect, p=0.04). 
There were no sex or training effects detected in LS, CS, AS, and RS (p>0.05). Females 
independent of training status had lower mean 24-hour hemodynamic load compared to males 
(Sex effect, p=0.00; Training effect, p=0.03). This was manifested as lower mean 24-hour resting 
and post-exercise mean aortic systolic blood pressure (aSBP, p=0.00), mean arterial pressure 
(MAP, p=0.00), mean aortic diastolic blood pressure (aDBP, p=0.00), and mean resting PWV 
(p=0.05) in females.  Female marathoners had lower mean Ea/Elv than both recreationally active 
females and male counterparts (Sex effect, p=0.05; Training effect, p=0.05). CONCLUSIONS: 
This study suggests that that although female marathoners had larger LVMI they did not have 
LV dysfunction or increased central hemodynamic load and had better overall ventricular-
vascular coupling compared to both recreationally active and male counterparts. Furthermore, 
chronic marathon training and racing does not appear to reduce LV function, or increase central 
hemodynamic load in otherwise healthy middle-aged men and women, suggesting that running 
multiple marathons is not detrimental to cardiovascular health.  
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Abbreviations 
 
AIx, augmentation index 
(a) SBP, (aortic) systolic blood pressure  
(a) DBP, (aortic) diastolic blood pressure  
BP, blood pressure 
BMI, body mass Index  
BSA, body surface area  
Ea, arterial elastance 
EDV, end-diastolic volume  
ESV, end-systolic volume 
EF, ejection fraction  
Elv, ventricular elastance 
FFM, fat free mass  
FS, fractional shortening  
GAS, global area strain  
GCS, global circumferential strain  
GLS, global longitudinal strain  
GRS. Global radial strain  
IVS, interventricular septum 
LVDd, left ventricle diameter during diastole  
LVDs, left ventricle diameter during systole  
LVM, left ventricle mass  
LVMI, left ventricle mass index  
LV, left ventricle  
MAP, Mean arterial pressure  
Pb, backward wave pressure  
Pf, Forward wave pressure  
PWD, posterior wall thickness 
PWV, pulse wave velocity  
Q, cardiac output  
RWT, relative wall thickness  
SV, stroke volume  
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Introduction 
 
 Endurance exercise training results in myocardial structural adaptations such as increases in 
wall thickness [7-10] and mass [11]. Historically these physiological adaptations were viewed as 
benign and considered a phenotypic expression of the “athlete’s heart” [12-14].  Although 
exercise is generally considered beneficial for the heart [6], there are controversial reports of 
increased cardiovascular mortality in life-long endurance athletes [89, 214]. Increases in 
ventricular mass with habitual endurance exercise training have been shown to be dependent on 
blood pressure, suggesting that myocardial enlargement may not only be a response to exercise, 
but an indicator of early subclinical cardiac target organ damage [215]. Indeed, select studies 
have reported reduced ventricular function [216, 217], adverse cardiac structural remodeling 
(e.g. increased ventricular stiffness and myocardial fibrosis [2, 3, 218, 219], and increased 
coronary artery calcification [220] occurring in male long-distance runners. 
 Aberrant ventricular remodeling and reduced myocardial function in endurance-trained 
individuals may be influenced by underlying central hemodynamic load.  Increased arterial 
stiffness and pressure from wave reflections results in altered ventricular-vascular coupling, 
increasing cardiac work and reducing cardiac efficiency, contributing to reduced myocardial 
contractile function [221], myocardial fibrosis [37], coronary calcification [222] and increased 
left ventricular (LV) mass [35]. Generally, regular endurance exercise training leads to 
reductions in arterial stiffness and pressure from wave reflections [38, 39]. However, studies 
suggest that strenuous endurance exercise may lead to increased arterial stiffness with possible 
increases in pressure from wave reflections [40, 41].  
   To date, literature noting adverse ventricular and vascular structural and functional adaptations 
in response to endurance training is largely, if not exclusively, in male marathoners [15, 27-29].  
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LV structural adaptations to endurance training are less pronounced in female athletes suggesting 
possible sex differences in response to the stimulus of exercise [17-24].  Studies suggest that 
females athletes display smaller LV mass and volumes compared to male athletes [21] even after 
adjusting for body size, lean body mass and training load [22, 25, 26]. Moreover, women 
experience reductions in arterial stiffness and wave reflections following strenuous endurance 
exercise [34, 42-48]. However, these studies are not performed in female marathoners, 
specifically.  Differential acute hemodynamic responses to endurance exercise over years of 
training may give rise to chronic sex differences in central hemodynamic load. Thus, female sex 
may confer a level of cardio-protection from possible cardiac mal-adaptations with habitual 
endurance exercise training.  Whether there are sex differences in ventricular-vascular changes 
with habitual endurance exercise requires further scrutiny.    
   The percentage of female marathon finishers in the United States has reached an all-time high 
(44%, 223, 344) and now rivals the number of male marathon finishers (56%, 284, 256) [223]. 
Understanding sex differences in ventricular-vascular coupling may give insight into the nature 
of cardiac remodeling (i.e. physiological or pathophysiological) and future cardiovascular risk in 
both male and female marathon runners.  Understanding the ventricular-vascular response to 
regular endurance exercise may also have important clinical implications for women as 
ventricular-vascular uncoupling in women has been linked to their greater risk of heart failure 
with preserved ejection fraction [44, 48].  Recoupling with exercise may offer an important 
therapeutic strategy to mitigate CVD risk [224]. 
   The purpose of the current study was to examine sex differences in ventricular-vascular 
coupling in marathon runners and recreationally active adults. Ventricular structure and function 
was assessed in detail as LV mass and LV strain using three-dimensional (3D) 
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echocardiography. Arterial stiffness and pressure from wave reflections were taken as proxies of 
central hemodynamic load and assessed using novel ambulatory (24-hour) recordings both under 
resting conditions and following acute exercise (as it may be argued that habitually endurance 
trained adults ambulate in a mostly post-exercise state). Finally, select measures from central 
hemodynamics and 3D echocardiography were combined and used to derive the ratio of arterial 
elastance to ventricular elastance as a global measure of ventricular-vascular coupling.  We 
hypothesized that compared to male marathoners, female marathoners would have more optimal 
ventricular-vascular coupling, smaller LV mass, higher LV function and lower 24-hour central 
hemodynamic load both at rest and following acute exercise.  
Methodology 
 
Participants.  
50 marathon runners (25 men, 25 women) and 50 recreationally active adults (25 men, 25 
women), 35-50 years of age were recruited for this study. Marathon runners were included in the 
study if they self-reported completing at least 5 full marathons over the course of the past 3 
years, were currently running 5-7 days a week, completing >25 miles/week at approximately 6 
min per mile to 10 min/mile, and performing ≤1-2 strength training sessions per week. This 
criterion is similar to previous studies that examined lifelong male marathoners and found 
fibrosis [27]. Participants were included in the recreationally active group if they were 
performing aerobic exercise <3 hours per week (jogging, running <10 miles per week), 
performing ≤1-2 strength sessions per week, and had not engaged in any half- or full marathons 
in the past 20 years.  
Exclusion criteria for all participants included diabetes mellitus, diagnosed cardiovascular 
disease, hypertension, hypercholesterolemia, current smoker, and obesity defined as BMI 
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>35kg/m2.  Only premenopausal, regularly menstruating women who were not taking any form 
of hormonal contraception were included in the current study. This study was approved by the 
Syracuse University Institutional Review Board and conformed to the standards outlined in the 
Declaration of Helsinki. All participants provided written informed consent prior to study 
initiation.  
Study Design.  
Participants were tested on four separate visits: 1) Health screening and resting vascular 
structure/function measurements followed by 24-hour ambulatory central hemodynamic 
measurement; 2) Peak aerobic fitness test, 3) Acute exercise followed by 24-hour ambulatory 
central hemodynamic measurement, and 4) 3-D Echocardiography. Visits 1-3 took place at the 
Human Performance Laboratory at Syracuse University and Visit 4 was completed at SUNY 
Upstate Medical University. Visits 1-3 were scheduled within 7 days to avoid sub-acute 
influences of training and changes in menstrual cycle. Visit 4 was scheduled at maximum within 
1-2 weeks of Visit 1. Female participants’ visits 1-3 were scheduled during the early follicular 
phase of the menstrual cycle (Days 1-7) to avoid influence of menstrual hormones on the 
vasculature.  
Health Screening. 
 Participants arrived to the Human Performance Laboratory following a 12-hour fast and 
abstinence from caffeine, alcohol and exercise (>24rs prior). Participants completed a health 
history, marathon history, menstrual questionnaire and the international physical activity 
questionnaire (IPAQ) [225] to confirm health status, exercise history, menstrual history and 
current physical activity levels.  Metabolic equivalents (METs) were calculated from the IPAQ 
as the sum of the total METs from moderate, vigorous, and walking activity from a 7-day period: 
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Total METs = (3.3 x minutes walking x days/week) + (4.0 x minutes moderate activity x 
days/week) + (8.0 x minutes vigorous activity x days/week). A 12-lead electrocardiogram was 
performed on all participants to ensure participants did not have pre-existing cardiac conditions 
or potentially dangerous arrhythmias. Height was measured with a stadiometer and weight with 
an electronic scale to determine Body Mass Index (BMI) and Body surface area (BSA). Waist 
circumference was measured with a tape measure at the level of the umbilicus at the end of a 
normal exhalation. Body fat percentage was assessed using air displacement plethysmography 
(BodPod; COSMED, Concord, CA). Fat free mass (FFM) was calculated as: Body weight – Fat 
Mass (as determined by body fat percentage x body weight).  
BSA was directly measured using a 3D body scanner (Vitus Smart LC3 scanner, Human 
Solutions).  A CCD-Camera with integrated image processing hardware was combined with a 
laser pointing towards the participant to generate an avatar. An avatar was then created using the 
body scan measurements and a triangular mesh surface reconstruction was then used to calculate 
BSA measures.  
Serum Lipoproteins (Total cholesterol (TC), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), triglycerides (TG)) and fasting plasma glucose (GLU) levels were measured 
via finger stick (Cholestech LDX, Alere Medical). The proportion by volume of red blood cells 
(i.e. hematocrit) (StatSpin, Inc, Norwood, Mass) and hemoglobin (The Hemocue Hemoglobin 
System, Hb201+; Angelholm, Sweden) were also assessed from a finger stick. 
Accelerometry.  
Physical activity levels were monitored with accelerometry worn on the right hip 
(ActiGraph GTX3+ Model 7164, ActiGraph, LLC Pensecola, FL) during 24 hours for 7 
consecutive days. At visit 1 participants were given the accelerometer. Participants were 
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instructed to remove the monitor when bathing or coming in contact with water. Data was 
considered non-wear time if interval of at least 60 minutes of zero activity intensity counts in 
accelerometer channel. Additionally, for participants’ data to be included in the study, 
participants needed to have 10 hours of data for 4 days. Sleep time was identified using similar 
algorithm created to calculate sleep [226, 227] and this algorithm was recently validated in a 
young adult sample [228]. Activity counts, non-wear time and moderate to vigorous intensity 
physical activity (MVPA) were processed using the low frequency extension [229]. Step counts 
were calculated using the default extension [230].  Time spent in MVPA, moderate and vigorous 
physical activity were defined as moderate intensity when greater than 2020 counts per minute 
were detected, and vigorous when greater than 5999 counts per minute were detected [231].  
Aerobic Capacity. 
Peak aerobic capacity (VO2 Peak) was determined using indirect calorimetry (TrueOne 
2400 Metabolic Measurement System, ParvoMedics, Sandy, Utah) at Visit 2. A graded exercise 
test on a treadmill was performed using the Jack Daniel’s Protocol [232]. Heart rate was 
measured continuously and ratings of perceived exertion (RPE) were assessed every two 
minutes, using a Polar Heart Rate Monitor and Borg RPE scale, respectively. A VO2 peak test 
was considered valid if 2 or the following criteria was achieved: 1) an R-value of 1.10 or higher; 
2) an RPE score of greater than 17; or 3) maximal heart rate achieved was greater than 85% age-
predicted maximum 4) plateau in HR and/or oxygen consumption with increasing intensity. 
Lifetime Training Hrs. 
 Lifetime training hrs was calculated from a self-reported number of hours/week of 
exercise and number of years performing the respective exercise on the exercise history 
questionnaire as: the average endurance hrs/week + the average strength hrs/week x 52 x number 
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of years. This number ensured that our participants are in fact regular exercisers. Previous studies 
that examine lifelong endurance athletes report an average of 4,670±4402 lifetime hrs of exercise 
[233].  
3D Echocardiography: LV Structure. 
3D echocardiography (3DE) was used to determine LV mass, volumes and function using 
Speckle-tracking Technology (STE) [234]. The 3DE ultrasound measurements comprise a 
dynamic multi-slice acquisition technology with the ability to simultaneously acquire images up 
to 12 slices of the myocardium in tri-plane measurements (frame rates >25 frames/s). For 3DE 
the LV volumes and mass and strain indices were obtained by acquiring an apical 4-chamber 
view of the myocardium. When necessary, the 3DE data acquisition was obtained in an end-
expiratory breath-hold lasting 6-8 seconds (depending on heart rate) and recorded at the LV apex 
with a mean volume rate of greater than or equal to 30 volume/second and a six-beat acquisition 
to ensure optimal temporal and spatial resolution. Data sets were stored digitally in raw data 
format and exported to a separate workstation (EchoPac, PC 110.1.1, GE Healthcare) equipped 
with commercially available software (4D Auto LVQ software, GE Healthcare) for off line 
analysis of LVM and 3D STE parameters. A mesh-based surface-tracking model along with 
automated tracing of the endocardial and epicardial border allowed for measurement of LVM, 
end-diastolic, end-systolic volumes and stroke volume (EDV, ESV, SV).  
LV Function: 3DE STE. 
Global and regional strain values were calculated based on speckle tracking technology 
(STE). A strain bull’s eye plot was accompanied by time–strain curves. Global longitudinal 
strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) were calculated 
as weighted averages of the regional values from the 17-myocardial segments. Global area strain 
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(GAS) was calculated as the percentage variation in the surface area defined by the longitudinal 
and circumferential strain vectors. The LV was divided into 3 regions including base, mid-LV 
and apex. The regional LS, CS, AS, RS was calculated as the average LS, CS, AS, and RS of the 
segments in the region respectively. Increased strain or a higher strain value indicates optimal 
contractile function whereas decreased strain or a lower strain percent indicates contractile 
dysfunction [50, 234]. All data acquisition was performed by a professionally trained echo-
cardiologist who was blinded to the study group identification. Inter-class correlation coefficients 
for LV strain analyses were: r=0.86, r=0.87, r=0.86, r=0.88 for longitudinal, circumferential, 
area, and radial, respectively.  
Resting Aortic Stiffness.  
Aortic stiffness was assessed using carotid-femoral pulse wave velocity (PWV) during 
Visit 1. Blood pressure waveforms from the carotid and the femoral artery were captured with 
applanation tonometry (AtCor Medical, Sydney, Australia) over a 10s period along with 
simultaneous ECG for R-wave gating.  The waveforms were measured between the: 1) right 
common carotid artery (CCA) and right femoral artery. The distances between measurement 
sites were measured in a straight line with a tape measure to the nearest millimeter. For measures 
of carotid-femoral PWV, distance from the sternal notch to the carotid pulse site was subtracted 
from the carotid-femoral path length to account for the bi-directional nature of pressure 
propagation. PWV was calculated using the difference in the distances between sites (Δ distance) 
and the measured time delay (Δ time) between proximal and distal waveforms.  
Resting Aortic Blood Pressure and Wave Reflections.  
Resting systolic (SBP) and diastolic blood pressure (DBP) were measured via an 
automatic device on the participant’s left arm (BP786N, Omron Healthcare Inc., Lakeforest, IL) 
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during Visit 1. Pressures were taken in duplicate and averaged. If values differed more than 5 
mmHg a third measure was taken and the average of the two closest measures was used for 
analyses. Aortic pressures were obtained via applanation tonometry. Aortic waveforms 
(estimated from radial waves using a validated generalized transfer function) were averaged to a 
single waveform for determination of aortic systolic blood pressure. Aortic pressure waveforms 
were calibrated to brachial mean pressure (MP) and DBP. MP and pulse pressure (PP) were 
calculated as 1/3 SBP + 2/3 DP and SBP – DBP, respectively. From this radial artery pressure 
wave form, a reconstructed central aortic pressure waveform was generated using a generalized 
validated transfer function to determine central BP and LV end systolic pressure (ESP).   
Augmentation Index (AIx) was used as a measure of global wave reflection magnitude.  
AIx was calculated as the difference between the early (P1) and late systolic (P2) peaks of the 
pressure waveforms to the total PP expressed as a percentage: (P2-P1)/(PP x 100) and 
standardized to a heart rate of 75 beats per minute (AIx75). Wave separation analysis was 
derived from the radial PWA data acquisition. In particular, aortic wave reflections, forward 
wave pressure (Pf) and backward wave pressure (Pb), were obtained from the analysis of each 
radial blood pressure waveform. Reflection magnitude was calculated as the ratio between Pb 
and Pf and taken as a measure of the magnitude of reflected wave pressure. 
Ambulatory 24h Central Hemodynamic Load.  
24-hr ambulatory central hemodynamic parameters were assessed using an oscillometric 
brachial cuff-based validated device (Welch Allyn 7100 ABPM, I.E.M., Stolberg, Germany) 
[194]. This device uses the ARCSolver method to estimate aortic pressures based on brachial 
pressure waves recorded with a brachial cuff [193]. From the aortic pressure wave aortic 
stiffness (PWV) and indices of wave reflections (Pf, Pb, RM and AIx) can be derived. 
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Participants were fit with a cuff on their non-dominant arm, based on the circumference of their 
left arm ensuring that the cuff bladder covered 80-100% of arm circumference and the bladder 
was placed over the brachial artery. The cuff was placed on the non-dominant arm with the 
tubing passing upwards around the participant’s neck to be connected to the monitor on the 
waist. These measurements were performed twice, for a 24-hour period (non-exercise condition, 
post-Visit 1) following a 24-hour period of no exercise and following a 24-hour period (post-
exercise post-Visit 3) after a standardized 30-minute moderate intensity running session 
(exercise condition, 60-70% HR max, post-Visit 3) in the laboratory.  
The definition of daytime and nighttime intervals was determined by using typical sleep 
time reported by participants prior to receiving the device. The device was formatted to take a 
measurement every 20-min during waking hours and every 30-min during night hours. After the 
data were obtained and transferred to a computer-based hypertension management software 
(HMS), the data were edited and excessive noise and artifacts were deleted.  The automated 
recording of pressures waves via cuff based oscillometry were calibrated non-invasively by 
brachial MAP/DBP values. This is currently the most reliable approach that provides more 
accurate estimations of aortic SBP values. These calibrated values are closest to the actual 
invasively measured aortic pressure values (C2-methodology). The European Society of 
Hypertension Guidelines state that there must be 70% of expected measurements every 30 
minutes throughout the 24-h period (14-20 measurements during daytime and 7 measurements 
during nighttime) [141]. At the very minimum there needs to be 2 valid daytime measurements 
per hour and 1 valid nighttime measurement per hour. If a participant’s trial did not meet these 
guidelines set forth by the European Society of Hypertension than the 24-h measurement was 
repeated.    
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Ventricular-Vascular Coupling 
Arterial elastance (Ea) was calculated as ESP/SV determined by applanation tonometry 
and 3D echocardiography, respectively. Ventricular elastance was calculated as ESP/ESV 
determined by applanation tonometry and 3D echocardiography, respectively. Global Ventricular 
vascular coupling was determined as the ratio of Ea to Elv.  
Statistical Analyses.  
Apriori power calculations (2-tailed test, independent groups) using an effect size of 1.64, 
power of 0.80, and alpha level of 0.05 indicate that sixteen participants per group would be 
necessary to detect sex differences and training differences across LVM, LV strain and 24-hour 
central hemodynamics. We powered our study based primarily on previous studies that examined 
sex and training differences in LVM and 24-hour BP. No study has used 3DE STE to examine 
LV strain in male and female endurance trained athletes and compared them to recreationally 
active counterparts.  
All data are presented as mean ± standard deviation and statistical significance was 
established a priori as p<0.05. Normality of distribution for variables was assessed qualitatively 
using histograms and Q-Q plots and quantitatively using Shapiro-Wilk test. Non-normally 
distributed variables were transformed and re-assessed for normality. We assessed descriptive 
characteristics, vascular and 2D and 3D cardiac parameters across sex and training status using a 
2x2 (2 sex groups x 2 training statuses) ANOVA. Main effects of sex, training status and sex x 
training interactions were further explored with Scheffe’s corrected post-hoc tests. In order to 
compare resting 24-hour ambulatory hemodynamics to post-exercise 24-hour ambulatory 
hemodynamics we used a 2x2x2 (2 sex groups x 2 training statuses x 2 time points) repeated 
measures ANOVA. Main effects of sex, training status, time, sex x training x time interactions 
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were further explored with Scheffe’s corrected post-hoc tests. 2x2 ANCOVA’s were performed 
for aortic PWV, 3D LVMI, and 24-hour aSBP while co-varying for variables that were 
significantly different between men and women and also known to affect LV structure and 
function. Additionally, we explored vascular correlates (PWV, RM, AIx, aSBP, Ea, Elv, Ea:Elv) 
of LV structure and function in men and women using Pearson’s Bivariate correlations.  
Results 
Participant Characteristics.  
52 marathon runners (28 women 41±5 yrs; 24 men, 42±5 yrs) and 49 healthy recreationally 
active controls (25 women 42±5 yrs; 24 men, 42±4 yrs) completed this study. Participant 
characteristics are shown in Table 1. All participants self-reported being Caucasian1 as their 
primary ethnicity. Participants were well-matched across groups for mean age and within groups 
(i.e. sex) for body mass index (BMI), body surface area (BSA) and waist circumference (Table 1; 
p>0.05). Across all groups, females had significantly lower mean body fat percentage, BMI, 
waist circumference, and BSA compared to males (Table 1; p<0.05). Both female and male 
marathoners had significantly lower mean body fat percentage compared to same sex controls 
(Table 1; p<0.05). There were no sex by training interactions in participant characteristics 
(p>0.05).  
1 Caucasian defined as “white” or of “European Descent”. Historically the use of Caucasian 
identifier was referred to as superior and non-Caucasian as inferior. Thus, the preference instead 
of using Caucasian is to identify as “white or of European Descent”. 
Blood Lipids and Red Blood Cell Profile. 
There was a significant sex effect and training effect in blood lipids (Table 1; p<0.05). Female 
marathoners and female controls had higher mean HDL, lower LDL, nHDL, TC/HDL and blood 
80 
 
 
glucose compared to male counterparts (Table 1; p<0.05). Female marathoners had significantly 
lower mean blood glucose compared to the female controls while male marathoners had similar 
mean glucose compared to male controls (Sex by Training interaction, p<0.05). There were no 
significant training effects in mean hematocrit and hemoglobin (p>0.05). Hematocrit was similar 
across all groups (p>0.05). Hemoglobin was significantly lower in the females compared to 
males, independent of training status (p<0.05).  
Marathon History.  
Male and female marathoners reported completing a similar mean number of marathons in the 
last year, last 3, and last 5 years. Female marathoners reported a significantly higher number of 
marathons in the last 20 years. All marathoners reported a similar average finishing time, miles 
per week and average running pace (Table 2; p>0.05). 
Aerobic Fitness and Physical Activity Levels. 
There was a significant sex effect in VO2 max and VO2 maxFFM where females had lower mean 
VO2 max compared to males (Table 2; p<0.05). Also, female marathoners and male marathoners 
had higher mean VO2 max and VO2 maxFFM compared to the female and male controls (Table 2; 
p<0.05). Thus, as expected there was a significant training effect in VO2 Max results and the 
marathoners were categorized into a significantly higher VO2 max percentile for their age (Table 
2; p<0.05). However, the significant training effect in VO2 maxFFM was only present in females, 
as male marathoners had similar VO2 maxFFM compared to male controls. There was no sex by 
training interaction in VO2 max or VO2 maxFFM (p>0.05), suggesting that the overall effect of sex 
and effect of training was similar across and within groups.  
There were no significant differences between groups on self-reported mean METs from 
IPAQ (p>0.05).  Accelerometry analysis was successfully recorded on seventy-four participants 
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(n=21 female marathoners, n=17 female controls, n=16 male marathoners, n=20 male controls). 
Accelerometry data indicated that the female marathoners had significantly more time spent in 
MVPA, steps per day, and moderate intensity minutes compared to the controls (Table 2; 
p<0.05), whereas male marathoners were similar to male controls on all indices (p>0.05). There 
was no significant sex by training interaction in physical activity levels, suggesting that 1) the 
effect of sex on levels of physical activity was similar between marathoners and controls and 2) 
the effect of training on levels of physical activity was similar between men and women 
(p>0.05).  
Resting Blood Pressure, Arterial Stiffness and Wave Reflections. 
Resting mean brachial SBP and DBP was significantly lower in females compared to males, 
irrespective of training status (Table 3; p<0.05). Brachial mean pressure was similar across 
groups and resting heart rate was significantly lower in both female and male marathoners 
compared to controls (Table 3; p<0.05). Mean aortic SBP, DBP, aortic PWV, Pf and Pb were all 
significantly lower in females compared to males (p<0.05), while aortic AIx and RM were 
significantly higher in females compared to males (p<0.05). When mean PWV was adjusted for 
differences in mean pressure, the sex effect in PWV was abolished (p>0.05). There were no 
significant sex x training interactions (p>0.05) suggesting similar sex differences in 
hemodynamics in both marathon and control groups and similar training effects in men and 
women.  
Ventricular Vascular Coupling: Arterial and Ventricular Elastance. 
Resting mean ESP was significantly higher in female marathoners compared male marathoners 
(p<0.05) and significantly lower in female controls compared to male controls (Table 3; p<0.05). 
Mean Ea was significantly higher in females compared to males irrespective of training status 
82 
 
 
(p<0.05). There was also a significant effect of training in Ea with female marathoners having a 
lower Ea compared to female controls (p<0.05). For indices of Elv, Female marathoners and 
controls had higher mean Elv compared to both male marathoners and controls (p<0.05). Mean 
Ea/Elv was significantly lower in female marathoners compared to both recreationally active 
females and male counterparts (p<0.05).  
3-D Echocardiography.  
For 3D indices, females, regardless of training status had smaller mean LVM, EDV, ESV, SV, 
and Q but larger LVMI, compared to their male counterparts (Table 4; p<0.05). There was a 
training effect detected in mean LVMI (adjusted for 3D BSA) with female marathoners having 
slightly larger LVMI compared to controls (p<0.05). Female marathoners had larger mean LVMI 
compared to males, independent of training status (p<0.05). There was no main effect of sex or 
training on SVBSA and QBSA (p>0.05). There were no sex, training or interaction effects detected 
in EF, 3D GLS, GCS, GAS, and GRS (p>0.05). When sex differences in mean LVMI were 
adjusted for mean PWV, brachial BP, aortic BP, AIx and RM sex differences in LVMI remained 
(p<0.05).  
24-hour Ambulatory Central Hemodynamics. 
Non-exercise control. 24-hour non-exercise mean SBP, MAP, DBP, aSBP, aDBP, PWV and aPP 
were lower in females compared to males regardless of training status (Table 5; p<0.05). Mean 
RM was significantly higher in females compared to males (p<0.05). 24-hour non-exercise mean 
HR was lower in female and male marathoners compared to the controls (p<0.05). 24-hour non-
exercise mean PP, AIx, Pb, and Pf were similar across groups (p>0.05). There was a significant 
training effect for mean aSBP only in men, whereby male marathoners had higher aSBP 
compared to male controls (p<0.05), however, there was no significant interaction. There were 
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no significant sex by training interactions detected in resting 24-hour hemodynamics (p>0.05) 
suggesting that 1) the effect of sex on 24-hour hemodynamics was similar within marathoners 
and controls and 2) the effect of training on 24-hour hemodynamics was similar between men 
and women.  
Post-exercise. 24-hour post-exercise, mean SBP, MAP, aSBP, aDBP and aPP were lower in 
females compared to males, regardless of training status (Table 6; p<0.05). 24-hour post-
exercise, mean RM was significantly higher in females compared to males independent of 
training status. Also, 24-hour post-exercise mean HR was significantly lower in female and male 
marathoners compared to the controls. There were no differences in 24-hour post-exercise mean 
PP, PWV, AIx, Pb and Pf (p>0.05). There were no significant interactions detected in post-
exercise 24-hour hemodynamics, suggesting that 1) the effect of sex on post-exercise 24-hour 
hemodynamics was similar within marathoners and controls and 2) the effect of training on 24-
hour hemodynamics was similar between men and women.  
When 24-hour non-exercise mean SBP, aSBP, aPP, PWV, MAP, AIx, Pb, Pf, and RM 
were compared to corresponding 24-hour post-exercise measures, there were no significant sex x 
training x time interactions (Table 6; p>0.05) suggesting that the effect of sex and training 
(across time) on non-exercise control day and post-exercise 24-hour hemodynamics was similar 
within marathoners and controls and between men and women, respectively.  
Vascular hemodynamic correlates of LV Structure and Function.  
Females. 24-hour PWV and 24-hour SBP were significantly associated with AS, RS and 3D-
LVMI (Table 7; p<0.05). 24-hour RM were significantly associated with 3D-LVMI but not with 
LV strain indices. Ea was associated with LVMI, RS and AS but not with 24-hour SBP, aSBP, 
24-hour AIx, 24-hour RM, or PWV (p<0.05). Elv was not associated with LVMI, 24-hour AIx, 
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24-hour SBP, aSBP or 24-hour RM, but was associated with 24-hour PWV, AS, and RS 
(p<0.050. Ea/Elv was associated with LVMI, AS, RS, 24-hour AIx and 24-hour PWV but not 
with 24-hour SBP or aSBP or RM (p<0.05).  
Males. 24-hour PWV, 24-hour SBP, 24-hour aSBP, AIx, and RM, were not significantly 
associated with 3D-LVMI or LV function (Table 8; p>0.05). Ea was not associated with LVMI, 
24-hour PWV, 24-hour AIx, RM, 24-hour SBP or aSBP, but was associated with RS, and AS 
(p<0.05). Elv and Ea/Elv was not associated with LVMI, 24-hour SBP, 24-hour AIx and RM but 
was associated with 24-hour PWV, RS, and AS (p<0.05).  
Discussion 
Using a cross-sectional design, we comprehensively examined sex differences in LV 
structure and function, 24-hour central hemodynamics and ventricular-vascular coupling in 
marathon runners and recreationally active adults. The main findings of this study were that: (1) 
female marathoners had larger LVMI and more optimal ventricular-vascular coupling compared 
to all other groups; (2) overall LV function was similar across all groups; and (3) females had 
lower central hemodynamic load than men irrespective of training status. Collectively, these 
findings suggest that although female marathoners had larger LVMI they did not have LV 
dysfunction, or increased central hemodynamic load and had better overall ventricular-vascular 
coupling. This finding suggests that cardiac hypertrophy in female marathoners was 
physiological and not pathological.  Moreover, while there were sex differences in central 
hemodynamics, chronic marathon training and racing does not appear to reduce LV function, or 
increase central hemodynamic load in otherwise healthy middle-aged men and women, 
suggesting that running multiple marathons is not detrimental to cardiovascular health.  
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LV Structure. Endurance athletes engage in prolonged frequent exercise, eliciting repeated 
increases in heart rate, blood pressure, stroke volume and cardiac output, which lead to increases 
in cardiac mass and dimensions [97]. Thus, chronic endurance trained individuals such as 
marathon runners are observed to have larger LVMI compared to non-endurance trained 
individuals [99, 100, 103]. In the current study, female marathoners had larger LVMI compared 
to recreationally active women. Despite training studies that indicate attenuated cardiac 
hypertrophy in women in response to endurance training [17], we found cross-sectional 
differences in LVMI that are consistent with increased cardiac mass reported in endurance 
athletes [97]. 
An unanticipated finding in the current study was that female marathoners had larger 
LVMI compared to male counterparts. Previous studies have noted, both in the general 
population and in endurance athletes, that women have smaller LVMI and volume compared to 
men [17-23]. Reasons for our findings might be physiological or methodological. In our sample, 
the total marathons completed by female marathoners in the past 20 years was greater than the 
males and may have contributed to why there was only a training effect in females. Moreover, 
we utilized 3DE to assess cardiac geometry. LV dimensions obtained from 3DE differ when 
compared to geometries obtained from conventional 2DE as 3DE does not rely on the same 
inherent assumptions for calculation of volumes (i.e. the LV is an ellipse).  Compared to 2DE, 
measures obtained from 3DE more closely approximate cardiac size determined by “gold 
standard” cardiac MRI [235]. Thus, use of 3DE may offer novel insight into sex-differences in 
cardiac adaptations with chronic exercise training.  Additional studies are needed using 3DE to 
quantify cardiac hypertrophy in marathon runners.  
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LV Function. Previous studies show that LV function might be better in athletes and in 
marathoners compared to other athletes and controls [3, 54, 236]. In our study, female 
marathoners had similar LV function compared to female controls. Studies in male marathoners 
find increased LVMI might be associated with decreased cardiac function [217, 219]. Thus, it 
might be expected that because female marathoners had larger LVMI in our sample, that they 
would also have lower LV function than female controls, but LV function was not lower in 
female marathon runners.  Our finding suggests that female marathoners have a larger LVMI but 
also preserved LV function. Thus, female marathoners appear to experience physiological 
cardiac enlargement in response to chronic marathon running. 
Although female marathoners had larger LVMI, we observed that both female and male 
marathoners had similar cardiac function, as measured by 3D LV strain, irrespective of training 
status. Previous studies suggest women in the general population have better overall LV function 
compared to men [30, 127]. In contrast to our hypothesis, we found no significant sex differences 
in LV function. Only one study to date has used 3DE to assess LV function via strain analyses in 
male athletes [77], which in accordance with our study, concluded that endurance athletes had 
similar strain to controls [77]. More studies are needed to examine the impact of chronic 
marathon training on cardiac function using 3DE to confirm our findings. Our results suggest 
that middle-aged adults who regularly run multiple marathons each year, do not have reduced 
LV function.  
 
24-hour Central Hemodynamic Load. Ventricular remodeling and cardiac function in 
endurance-trained individuals may be influenced by underlying central hemodynamic load.  
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Endurance exercise reduces arterial stiffness and pressure from wave reflections and thus is 
associated with reduced central hemodynamic load and better LV function [147-152]. However, 
some studies suggest that strenuous long-term endurance exercise training and acute endurance 
exercise may increase arterial stiffness and wave reflections [40, 41, 148, 153] in male marathon 
[40], and ultra-marathon [41] runners which may in turn have a detrimental effect on cardiac 
structure and function [177, 181, 182]. We found that both female and male marathoners had 
similar 24-hour arterial stiffness, blood pressure and wave reflections compared to recreationally 
active controls on both non-exercise and exercise days and this might explain similar LV 
function among groups. Our findings are in agreement with a few cross-sectional studies that 
note no differences in arterial stiffness and blood pressure between endurance athletes and 
controls [148, 158].  
Our study is the first study to examine sex differences in 24-hour arterial stiffness, blood 
pressure and wave reflections in marathon runners. We found that females irrespective of 
training status had lower 24-hour arterial stiffness, blood pressure and higher wave reflections 
compared to males. Our finding is supported by previous studies that find sex differences in 
resting hemodynamics whereby women have lower overall hemodynamic load compared to men 
[31-33, 42]. Our study extends these sex differences to the marathon runner population. 
Moreover, even though female marathoners had larger LVMI, they did not have higher central 
hemodynamic load on both non-exercise and exercise days, further supporting the notion that 
adaptations in LVMI are likely physiological and not pathological.  
 
Ventricular-Vascular Coupling. When we assessed ventricular-vascular coupling, a measure of 
the interaction between the LV and the arterial system to determine cardiac performance and 
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energetics, we found that female marathoners had better overall ventricular vascular coupling 
compared to both recreationally active controls and male counterparts. Adequate coupling 
between the LV and the arterial system is important as it results in optimal transfer of blood from 
the LV to the periphery without excessive changes in pressure [4]. Ventricular-vascular 
uncoupling with age in women has been linked to greater risk of heart failure with preserved 
ejection fraction [44, 48]. Thus, our findings suggest that aforementioned cardiac and vascular 
adaptations in female marathoners may contribute to more optimal overall ventricular-vascular 
coupling.  
 
Correlates of LV structure and function in men and women. Based on the theoretical 
relationships between LVMI, LV function, central hemodynamic load and ventricular vascular 
coupling, we explored various hemodynamic correlates of LVMI and LV function in women and 
men. In women, a larger LVMI was correlated with lower arterial stiffness, better LV function 
and better ventricular vascular coupling. However, in men LVMI was not associated with LV 
function, or central hemodynamics. Our findings suggest clear sex differences in correlates of 
LV structure and function and this is supported by previous studies [48]. This finding also 
substantiates our finding in the current study that female marathoners had a larger LVMI that 
might be associated with lower central hemodynamic load and better ventricular vascular 
coupling. 
 
Physical Activity Levels  
In the current study, we objectively measured physical activity levels in both marathoners and 
recreationally active controls. We found that female marathoners spent significantly more time in 
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MVPA and had more steps/day compared to recreationally active females, while male 
marathoners had similar levels of MVPA and steps/day to male controls. Furthermore, we found 
that both female and male marathoners spent a similar amount of time in vigorous and moderate 
activity/day as compared to their recreationally active counterparts. It might be expected that 
since marathoners engage in frequent high volumes of endurance exercise that they would be 
more active than their recreationally active counterparts. However, our findings are similar to 
few studies that have found low physical activity levels in marathon runners [237]. Reasons for 
the similarities in physical activity levels between marathoners and controls might be explained 
by high levels of inactivity in marathoners, despite frequent exercise training. Although 
marathoners might run once a day, most days of the week, the rest of their day they might spend 
a significant amount of time not very active or sitting and thus, are very sedentary or inactive. 
Indeed, studies suggest that marathoners actually spend up to 10 hours a day sitting during the 
week [237]. Future studies are necessary to examine physical activity levels in marathoners 
compared to non-marathoners to determine the implications of these findings.  
 
Limitations and Additional Considerations.  
Study Strengths. By design we did not incorporate a true sedentary control group. Recreationally 
active individuals are much healthier than sedentary individuals, as sedentary behavior is 
associated with increased central hemodynamic load and disease [203, 204]. Thus, incorporating 
a recreationally active control group into the current study was a strength. Additionally, 3DE is a 
novel, reliable technique and is a more technologically sensitive measurement compared to 2DE 
that is used in previous studies.  
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Study Limitations. All participants in the current study self-reported being of European descent 
or white, thus our study results cannot be extrapolated to other races and ethnicities. Reasons for 
lack of diversity in our study might be due to the lack of diversity in recruitment area of Central 
New York, timing of study measures being during the work day, lack of transportation and 
access to the study facilities or family obligations. Future studies should examine racial/ethnic 
differences in cardiovascular adaptations to endurance exercise. There are also potential 
limitations in our exploration of the relationship between measurements of ventricular vascular 
coupling and LVMI, in regards to multicollinearity, as indices used to calculate ventricular 
vascular coupling are also used in the calculation of LVMI. However, our findings from 
tonometry and 24-hour oscillometry support the overall findings that a larger LVMI in female 
marathoners is not pathological. Lastly, it is important to note, that this study was cross-sectional 
in nature and thus, we only have one 3DE measurement on these participants and do not know 
the dynamic LV changes that could occur due to training. As a first study to utilize 3DE to 
characterize sex differences in LVM and LV function in individuals who have run multiple 
marathons, we believe are findings are still novel and informative.  
 
Implications. The results of our study suggest that although female marathoners had larger LV 
mass, they had preserved LV function, lower central hemodynamic load and optimal ventricular-
vascular coupling. Previous studies that examine male marathoners with similar cardiac 
adaptations show that a larger ventricle is associated with reduced function, and higher 
hemodynamic load [215-217]. Thus, female sex may confer a level of cardio-protection from 
possible cardiac mal-adaptations with habitual endurance exercise training.  Understanding the 
ventricular-vascular response to regular endurance exercise may also have important clinical 
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implications for women as ventricular-vascular uncoupling with age in women has been linked 
to greater risk of heart failure with preserved ejection fraction [44, 48].  Recoupling with 
endurance exercise may offer an important therapeutic strategy to mitigate CVD risk in women 
[224].  
 
Conclusions. The main findings of this study were that: (1) female marathoners had larger 
LVMI and better ventricular-vascular coupling compared to all other groups; (2) overall LV 
function was similar among all groups; (3) females had lower central hemodynamic load then 
men irrespective of training status. Our findings suggest that although female marathoners had 
larger LVMI they did not have LV dysfunction or increased central hemodynamics load and had 
better overall ventricular-vascular coupling. Moreover, while there were sex differences in 
central hemodynamics, chronic marathon training and racing does not appear to reduce LV 
function, or increase central hemodynamic load in otherwise healthy middle-aged men and 
women, suggesting that running multiple marathons is not detrimental to cardiovascular health. 
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Table 1: Characteristics of Marathoners and Controls  
 
Variable    
Female 
Marathon
ers (n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoner
s (n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
Anthropometrics 
     Age (years) 41±5 42±5 42±5 42±4 0.83 0.75 0.27 
     Height (cm) 164±7* 165±6† 178±7 178±7 0.00 0.95 0.51 
     Weight (kg) 62±8* 68±12† 82±12 81±3 0.00 0.37 0.20 
     Body Mass Index (kg/m2) 22.7±3.1* 24.3±4.0† 29.7±4.7 29.5±4.7 0.00 0.31 0.20 
     Waist Circumference (cm) 76±8* 79±9† 89±11 90±8 0.00 0.21 0.33 
     Body fat (%) 23.1±6.2*‡ 28.9±9.3† 20.4±7.1† 22.0±7.0 0.00 0.01 0.16 
     3-Dimensional BSA (m2) 1.60±0.13* 1.67±0.15† 1.90±0.15 1.90±0.17 0.00 0.32 0.16 
Lipid Profile        
    Total Cholesterol (mg/dl) 187±23 198±35 197±40 196±42 0.54 0.55 0.45 
    High Density Lipoprotein (mg/dl) 72±15* 66±19† 56±13 53±17 0.00 0.17 0.67 
    Glucose (mg/dl) 84±7* 90±8† 96±8 94±8 0.00 0.13 0.01 
    Triglycerides (mg/dl) 89±34 117±86 113±58 109±55 0.49 0.41 0.25 
    Low Density Lipoprotein (mg/dl) 97±30* 114±32† 121±39 123±41 0.03 0.21 0.29 
   Non-High Density Lipoprotein (mg/dl) 115±28* 135±36† 141±41 143±44 0.03 0.18 0.27 
    Total Cholesterol/High Density Lipoprotein 2.7±0.9* 3.4±1.4† 3.7±1.1 4.2±2.0 0.00 0.06 0.98 
Red Blood Cell Profile        
   Hematocrit (%) 44±4 44±4 44±5 46±4 0.33 0.29 0.29 
   Hemoglobin (mg/dl) 13.0±1.1* 13.1±0.7† 14.3±1.3 14.6±1.1 0.00 0.35 0.91 
BSA, Body Surface Area. ‡Significantly different than female controls; *Significantly different than male marathoners; †Significantly 
different than male controls; Significance level at p<0.05. SxT interaction, Sex x Training Interaction.  
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Table 2: Marathon History, Fitness and Physical Activity Levels  
 
 
 
 
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoners 
(n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
Marathon History        
   Number of Marathon in last 20 years (#) 16.2±12.4 - 15.0±15.4 - 0.05 - - 
   Number of Marathons in last 5 years (#) 10.7±10.0 - 9.2±8.2 - 0.15 - - 
   Number of Marathons in last 3 years (#) 6.5±1.0  6.7±1.5 - 0.18 - - 
   Number of Marathons in last 1 year (#) 3.1±2.0 - 2.0±2.0 - 0.08 - - 
   Average Marathon Finishing Time (hours) 4.0±0.6 - 3.7±0.8 - 0.08 - - 
   Miles per week (miles) 40.8±5.0 - 42.1±3.0 - 0.10 - - 
   Average Running Pace (mph) 6-8mph - 6-8mph -  - - - 
   Lifetime Training Hours (hrs) 5616±1000 - 5200±900 - 0.30 - - 
Aerobic Fitness Levels        
   VO2 max (ml/kg/min) 47.5±5.5*‡ 38.6±8.1 53.4±6.1† 49.8±6.9 0.00 0.00 0.07 
   VO2 Max (ml/FFM/min) 61.9±6.2*‡ 53.7±8.9† 66.9±7.1 63.4±7.4 0.00 0.00 0.09 
   VO2 Max Age Percentile (%)^ 97.5 77.5 99.0† 78.0 0.32 0.04 0.50 
   Heart Rate max (bpm) 179±9* 181±12 176±8† 184±11 0.00 0.05 0.03 
Physical Activity Levels^        
   Time spent in MVPA (min/day) ^ 55±25‡ 34±15 55±20 41±21 0.57 0.00 0.43 
   Mean Steps Per Day (#) ^ 11679±4231‡ 8158±1910 9969±2114 9227±2772 0.87 0.00 0.22 
   Mean Duration of Vigorous (min/day)^ 11.75±12.7 6.4±8.2 10.0±13.7 8.9±11.4 0.97 0.27 0.41 
   Moderate Intensity Minutes (min/day)^ 46.5±22.6‡ 27.2±13.3 41.8±22.7† 33.4±16.0 0.55 0.00 0.72 
   Metabolic Equivalents (min/week) 6988±6704 2895±267 5543±4678 6908±11402 0.79 0.88 0.06 
^ACSM Guidelines Age Percentiles. Accelorometry measured over a 7-day period; MVPA, Moderate to Vigorous Physical 
Activity. SxT interaction, Sex x Training Interaction. ‡Significantly different than female controls; *Significantly different 
than male marathoners; †Significantly different than male controls; Significance level at p<0.05. 
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Table 3: Resting Brachial Blood Pressure and Aortic Hemodynamics  
 
 
Figure 4.1: LVMI 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoners 
(n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
Brachial 
   SBP (mmHg) 114±10* 114±13† 125±9 124±8 0.00 0.74 0.94 
   DBP (mmHg) 74±7* 75±8† 77±8 79±6 0.02 0.28 0.86 
   Mean Pressure (mmHg) 88±7 88±9 93±8 93±6 0.12 0.05 0.05 
   Heart Rate (bpm) 51±6*‡ 59±10† 49±7† 56±8 0.09 0.00 0.97 
Aortic        
   SBP (mmHg) 108±10* 107±14† 118±11 114±7 0.00 0.23 0.47 
   DBP (mmHg) 74±6* 75±8† 77±7 79±6 0.01 0.21 0.91 
   PWV (m/s) 6.2±1.0* 6.6±1.2† 7.2±1.1 6.8±1.0 0.01 0.96 0.07 
   AIx (%) 27±11* 28±16† 15±16 14±13 0.00 0.58 0.56 
   RM 0.74±0.15* 0.68±0.15† 0.62±0.17 0.56±0.14 0.00 0.08 0.91 
   Pf (mmHg) 22±4* 20±6† 30±10† 26±5 0.00 0.02 0.42 
   Pb (mmHg) 16±3 13±4 18±5† 14±4 0.08 0.00 0.94 
   ESP (mmHg) 93±7* 90±10† 87±9† 97±9 0.00 0.42 0.79 
Ea/Elv        
   Ea 1.46±0.26*‡ 1.76±0.70† 1.43±0.50 1.43±0.40 0.01 0.01 0.79 
   Elv 2.30±0.62* 2.21±0.61† 1.71±0.71 1.81±0.64 0.01 0.45 0.70 
   Ea/Elv 0.67±0.20*‡† 0.93±0.36† 0.85±0.42 0.85±0.31 0.05 0.05 0.41 
SBP, Systolic Blood Pressure DBP, Diastolic Blood Pressure PWV, pulse wave velocity AIx, Augmentation Index; RM, Reflection 
Magnitude (Pb:Pf);  Pb, Backward Pressure due to Wave Reflections;  Pf, Forward Pressure due to Wave Reflections; Ea, arterial 
elastance; Elv, ventricular elastance; ‡Significantly different than female controls; *Significantly different than male marathoners; 
†Significantly different than male controls; Significance level at p<0.05. SxT interaction, Sex x Training Interaction.        
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‡Significantly different than female controls; *Significantly different than male marathoners; †Significantly different than male 
controls; Significance level at p<0.05. 
 
 
 
Figure 4.2: LV Area Strain  
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Table 4: 3-Dimensional Echocardiography: LV Structure and Function  
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Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoners 
(n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect  
Training 
Effect 
SxT 
Interaction 
LV Structure         
   LVM (g)  120±9* 117±9† 130±15 129±15 0.00 0.30 0.94 
   EDV (ml)  107±17* 101±20† 137±26 132±32 0.00 0.15 0.69 
   ESV (ml)  43±11* 44±15† 64±20 60±20 0.00 0.64 0.43 
   SV (ml)  64±11* 56±16† 73±18 73±20 0.00 0.16 0.21 
   SV/BSA (L/m2) 39±7 33±10 38±9 38±9 0.70 0.06 0.10 
   Q (L/min) 3.5±0.8* 3.7±1.0 3.8±0.89 4.3±1.3 0.04 0.23 0.26 
   Q/BSA (L/min/m2)  2.6±0.4 2.1±0.6 1.9±0.5 2.1±0.5 0.33 0.48 0.20 
LV Function         
   Ejection Fraction (%)  60.2±6.9 56.1±10.4 53.5±9.9 54.9±8.5 0.26 0.40 0.10 
   3D Longitudinal Strain (%) -17.8±4.2 -15.8±5.0 -15.7±2.9 -16.3±4.4 0.20 0.55 0.16 
   3D Circumferential Strain (%) -17.3±3.9 -15.6±3.6 -15.8±3.2 -16.2±3.3 0.41 0.32 0.32 
   3D Area Strain (%) -29.4±5.2 -25.8±6.5 -26.7±4.4 -26.9±5.8 0.28 0.31 0.23 
   3D Radial Strain (%) 51.5±15.6 44.2±14.5 43.7±10.3 45.6±12.0 0.25 0.21 0.34 
BSA, Body Surface Area.; LVM, Left Ventricle Mass; LVMI, Left Ventricle Mass Index; EDV, End Diastolic Volume; ESV, End 
Systolic Volume; 3D, 3 dimensional. SV, Stroke Volume; Q, Cardiac Output; ‡Significantly different than female controls; 
*Significantly different than male marathoners; †Significantly different than male controls; Significance Level at p<0.05. SxT 
interaction, Sex x Training Interaction. 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Non-exercise 24-hour aSBP 
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*Significantly different than male marathoners; †Significantly different than male controls; Significance Level at p<0.05 
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Table 5: Non-exercise 24-hour Central Hemodynamics   
Variable^   
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoner
s (n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
SBP (mmHg) 108±8* 111±10† 116±6 115±6 0.00 0.29 0.08 
MAP (mmHg) 85±7* 88±9† 93±5 92±5 0.00 0.45 0.10 
DBP (mmHg) 66±6* 68±8† 74±4 83±5 0.00 0.73 0.16 
PP (mmHg) 42±6 43±5 42±5 42±5 0.75 0.23 0.36 
Heart Rate (bpm) 59±6*‡ 66±8† 55±6† 61±6 0.00 0.00 0.85 
aSBP (mmHg) 116±9* 113±11† 131±10† 124±9 0.00 0.03 0.22 
aDBP (mmHg) 72±6* 70±9† 79±7 74±17 0.02 0.12 0.47 
aPP (mmHg) 49±9* 49±9† 56±9 51±7 0.00 0.11 0.15 
AIx (%) 16±12* 16±19† 13±4 12±5 0.16 0.91 0.81 
PWV (m/s) 5.9±0.5* 5.9±1.1† 6.2±0.5 6.0±0.5 0.05 0.92 0.24 
RM  0.63±0.06* 0.67±0.04† 0.61±0.04 0.57±0.10 0.00 0.99 0.08 
Pb (mmHg) 14±3 15±3 15±4 16±4 0.73 0.90 0.04 
Pf (mmHg) 22±4 22±4 24±7 23±5 0.18 0.98 0.36 
^All Variables expressed as AUC/relative to number of measurements. SBP, Systolic Blood Pressure; MAP, Mean Arterial Pressure; 
DBP, Diastolic Blood Pressure; PP, Pulse Pressure; aSBP, Aortic Systolic Blood Pressure; aDBP, Aortic Diastolic Blood Pressure; 
aPP, Aortic Pulse Pressure; AIx, Augmentation Index; RM, Reflection Magnitude; Pb, Reflected Wave Pressure; Pf, Forward Wave 
Pressure. ‡Significantly different than female controls; *Significantly different than male marathoners; †Significantly different than 
male controls; Significance Level, p<0.05. SxT interaction, Sex x Training Interaction. 
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Figure 4.4: Post-exercise 24-hour aSBP 
 
 
 
*Significantly different than male marathoners; †Significantly different than male controls; Significance Level at p<0.05 
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Table 6: 24-hour Central Hemodynamics Post-Aerobic Exercise 
 
Variable^   
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoners 
(n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
SBP (mmHg) 108±7* 111±12† 115±6 114±6 0.00 0.17 0.15 
MAP (mmHg) 86±6* 88±10† 92±5 92±5 0.00 0.20 0.33 
DBP (mmHg) 67±6* 68±10† 72±5 73±7 0.00 0.31 0.68 
PP (mmHg) 41±6 43±5 42±4 42±4 0.80 0.37 0.06 
Heart Rate (bpm) 59±6*‡ 67±7† 54±7† 61±8 0.00 0.00 0.84 
aSBP (mmHg) 114±7* 113±11† 127±10 122±8 0.00 0.28 0.51 
aDBP (mmHg) 72±7* 67±7† 75±5 77±9 0.00 0.45 0.17 
aPP (mmHg) 44±8* 46±5† 53±5 49±7 0.00 0.73 0.97 
AIx (%) 17±11 16±15 14±6 16±4 0.21 0.47 0.51 
PWV (m/s) 5.9±0.5 5.8±0.5 6.0±0.5 6.0±0.5 0.23 0.73 0.97 
RM  0.62±0.06* 0.65±0.08† 0.60±0.05 0.58±0.10 0.00 0.92 0.06 
Pb (mmHg) 13.6±3.5 14.2±2.6 13.4±2.6 12.7±3.8 0.22 0.93 0.19 
Pf (mmHg) 21.6±5.0 21.8±3.0 22.1±3.9 21.7±4.8 0.80 0.94 0.61 
^All Variables expressed as AUC/relative to number of measurements. SBP, Systolic Blood Pressure; MAP, Mean Arterial Pressure; 
DBP, Diastolic Blood Pressure; PP, Pulse Pressure; HR, Heart Rate; aSBP, Aortic Systolic Blood Pressure; aDBP, Aortic Diastolic 
Blood Pressure; aPP, Aortic Pulse Pressure; AIx, Augmentation Index; RM, Reflection Magnitude; Pb, Reflected Wave Pressure; Pf, 
Forward Wave Pressure. ‡Significantly different than female controls; *Significantly different than male marathoners; †Significantly 
different than male controls; Significance Level, p<0.05. SxT interaction, Sex x Training Interaction. 
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Variable  
 
 
 
 
 
Area 
Strain 
 
 
 
 
 
Radial 
Strain 
 
 
 
 
 
24-hour 
PWV 
 
 
 
 
 
 
3D LVMI 
 
 
 
 
 
24-hour 
SBP  
 
 
 
 
 
24-hour 
aSBP  
 
 
 
 
 
24-hour 
AIx  
 
 
 
 
 
24-hour 
RM  
 
 
 
 
 
 
Ea 
 
 
 
 
 
 
Elv 
Radial Strain  -0.929* 
     
    
24-hour PWV 0.346* -0.348* 
    
    
3D LVMI -0.440* 0.370* -0.100 
   
    
24-hour SBP 0.290* -0.308* 0.168 -0.249 
  
    
24-hour aSBP 0.214 -0.237 0.080 -0.021 0.749* 
 
    
24-hour AIx -0.116 0.140 -0.141 -0.056 -0.034 0.142     
24-hour RM 0.108 -0.043 0.251 -0.122 0.018 0.001 0.789*    
Ea 0.635* -0.551* 0.184 -0.265* 0.195    0.115 0.123 0.075   
Elv -0.316* 0.317* -0.213 0.202 -0.203  -0.035 0.134 0.076 0.180  
Ea/Elv 0.681* -0.590* 0.303* -0.334* 0.088 0.090 -0.693* 0.133 0.730* -0.581* 
*Correlation is significant at the 0.05 level (2-tailed).  
2D, Two-dimensional        
    
  
3D, Three-dimensional   
  
  
 
LV, Left Ventricle       
LVM, Left Ventricle Mass  
  
  
 
BSA, Body Surface Area       
24-hour values are AUC/relative       
SBP, Systolic Blood Pressure       
a, Aortic  
  
  
 
AIx, Augmentation Index 
RM, Reflection Magnitude        
    
  
Table 7: Vascular correlates of LV Structure and Function in Women 
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Variable  
 
 
Area 
Strain 
 
 
Radial 
Strain 
 
 
24-hour 
PWV 
 
 
3D 
LVMI 
 
 
24-hour 
SBP  
 
 
24-hour 
aSBP  
 
 
24-hour 
AIx  
 
 
24-hour 
RM  Ea 
 
 
 
Elv 
Radial Strain  -0.919 
       
  
24-hour PWV 0.023 -0.191 
      
  
3D LVMI 0.084 -0.024 -0.297 
     
  
24-hours SBP  0.048 -0.152  0.462* -0.215 
    
  
24-hours aSBP 0.015 -0.126 0.146 -0.074 0.556* 
   
  
24-hour AIx -0.179 0.126 -0.084 -0.044 -0.048 -0.084 
  
  
24-hour RM 0.211 -0.285 -0.022 0.166 0.063 0.256 0.318* 
 
  
Ea 0.399* -0.399* -0.034 -0.272 -0.141 -0.084 -0.181 0.045   
Elv -0.612* 0.653* -0.375* -0.210 -0.158 -0.060 -0.080 -0.078 0.241  
Ea/Elv 0.835* 0.786* 0.550* -0.091 0.142 0.156 -0.049 0.212 0.509* -0.644* 
*Correlation is significant at the 0.05 level (2-tailed).   
2D, Two-dimensional            
3D, Three-dimensional            
LV, Left Ventricle           
LVM, Left Ventricle Mass           
BSA, Body Surface Area          
 
24-hour values are AUC/relative            
SBP, systolic Blood Pressure            
PP, Pulse Pressure            
a, Aortic           
AIx, Augmentation Index           
RM, Reflection Magnitude 
PWV, Pulse Wave Velocity           
 
 
 
Table 8: Vascular correlates of LV Structure and Function in Men 
 
Supplemental Table 9: Comparison of Non-exercise 24-hour hemodynamics to Post-AE hemodynamics 
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^All Variables expressed as AUC/relative to number of measurements. SBP, Systolic Blood Pressure; MAP, Mean Arterial Pressure; 
DBP, Diastolic Blood Pressure; PP, Pulse Pressure; HR, Heart Rate; aSBP, Aortic Systolic Blood Pressure; aDBP, Aortic Diastolic 
Blood Pressure; aPP, Aortic Pulse Pressure; AIx, Augmentation Index; PWV, Pulse-wave velocity; RM, Reflection Magnitude; Pb, 
Reflected Wave Pressure; Pf, Forward Wave Pressure. ‡Significantly different than female controls; *Significantly different than male 
marathoners; †Significantly different than male controls; Significance Level, p<0.05. SxT interaction, Sex x Training Interaction. 
 
Variable^   
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathoners 
(n=24) 
Male 
controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
Time 
Effect 
SxTxTime 
Interaction 
Non-exercise SBP (mmHg) 108±8 111±10 116±6 115±6 0.35 0.78 0.41 0.83 
Post-AE SBP (mmHg) 108±7 111±12 115±6 114±6     
Non-exercise aSBP (mmHg) 116±9* 113±11† 131±10 124±9 0.00 0.15 0.93 0.56 
Post-AE aSBP (mmHg) 114±7* 113±11† 127±10 122±8     
Non-exercise aPP (mmHg) 49±9* 49±9† 56±9 51±7 0.00 0.73 0.15 0.21 
Post-AE aPP (mmHg) 44±8* 46±5† 53±5 49±7     
Non-exercise MAP (mmHg) 85±7 88±9 93±5 92±5 0.18 0.48 0.30 0.43 
Post-AE MAP (mmHg) 86±6 88±10 92±5 92±5     
Non-exercise AIx (%) 16±12 16±19 13±4 12±5 0.09 0.45 0.31 0.20 
Post-AE AIx (%) 17±11 16±15 14±6 16±4     
Non-exercise PWV (m/s) 5.9±0.5 6.1±1.1 6.2±0.5 6.0±0.5 0.32 0.83      0.41        0.95 
Post-AE PWV (m/s) 5.9±0.5 5.8±0.5 6.0±0.5 6.0±0.5     
Non-exercise Pb (mmHg) 14±3 15±3 15±4 13.1±4 0.96 0.41 0.07 0.06 
Post-AE Pb (mmHg) 14±3 14±3 13±3 13±4     
Non-exercise Pf (mmHg) 22±4 22±4 24±7 23±5 0.30 0.98 0.36 0.51 
Post-AE Pf (mmHg) 22±5 22±3 22±4 22±5     
Non-exercise RM 0.63±0.06 0.67±0.04 0.61±0.04 0.57±0.10 0.38 0.81 0.70 0.46 
Post-AE RM 0.62±0.06 0.65±0.08 0.60±0.05 0.58±0.10     
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Chapter V: Summary, Future Directions and Conclusions 
 Over the past few decades there has been increased participation in endurance events, such as 
marathons. The impact of aerobic exercise on risk for CVD is well-established as beneficial for 
the cardiovascular system. However, there is some debate as to whether excessive endurance 
exercise, such as completing multiple marathons, is detrimental to the cardiovascular system. 
Some studies in male marathoners note adverse cardiac structural remodeling, ventricular 
contractile abnormalities [2, 3] coronary artery calcification and fibrosis [2, 3]. Despite, well-
established sex differences in cardiovascular risk and physiology across the lifespan, and an 
increase in the number of women marathon participants, no studies have examined sex 
differences in the impact of chronic endurance exercise on cardiovascular system. Thus, our 
study examined sex differences in cardiovascular structure, function and vascular hemodynamics 
in marathon runners and recreationally active individuals.  
Our initial hypotheses were largely unsupported by our findings (Figure 5.1). 
Unexpectedly, we found that female marathoners had larger relative LV and better ventricular 
vascular coupling compared to recreationally active females and male counterparts. Additionally, 
we found marathoners to have similar LV function and 24-hour hemodynamics compared to 
recreationally active controls. However, females irrespective of training status had lower overall 
hemodynamic load. This suggests that running multiple marathons does not appear to reduce LV 
function or increase hemodynamic load (i.e. blood pressure, aortic stiffness and wave reflections) 
in middle aged men and women. Upon further exploration, female marathoners also had 
significantly higher ventricular-vascular coupling, an index for myocardial performance and 
efficiency. Indeed, our data suggests that a larger LVMI in female marathoners was associated 
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with increased cardiac contractility and efficiency, lower hemodynamic stress, and preserved LV 
function.  
 
Figure 5.1: Theoretical Framework with Hypotheses and Findings. Red indicates findings that 
did not support our hypotheses. 
   
Implications 
CVD is the leading cause of morbidity and mortality in women in the United States 
[195]. With increasing age, risk for CVD in women exceeds that in men [196]. It is expected that 
by 2020 approximately 20% of the population of the United States will be 65 years or older 
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[197]. As women age, they experience greater increases in artery stiffness and hypertension 
compared to men, which contributes to reduced LV function and increased incidence of heart 
failure. Therefore, it is important that we examine how strategies to reduce risk for CVD, impact 
at risk populations, such as women. 
 Aerobic exercise is a well-established and effective lifestyle strategy to attenuate risk for 
CVD in women [198-200]. Over the past 30 years there has been a steady increase in the number 
of women racing competitive endurance events such as marathons. However, there is little 
research examining the effects of this chronic strenuous endurance exercise training on 
cardiovascular health in women. Recent research in men suggests the potential for adverse 
ventricular remodeling, coronary plaque, and myocardial fibrosis, which are associated with 
cardiac arrhythmias and sudden cardiac death [27-29].  
The results of our study suggest that although female marathoners had larger LV mass, 
they had preserved LV function, lower central hemodynamic load and optimal ventricular-
vascular coupling. Previous studies that examine male marathoners with similar cardiac 
adaptations show that a larger ventricle is associated with reduced function, and higher 
hemodynamic load. Thus, female sex may confer a level of cardio-protection from possible 
cardiac mal-adaptations with habitual endurance exercise training.  Understanding the 
ventricular-vascular response to regular endurance exercise may also have important clinical 
implications for women as ventricular-vascular uncoupling with age in women has been linked 
to greater risk of heart failure with preserved ejection fraction [44, 48].  Recoupling with 
endurance exercise may offer an important therapeutic strategy to mitigate CVD risk in women 
[224].  
Future Directions  
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Future studies stemming from this study might examine older marathoners (>50 years) to 
determine whether these sex differences extend into older age, particularly when women reach 
menopause. Prior to menopause women are expected to have lower cardiovascular risk than age-
matched men [238]. Indeed, pre-menopausal women have lower hemodynamic stress compared 
to men [45, 238]. The results from our study confirm these previous findings and suggest that 
this is even true in female marathoners. However, risk for CVD in women shifts once women 
reach menopause. In post-menopausal women experience a larger reduction in vascular function 
and are at a two-fold increase for cardiovascular events after the age of 50 years, compared to 
men [238]. It would be compelling to determine whether chronic marathon running might 
prevent the menopause related increased in hemodynamic load. Equally, it would be interesting 
to determine if, similar to our findings, post-menopausal female marathoners have lower 
hemodynamic load compared to age-matched male marathoners.  
We evaluated sex differences in LV structure and function based on one single 
echocardiography measure. A future study might follow up with the participants in the current 
study to re-evaluate their LV structure, function and hemodynamics to determine whether these 
sex differences persist in 3-6 months or even 3-5 years. We do not know how dynamic the 
changes to the LV are in response to endurance training or whether our results were actually due 
to the marathon training or random error. In order to truly confirm our results, we would ideally 
like to perform a follow-up study with the current study participants. Another study possibility 
would be to include a true sedentary control group, in addition to the recreationally active and 
marathon group. This might give us a broader spectrum for the type of changes that occur to the 
LV in response to no physical activity or exercise compared to moderate levels of activity to 
marathon training. Although this study would then incorporate six study groups and be a 
109 
 
 
substantial study design to take on, it would provide insight into sex differences in LV function 
and hemodynamics across exercise groups.  
Furthermore, there is still limited research on sex differences in how chronic marathon 
running impacts the cardiovascular system beyond the level of the heart. For instance, we know 
there are physiological sex differences in the other systemic arteries, such as the leg (femoral) 
arteries that are readily impacted by marathon training. Systemic vascular health has implications 
for overall cardiovascular risk. Additionally, there are known sex differences in the 
cerebrovascular health and we currently do not know how chronic endurance exercise impacts 
cerebrovascular health. Cerebrovascular health has implications for overall cardiovascular risk, 
cerebrovascular disease and dementia. Thus, future studies might examine sex differences in 
femoral and cerebral hemodynamics in marathoners.   
During the course of the data collection for this study we simultaneously collected additional 
data to preliminarily examine sex differences on the effect of chronic endurance training on 
systemic vasculature. More specifically, during the first study visit, we examined femoral arterial 
health and simultaneously measured medial cerebral artery hemodynamics (measurements of 
brain blood flow). The following is a summary of our additional findings stemming from our 
investigation of sex differences in cardiac adaptations to chronic endurance exercise. These 
findings will be the subject of future studies and publications that examine sex differences in 
cardiovascular adaptations to chronic endurance exercise.  
Preliminary Data 1: Sex Differences in Cerebral Blood Flow and Vascular Hemodynamics in 
Marathon Runners 
Aortic stiffness increases with aging and is associated with cognitive decline [239, 240]. 
Increases in aortic stiffness may lead to increased cerebral pulsatility, which is associated with 
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reduced cerebral perfusion [136] [241] and increased risk for cerebrovascular disease and dementia 
[136] [241]. Interestingly, across the lifespan women have lower arterial stiffness and better 
cerebral perfusion compared to men [242]. Regular physical activity reduces arterial stiffness 
[243]. Thus, aerobic exercise is a strategy to reduce aortic stiffness, and improve cerebral 
perfusion. Although aerobic exercise has a favorable effect on arterial stiffness, too much exercise 
may be detrimental to the vasculature. For instance, marathon runners, who engage in habitual 
aerobic exercise may have increased arterial stiffness [40]. In contrast, the results of our current 
study suggest that marathoners have similar aortic stiffness compared to their recreationally active 
counterparts. Nonetheless, females irrespective of training status had lower arterial stiffness and 
blood pressure compared to men. However, to date no study has examined sex differences in 
cerebral perfusion and arterial stiffness in an endurance-trained or marathon runner population 
[244]. Thus, the purpose of the current study was to examine aortic stiffness and cerebral blood 
flow in male and female marathon runners and recreationally-active controls.  
Eighty-six marathon runners and recreationally active controls participated in the current 
study; n=19 male controls (age 41±4 years), n=23 male marathoners (age 42±5 years), n=25 female 
controls age (42±5 years), and n=19 female marathoners (42±5 years). Participants completed one 
visit to the Human Performance Laboratory, 12 hours fasted, no caffeine, alcohol or exercise.  
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Measures taken in addition to those already 
outlined in the current study (Chapter V) were: 
1) common carotid artery (CCA) stiffness 
measured using eTracking. The carotid artery 
was imaged below the carotid bulb using 
ultrasound (ProSound α7, Aloka, Tokyo, Japan) 
and a 7.5- 10.0 MHz linear-array probe; 2) 
Middle cerebral artery (MCA) blood velocity 
(MnV), pulsatility index (PI) were measured using Transcranial Doppler (TCD) using a 2-MHz 
transcranial probe applied to the left temporal window. A one-way Analysis of Variance 
(ANOVA) determined mean differences within and between groups on main outcomes. Data 
were analyzed in SPSS (SPSS Inc., IBM; Chicago, IL) with a significance level set a priori at 
p<0.05.  
The results from this data show that CBF MnV was similar between male marathoners and 
male controls (Table 5.2, 63±11 vs. 65±14 m/s, p<0.05) and female marathoners and female 
controls (80±15 vs. 74±14 m/s, p<0.05). Interestingly, CBF MnV was significantly higher in 
female marathoners compared to male marathoners (74±14 m/s vs. 63±11 m/s, p<0.05). Cerebral 
PI and aortic stiffness were similar between male marathoners and male controls (0.70±0.10 vs. 
0.71±0.10 and 6.8±1.1 vs. 7.0±1.1 m/s, respectively, p>0.05) and female marathoners and female 
controls and (0.70±0.10 vs. 0.72±0.08 and 6.8±1.0 vs. 6.5±1.1 m/s, respectively, p>0.05). Cerebral 
PI and aortic stiffness were also similar between male and female marathoners (0.71±0.10 vs 
0.70±0.10 vs. and 7.0±1.1 vs. 6.8±1.0 m/s, respectively, p>0.05). 
In conclusion, male marathoners and male controls had similar aortic stiffness, cerebral 
Middle cerebral artery blood 
pressure waveforms which 
comprise cerebral blood flow. 
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mean velocity and pulsatility. Female marathoners and female controls had similar aortic stiffness, 
cerebral mean velocity and pulsatility. Interestingly, female marathoners had significantly higher 
cerebral mean velocity compared to male marathoners. Thus, the current study suggests that 
regular participation in marathons is not detrimental or beneficial to arterial health or cerebral 
blood flow. Reasons that female marathoners may have better cerebral perfusion compared to male 
counterparts might be due to the protective effects of estradiol. Higher levels of estradiol are 
associated with increased systemic perfusion, improved arterial stiffness and increased cerebral 
perfusion. Notably, studies in post-menopausal women show with increasing age concomitant 
reductions in cerebral perfusion may be predominantly due to the absence of estrogen (10).   
 These data are similar to our findings that LV structure, function and hemodynamics were 
similar between marathoners and controls in both men and women. Additionally, similar to our 
findings regarding LVMI, female marathoners had better cerebral perfusion and cardiac 
performance compared to male marathoners. Increased cerebral perfusion in female marathoners 
may be associated with reduced risk for cerebrovascular disease and dementia. This is important 
as post-menopausal women have a two-fold risk for development of cardiovascular disease and 
development of dementia [226]. Thus, future studies are needed to determine whether these 
beneficial adaptations observed in female marathoners extend to post-menopausal women, when 
women lose the protective effects of estrogen.
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Table 5.1: Cerebral and Carotid Hemodynamics      
 
Male 
Marathoners 
Male 
Controls 
Female 
Marathoners Female Controls   
  (n=23) (n=19) (n=19) (n=25) Sex Effect Training Effect 
SXT 
Interaction  
Aortic SBP (mmHg) 114±10 109±12 111±13 110±12 0.00 0.74 0.94 
Aortic DBP (mmHg) 77±7 75±7 74±6 76±7 0.02 0.28 0.86 
Aortic PWV (m/s) 6.9±1.1 6.8±1.1 6.7±1.1 6.5±1.1 0.90 0.85 0.70 
MCA MnV (cm/s) 62±11 65±14 79±15* 74±14 0.02 0.35 0.55 
MCA PI  0.71±0.10 0.70±0.10 0.70±0.10 0.72±0.08 0.87 0.75 0.90 
CCA IMT systole (mm) 0.47±.07 0.54±.13 0.50±.14 0.48±0.11 0.39 0.30 0.09 
CCA Diameter systole (mm) 5.15±0.36 4.98±0.43 5.79±0.41 5.83±0.42 0.00 0.30 0.14 
CCA IMT End Diastole (mm) 0.44±0.06 0.49±0.09 0.48±0.16 0.46±0.10 0.72 0.63 0.10 
CCA Diameter End Diastole (mm) 5.60±0.36 5.34±0.47 6.26±0.47 6.27±0.47 0.00 0.13 0.10 
CCA PI 1.29±0.21 1.30±0.25 1.65±0.34 1.56±0.25 0.00 0.41 0.34 
CCA MnV (cm/s) 40.7±5.7 42.3±5.6 36.4±6.1 50.7±58.9 0.73 0.10 0.29 
SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; PWV, Pulse Wave Velocity; MnV, Mean Velocity; PI, Pulsatility Index; IMT, Intima Media Wall 
Thickness; CCA, Common carotid artery. * Significantly different than male marathoners, Significance, p<0.05.  
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Preliminary Data 2: Sex Differences in Femoral Hemodynamics in Marathon Runners  
Shear Stress is the frictional force of blood on the arterial wall and it is essential for arterial 
adaptations to various stimuli [160, 245]. At rest, shear stress exhibits a pattern whereby during 
systole the blood travels towards the periphery (antergrade shear) and during diastole the blood 
travels back towards the heart (retrograde shear). Antegrade shear has anti-atherogenic effects on 
the vasculature [160], while increases in retrograde shear are associated with proatherogenic 
effects [245]. Increases in retrograde shear are associated with increased arterial stiffness in the 
systemic vasculature [233]. The vasculature in the lower limbs, such as the femoral arteries are 
more susceptible to increases in retrograde shear. Thus, it is crucial to prevent increases in 
retrograde shear to reduce risk for atherosclerosis.  
Exercise is potent stimulus to augment blood flow, shear stress and thus, is beneficial to 
the vasculature. Exercise-trained arteries are notably larger in diameter and have attenuated 
retrograde blood flow and shear compared to sedentary individuals.  Exercise is thus, a beneficial 
means to attenuate resting retrograde shear. Endurance athletes, such as, marathon runners, 
engage in chronic prolonged bouts of exercise and thus, experience prolonged increases in shear 
stress. Some studies suggest that prolonged shear stress, such as occurs with endurance exercise, 
are paradoxically associated with increased arterial stiffness. Whether marathon runners have 
increased retrograde shear is unknown.  
 Given that marathoners predominately stress and train their legs, examining femoral 
blood flow patterns in marathon runners might provide ideal insight into the effects of chronic 
endurance exercise on femoral artery hemodynamics. Interestingly, women are reported to have 
lower aortic stiffness, and lower retrograde blood flow compared to men. However, it is 
currently unknown whether there are sex differences in leg blood flow patterns in marathon 
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runners. Thus, the aim of this study was to examine sex differences in superficial femoral artery 
stiffness and shear patterns in marathoners and recreationally-active adults.  
101 (53 female, 48 male) healthy marathon runners and recreationally active adults (35-50 
years) participated in the current study. Participants completed one visit to the Human Performance 
Laboratory, 12 hours fasted, no caffeine, alcohol or exercise.  
Measures taken in addition to those already outlined in the current study (Chapter V) 
were: 1) Femoral-Tibialis Anterior (Leg) Pulse Wave Velocity (PWV). Applanation tonometry 
of femoral and tibalis-anterior (ankle) pulse sites assessed pulse wave velocity as a measure of 
leg stiffness (SphygmoCor, AtCor Medical; Sydney, Australia); 2) 
Superficial Femoral Artery was imaged using Doppler ultrasound 
technology (ProSound α7, Aloka, Tokyo, Japan) The T- and R-
wave diameter and intima-media thickness (IMT) measurements 
were taken from their respective image; 3) Systolic antegrade, 
systolic retrograde, and diastolic antegrade, and mean blood 
velocity (Vm) were measured with Doppler ultrasound. These 
variables were automatically calculated by the echo-tracking software. Vm was computed with 
the following formula:!" = ∫!(&)(&/*+. ∫!(&)(& is the velocity-time integral of the velocity 
waveform, and FT is flow time; 4) Shear rate was calculated using the following formula: Shear 
rate= 4 x (Vm/Diameter). A one-way Analysis of Variance (ANOVA) determined mean 
differences within and between groups on main outcomes. Data were analyzed in SPSS (SPSS 
Inc., IBM; Chicago, IL) with a significance level set a priori at p<0.05. 
 The results from this data show that femoral-tibialis anterior PWV was significantly 
higher in males compared to females, independent of training status (Table 5.2; p<0.05). IMT in 
Systolic Antegrade Flow  
Diastolic 
Antegrade 
Flow 
Retrograde Flow  
SFA Blood Flow Patterns 
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end diastole was similar between males and females but significantly higher in male marathoners 
compared to male controls (p<0.05). IMT in end systole was similar between all groups 
(p>0.05). SFA diameter in end diastole and end systole was smaller in females than males but 
both marathoners had larger diameters compared to controls (p<0.05). There were no differences 
in antegrade and retrograde pulsatility index (PI) (p>0.05). Antegrade MnV was higher in 
females than males, independent of training status (p<0.05). Retrograde MnV and diastolic 
antegrade PI was significantly lower in female marathoners compared to both recreationally 
active females and men, independent of training status (p<0.05). Diastolic antegrade MnV was 
lower in females than males, irrespective of training status (p<0.05). Systolic and diastolic 
antegrade shear were higher in females than males (p<0.05). There were no differences in 
retrograde shear or oscillatory shear index (p>0.05).  
 In conclusion, marathoners had larger femoral arteries compared to the recreationally 
active adults. Femoral artery stiffness was higher in men compared to women. Although female 
marathoners had lower retrograde blood flow compared to both recreationally active females and 
males, retrograde shear was similar between all groups. Females overall had higher antegrade 
blood flow and shear compared to males. This data suggests that running multiple marathons 
does not increase retrograde blood flow or shear stress and thus, may not be pro-atherogenic. 
Moreover, females irrespective of training status had lower leg stiffness, higher antegrade blood 
flow and shear, suggesting women may have better arterial function, and reduced risk for 
systemic atherosclerosis. Reasons for why women have higher antegrade blood flow and shear 
stress might be due to the presence of estrogen which is known to potentiate the production of 
nitric oxide and other vasoactive substances to promote arterial vasodilation and augment shear 
stress [180].  
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 Similar to the findings of our larger scale study, marathon running does not appear to 
augment pro-atherogenic shear patterns in the femoral artery and is thus, not associated with 
increased atherosclerosis. Females regardless of training status have better leg blood flow, higher 
shear rates and lower leg artery stiffness. Future studies should incorporate indices of artery 
function to confirm these findings and examine femoral blood flow patterns in post-menopausal 
women to determine whether these findings extend to an older population that is at an increased 
risk for atherosclerosis.  
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Table 5.2: SFA 
Hemodynamics  
 
 
       
Variable  Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathone
rs (n=24) 
 
Male controls 
(n=24) 
 
 
Sex Effect 
 
 
Training 
Effect 
 
 
SxT  
Femoral-tibialis Anterior PWV (m/s) 4.2±3.0* 5.3±3.7* 5.8±4.3^ 7.2±3.8 0.03 0.15 0.79 
SFA IMT End Diastole (mm) 0.39±.06 0.39±0.08 0.42±0.10^ 0.36±0.06 0.96 0.03 0.12 
SFA Diameter End Diastole (mm) 5.30±0.52*^ 4.98±0.45* 6.79±0.53 6.46±0.82 0.00 0.00 0.85 
SFA IMT End Systole (mm) 0.39±0.06 0.38±0.06 0.40±0.07 0.37±0.08 0.91 0.32 0.57 
SFA Diameter End Systole (mm) 5.48±0.61*^ 5.18±0.51* 6.95±0.60^ 6.63±0.83 0.00 0.01 0.88 
SFA PI Systolic Antegrade 1.70±0.14 2.15±2.34 1.71±0.15    1.71±0.12 0.35 0.33 0.33 
SFA-MnV Systolic Antegrade (cm/s) 38.5±6.5* 38.0±8.5* 34.8±5.2 35.1±5.1 0.01 0.95 0.85 
SFA-PI Retrograde (cm/s) 1.34±1.1 1.12±0.23 1.26±0.55 1.14±0.30 0.81 0.17 0.64 
SFA-MnV Retrograde (cm/s) 15.7±2.2*^ 18.1±3.9 18.4±4.3 19.2±3.9 0.04 0.04 0.43 
SFA-PI Diastolic Antegrade (cm/s) 0.76±0.27* 0.85±0.36 0.95±0.28 0.89±0.31 0.05 0.98 0.35 
SFA-MnV Diastolic Antegrade (cm/s) 9.2±2.5^ 8.6±1.7 9.8±1.4 10.1±1.6 0.01 0.48 0.15 
Systolic Antegrade shear (/s) 281.0* 293.4* 218.7 211.8 0.04 0.18 0.65 
Retrograde Shear (/s) 118.5 145.4 108.4 118.9 0.10 0.15 0.75 
Diastolic Antegrade Shear (/s) 67.2*^ 66.4* 56.4 60.9 0.05 0.25 0.65 
Oscillatory Shear Index  0.30 0.30 0.30 0.40 0.85 0.86 0.96 
 PWV, Pulse Wave Velocity; SFA, superficial femoral artery; IMT, Intima thickness; PI, Pulsatility 
Index; MnV, Mean Velocity; *Significantly different than males; ^Significantly different than controls, 
p<0.05.  
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Additional Considerations: Impact of Race and Ethnicity.  
In the current study, all participants self-reported Caucasian (i.e. White or of European 
Descent) as their race/ethnicity. This may be reflective of the actual race/ethnic make-up of 
marathon race participation. In the United States, it is reported that 90% of marathon finishers 
are White, 5.1% Hispanic, 3.9% Asian/Pacific Islander, and 1.6% Black [223].  Reasons for a 
lack of diversity in the marathon running population may be due to specific barriers to 
participation and/or social and cultural stereotypes that surround sport participation and success.  
 Some barriers to marathon race participation might be 1) access to training programs, 
gym facilities, and coaches; 2) cost of race participation and training equipment; 3) time to train 
due to family or job obligations (as a few examples). Additionally, social and cultural stereotypes 
exist with regards to sport participation and success. In particular, some cultures perceive that 
only certain sports are performed by certain races or ethnicities. Similarly, some cultures 
perceive they will only have success in certain sports based on the stereotypes projected from 
society and culture (i.e. professional sports). Efforts through scholarships, education, and 
increased access to training opportunities should be made to reduce the diversity gap in marathon 
race participation.  
 Moreover, there are well-established racial and ethnic differences in risk for 
cardiovascular disease (CVD) across the lifespan [246]. Risk for CVD and CVD mortality is 
higher in blacks compared with white counterparts [246]. Interestingly, despite Hispanics having 
a higher risk for CVD they have a lower overall CVD mortality compared to [247] non-Hispanic 
counterparts. Asians/Pacific Islanders have lower CVD risk and mortality but a higher risk for 
stroke [248]. These racial and ethnic differences in CVD risk and mortality might stem from 
well-established racial and ethnic differences in vascular function. In particular, studies in 
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African Americans have shown that African Americans have higher blood pressure [250], 
arterial stiffness [251] and development of heart failure [252] earlier in life compared with white 
Americans, and this is apparent across the life span [251, 253, 254]. Additionally, African 
Americans have been reported to have an exaggerated blood pressure response to acute exercise 
which might impact heightened risk for CVD [255]. Both resting and exercise related 
cardiovascular function is less clear in Asian and Hispanic populations. Future studies are 
necessary to examine the racial and ethnic differences in cardiovascular responses to endurance 
exercise. In regards to the current study, future studies are necessary to discern the effect of 
chronic endurance exercise (i.e. marathons) on cardiovascular function and risk for CVD in a 
multi-ethnic population.  
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Conclusion 
The main findings of this study were that: (1) female marathoners had larger LVMI and better 
ventricular-vascular coupling compared to all other groups; (2) overall LV function was similar 
among all groups; (3) females had lower central hemodynamic load then men irrespective of 
training status. Our findings suggest that although female marathoners had larger LVMI they did 
not have LV dysfunction or increased central hemodynamics load and had better overall 
ventricular-vascular coupling. Thus, female marathoners experienced physiological not 
pathological cardiac hypertrophy. Moreover, while there were sex differences in central 
hemodynamics, chronic marathon training and racing does not appear to reduce LV function, or 
increase central hemodynamic load in otherwise healthy middle-aged men and women, 
suggesting that running multiple marathons is not detrimental to cardiovascular health. 
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Summary of Findings  
• Female marathoners had larger LVMI and better ventricular-vascular coupling compared to all 
other groups. 
• Overall LV function was similar among all groups. 
• Females had lower central hemodynamic load then men irrespective of training status. 
• Female marathoners had larger LVMI they did not have LV dysfunction or increased central 
hemodynamics load and had better overall ventricular-vascular coupling. 
• Chronic marathon training and racing does not appear to reduce LV function, or increase central 
hemodynamic load in otherwise healthy middle-aged men and women. 
• Running multiple marathons is not detrimental to cardiovascular health in middle-aged men and 
women. 
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provided with a copy of the consent form. Regulations also require that you keep a copy 
of this document for a minimum of three years after your study is closed.  
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125 
 
 
subjects or others must be reported to the IRB within 10 working days of occurrence.  
 
Research Integrity & Protections | 214 Lyman Hall | Syracuse, NY 13244-1200 | 
315.443.3013 | orip.syr.edu  
Thank you for your cooperation in our shared efforts to assure that the rights and 
welfare of people participating in research are protected.  
Katherine McDonald IRB Chair  
DEPT: Exercise Science, 820 Comstock Ave. – Rm. 201CC: Kan Liu, Wesley Lefferts, 
Jacqueline Augustine, Jacob DeBlois, Robert Voelker  
 
Research Integrity & Protections | 214 Lyman Hall | Syracuse, NY 13244-1200 | 
315.443.3013 | orip.syr.edu  
  
 
 
 
 
 
 
 
 
 
 
 
126 
 
 
 
DATE: August 1, 2017  
 
TO: Kan Liu, MD, PhD  
FROM: SUNY Upstate IRB  
 
SUBMISSION TYPE: Amendment/Modification  
PROJECT TITLE: [1005999-4] Sex Differences in Cardiovascular Adaptations to 
Chronic Endurance Exercise  
 
UPSTATE IRB #: 2017-0  
 
ACTION: APPROVED  
APPROVAL DATE: August 1, 2017  
EXPIRATION DATE: March 12, 2018  
REVIEW TYPE: Expedited Review  
 
 
Thank you for your submission of Amendment/Modification materials for this project. 
The SUNY Upstate IRB has APPROVED your submission. The materials submitted 
were reviewed in accordance with Federally-defined categories of expedited review 
outlined in 45 CFR 46.110(b) and 21 CFR56.110(b).  
All research must be conducted in accordance with this approved submission. As the 
Principal Investigator, you are responsible for the overall conduct of this research study.  
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Please note that any modifications to the project as approved must be reviewed and 
approved by this committee prior to initiation (unless the change is required to eliminate 
an immediate hazard to the subjects).  
Where obtaining informed consent/permission/assent is required as a condition of 
approval, be sure to assess subject capacity in every case, and continue to monitor the 
subject's willingness to be in the study throughout his/her duration of participation. Only 
use current, Upstate-stamped forms in the consent process and retain a complete copy of 
each signed form with your study records. Consent must be obtained and documented 
prior to the initiation of any study procedures. Provide each participant with a complete 
copy of the signed consent document.  
Report All UNANTICIPATED PROBLEMS involving risks to subjects or others and 
SERIOUS and UNEXPECTED adverse events promptly to this office, per the IRB 
policy. All FDA and sponsor reporting requirements should also be followed.  
Report any COMPLAINTS regarding this project to this office.  
You are reminded that you must apply for, undergo review, and be granted continued 
approval for this study before March 12, 2018 in order to be able to conduct your study in 
an uninterrupted manner. If you do not receive approval before this date, you must cease 
and desist all research involving human subjects, their tissue and their data until such 
time as approval is granted.  
If you have any questions, please contact Jean DeCicco at 315-464-4317 or 
deciccoj@upstate.edu. Please include your project title and reference number in all 
correspondence with this committee.  
Documents in this submission:  
• Amendment/Modification-Form-AmendmentRequest_7-28-
17.doc(UPDATED:07/31/2017)• ConsentForm-
1005999Upstateconsentformver07282017.docx(UPDATED:07/31/2017) • 
RegistrationFormforIRBReview-
RegistrationFormforIRBReview(UPDATED:07/26/2017)  
Unless otherwise stated, all documents submitted in previous packages have been 
approved by the SUNY Upstate IRB.  
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CONSENT & AUTHORIZATION FORM 
 
STUDY TITLE: Sex Differences in Cardiovascular Adaptations to Chronic Endurance Exercise 
 
UPSTATE MEDICAL UNIVERSITY PRINCIPAL INVESTIGATOR:  
 
Kan Liu, PhD, MD 
750 East Adams Street, Syracuse, NY 13210 
6th Floor University Hospital 
315-464-5735 
  
SYRACUSE UNIVERSITY PRINCIPAL INVESTIGATOR: 
 
Kevin Heffernan, PhD 
820 Comstock Avenue, Syracuse, NY 13210 
Syracuse University, Women’s Building, Room 201 
315-443-9801 
 
INTRODUCTION: 
 
Please read this form carefully. It tells you important information about a research study. A 
member of the research team will also talk to you about taking part in this research study.  
People who agree to take part in research studies are called “subjects.” This term will be used 
throughout this consent form. 
 
We are inviting you to participate in a research study run by Dr. Kan Liu MD, PhD, Dr. Kevin 
Heffernan, PhD and Mrs. Jacqueline Augustine. Involvement in the study is voluntary, so you may 
choose to participate or not to participate.  This informed consent and authorization form explains 
the study to you and what your participation will entail. Please feel free to ask questions about the 
research if you have any. We will be happy to explain anything in more detail if you wish.  
 
BACKGROUND/PURPOSE: 
 
Over the past three decades the number of marathon finishers has increased from 25,000 in 1976 
to 550,636 in 2015.  We are interested in examining the effects of long-term endurance exercise, 
such as running, on the heart. Even though exercise is considered to be beneficial for the heart, 
questions exist with regards to whether years of long-term endurance exercise may predispose 
individuals to cardiovascular risk. Interestingly, the way the heart adapts to endurance training 
and racing may differ between men and women. However, despite the increased participation of 
women in endurance events such as, marathon races, very few studies have included women. 
Thus, little is known regarding the effect of endurance training on the heart in women compared 
to men. 
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The purpose of this study is to examine heart size and function in endurance-trained men and 
women and compare the results to recreationally active healthy men and women. We are also 
interested in examining why there might be sex differences in heart size and function in 
endurance-trained athletes. Therefore, we will also examine 24-hour blood pressure and artery 
function to determine if 24-hour blood pressure and artery function may explain sex differences 
in heart size and function in endurance trained men and women.  
 
 
GENERAL STUDY INFORMATION: 
If you choose to participate in this study, you will visit the Syracuse University Exercise Science 
Laboratory, located in the Women’s Building at Syracuse University three times for health 
screening and for the exercise portions of the study.  You will also need to visit SUNY Upstate 
Medical University, University Hospital Echocardiography Lab, one time for an imaging study 
of your heart. Each visit will take approximately 60-90 minutes.   
 
100 participants (25 endurance trained men, 25 endurance trained women; 25 recreationally 
active men, 25 recreationally active women) will be enrolled in this study. All participants will 
be 35 to 50 years of age. Additionally, women participants must be premenopausal and not using 
hormonal contraception (e.g. oral pill, Depo-Provera, IUD, transdermal patch, that contain 
hormones: estrogen/progesterone in varying levels) as indicated by the health history 
questionnaire and menstrual history questionnaire.  
 
Inclusion Criteria 
 
You are being asked to participate in the current study because you are a male or female between 
the ages of 35-50 years old and an otherwise healthy regular marathon runner who fits the 
following criteria:  
• Currently training for a marathon race  
• Completed ≥1 marathon per year over the course of the past ≥5 years  
• Regularly run ≥25 miles per week, runs 5-7 times per week on average, approximately ≥6 
mph (≤10 minutes/mile) 
• Engage in ≤1-2 extensive strength training sessions per week   
 
You may also be asked to participate if you are between the ages of 35-50 years and an 
otherwise healthy recreationally active individual who fits the following criteria: 
• Not currently training for a half marathon or marathon race  
• Never completed marathon and if you have, the marathon was completed ≥20 years ago 
• Regularly exercise 2-3 times per week for ≤30 minutes (i.e. walk, jog, run ≤10 miles per 
week, cycle, swim, aerobic, strength training) at a moderate to easy intensity 
• Do not regularly participate in races or competitions.  
 
Exclusion Criteria  
  
You may be excluded from the study participation for any of the following reasons:   
• Known Cardiovascular disease  
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• BMI >35 kg/m2, indicating obesity 
• Hypertension >140/90 mmHg 
• Hyperlipidemia >200 mg/dl total cholesterol, >150 mg/dl LDL 
• Diagnosed atherosclerosis by a physician 
• A cardiac event in the past 6 months 
• Thyroid disorder and diabetes (>110 mg/dl glucose) 
• Orthopedic Injury preventing exercise such as, ankle sprain, knee injury, stress fracture, 
torn/sprained ligaments/tendons 
• Kidney disease  
 
 
STUDY PROCEDURES: 
 
Study Design. This study will consist of 4 study visits. Visits 1-3 (Syracuse University, Exercise 
Science Department) will be scheduled within 7 days to avoid potential effects of training and 
hormonal changes due to the menstrual cycle. Visit 4 (SUNY Upstate Medical University) will 
be scheduled within 2 weeks of Visit 1. The total time for study participation is approximately  
4 ½ to 6 hours.  
 
Visit 1: Informed Consent and Health Screening Visit: Syracuse University, Exercise Science 
Laboratory (~1 hour) 
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• Prior to the health screening visit You will be given and explained the consent form which will 
detail all study procedures. You will fill out and sign this consent form if you would like to 
participate in this study.  
• For the health screening visit we ask you to arrive first thing in the morning ≥12 hours fasted 
(i.e. no food, caffeine, or alcohol for the past 12 hours).  We ask this so that we can accurately 
measure your cholesterol, blood pressure, body composition, and blood sugar to determine 
overall health status for further participation in the study (described further below).  A light snack 
will be provided after this visit.   
• We also ask that you arrive to the laboratory ≥24 hours post-exercise to avoid changes in artery 
function associated with exercise.  
• Female participants will be asked to arrive at the laboratory during the early follicular phase of 
their menstrual cycle also known as Days 1-7 of the menstrual cycle which is  the week of their 
menses period (you can come into the laboratory the day of the start of your period up to 7 days 
after the start of your period).  
• To determine if you are eligible for the study you will be given a detailed health history 
questionnaire, menstrual history questionnaire, marathon and running history questionnaire, a 
sleep and physical activity questionnaire and a depression questionnaire.  Additionally, we will 
measure your height and weight using a stadiometer and electronic scale, in the same manner 
typically done at the doctor’s office.   
• We will also have you perform a brief paper cognitive test to assess basic brain function.  
• We will ask you to give us a small urine sample so that we can check the function of your kidneys 
and your hydration status at the time of the visit.  We will provide a small sample container and 
escort you to the restroom.   
• We will then estimate your body composition (percent body fat) using a BodPod and 3-D body 
scanner that will require you to wear tight fitting, minimal clothing for greatest accuracy in 
estimations.  You will be asked to sit quietly in a chamber that resembles a giant egg for 
approximately two, 60-second intervals. This machine measures your body volume to estimate 
body fat.  For the 3-D body scanner we will have you stand in the middle of the scanner in the 
same outfit you wear for the BodPod and 3 laser-guided cameras will scan down your body from 
head to toe.  These lasers are not dangerous and will not damage your eyes, if your eyes are 
sensitive however we will invite you to close your eyes for the scan. The scan takes 
approximately 10 seconds for the cameras to move from your head to your toes.  
• We will measure your blood pressure in both arms.  We will place a blood pressure cuff around 
both your left and right upper arms (bicep) and they will inflate and deflate slowly. This is the 
same measurement that is often done at the Doctors office during a routine visit. We will take 
this measurement both while you are sitting, and while you are lying down. 
• We will also measure your hemoglobin/hematocrit, cardiac function, cholesterol, glucose, and 
whole-body inflammation by obtaining a few small drops of blood from your fingertip (finger 
prick).  These tests require that you arrive >12 hours fasted. 
• Next, we will measure blood pressure at specific blood vessels in the body.  To do so, we will 
take a small tonometer (a small pen-like device that senses pressure) and press it gently against 
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the carotid artery (neck), radial artery (wrist), and femoral artery (upper leg/hip). We will do this 
while simultaneously measuring your heart rate from electrodes placed on your ribs and 
shoulder. We can use these pressure waves to calculate how stiff your blood vessels are.  
• As you leave the screening visit we will send you home with a small physical activity monitor, 
heart rate monitor and at-home 24-hour blood pressure monitor (further instructions attached)   
• The physical activity monitor is less than 2 inches in length and will measure how much you 
move throughout the week.  You will be instructed to wear a stretchy belt that will allow the 
monitor to sit snug against your right hip. We ask that you wear the activity monitor for 24 hours 
for a full 7 days, only removing it when involved in water activities such as showering/bathing 
and swimming (activity/training log will be provided).  
• We ask that you wear the heart rate monitor for each and every training/exercise session for 7 
days. We will also ask you to wear the 24-hour blood pressure monitor for the duration of 24 
hours following your visit and not to engage in exercise while wearing this device. Please do not 
wear the monitor in water activities such as showering/bathing and swimming.   
• Depending on your health status determined from the answers you provide on the health 
questionnaires we may ask you to contact your physician and receive permission to continue 
with the exercise portion of the study on subsequent visits. 
• All screening test results will be reviewed to determine if you can continue in the study. Test 
results which may indicate a health problem and which may exclude you from study participation 
will be shared with you so you can follow-up with your primary health care provider.  
 
Visit 2: Cardiorespiratory Fitness (exercise) Test: Syracuse University, Human Performance 
Laboratory (~1 hour) 
• For the first exercise visit we ask you to arrive not having eaten within the past 3 hours.  Intense 
exercise may upset your stomach if you have recently eaten.  Therefore, we ask you to refrain 
from exercising or consuming alcohol or caffeine (including caffeinated coffee, tea, soda or 
energy drinks) on the day that you come into the lab.   
• We will first prepare you for the cardiorespiratory fitness test. We will have you walk on the 
treadmill and then rest. At this time, we will explain the exercise protocol to you.  
• The cardiorespiratory fitness test will consist of a running exercise, starting at a very low 
intensity for warm-up, and increasing exercise intensity with time.  We will increase the intensity 
of exercise by increasing the speed that you are running at and then at later stages in the test the 
grade (incline) of the treadmill will increase slightly until you cannot run for any longer.   The 
goal of this test is to measure how much oxygen your body can consume during exercise.  The 
more oxygen you can take in, the more fit you are.  We will instruct you to continue exercising 
as long as you can.  The test will end whenever you believe you cannot exercise any harder.  If 
you are ever uncomfortable or concerned you may end the test at any time. The exercise test will 
usually last somewhere between 10-20 minutes.   
• During the exercise test we will measure the following… 
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§ Your blood pressure on the upper arm. 
§ The oxygen delivery to your calf muscle using a small sensor 
enclosed in a compressive stocking. 
§ Your heart rate using a thin strap that will be placed directly 
on the skin around your chest. 
§ The amount of oxygen you are consuming using a small 
device that is worn like a small backpack with a facemask 
(see image on the left). 
§ How hard you think you are working using a scale ranging 
from 6 (no work) to 20 (working as hard as you can). 
• After ending the test, we will have you cool down and recover briefly by exercising at a very 
low intensity for 3-5 minutes before dismissing you. 
• We will provide you with a snack and water following the test.  
 
Visit 3: Acute exercise: Syracuse University, Human Performance Laboratory (~1.5 hours) 
• For the second exercise visit we ask you to arrive >4 hours fasted (i.e. no food, caffeine, or 
alcohol for the past 4 hours) and to wear shorts and a T-shirt.  At this visit we will measure your 
blood vessels, blood pressure, and brain function both before, and after, 30-minutes of moderate-
intensity running/walking exercise.   
• First, we will measure your blood pressure in the same manner as the previous visits. This is the 
same measurement that is often done at the Doctors office during a routine visit. We will take 
this measurement both while you are sitting, and while you are lying down. 
• Next, we will measure blood pressure at specific blood vessels in the body.  To do so, we will 
take a small tonometer (a small pen-like device that senses pressure) and press it gently against 
the carotid artery (neck), radial artery (wrist), and femoral artery (upper leg/hip). We will do this 
while simultaneously measuring your heart rate from electrodes placed on your ribs and 
shoulder. We can use these pressure waves to calculate how stiff your blood vessels are.  
•  Next, we will measure your neck and leg blood flow and brain blood flow using two non-
invasive (no needles, no blood) techniques, Doppler ultrasound and blood flow sensors. 
Ultrasound probes will be placed on your neck, upper leg/thigh and on the side of your face (near 
your temple, between your eye and ear) to assess neck and leg artery stiffness and blood flow 
and brain blood flow. Additionally, a blood flow sensors will be placed on the forehead and 
secured with a headband to assess brain blood flow.  
• Once you have completed the resting artery measures we will remove our instruments and you 
will begin the 30-minute exercise bout. The running/walking intensity will be set at a workload 
to approximate 60-70% of your heart rate maximum (determined from visit 2). 
• During the 30-minute running exercise bout we will measure blood pressure, heart rate, how 
hard you think you are working, and how much oxygen you are breathing in using the same 
techniques from the cardiorespiratory fitness test.   
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• After completing the exercise bout, we will have you return to the testing table and let you 
recover for approximately 5 minutes while we set our instruments back up.  After that we will 
repeat the same measures from before exercise (cardiac function blood markers, blood pressure, 
blood flow, cognitive function).   
• Once the measurements are complete, we will remove our instruments and we will then give you 
the same 24-hour blood pressure monitor you received at Visit 1 to be worn for another 24-hours 
and only taken off while showering or coming in contact with water. You will be asked to refrain 
from exercise while wearing the monitor and to bring it back within 48 hours of visit 3. You will 
then be permitted to leave.  
• This exercise visit will take approximately 90 minutes to complete (15-20 minutes pre-testing, 
30 minutes’ exercise, 30-minutes post-exercise).   
• If you wish to withdraw from the study at any time you are free to do so.   
 
Visit 4: 3-dimensional Echocardiography Visit: SUNY Upstate Medical University, 6th Floor 
Echo Laboratory (~1 hour) 
• For the fourth and final visit, you will meet Jacqueline Augustine, researcher, in the lobby 
of Upstate University Hospital. You will be escorted to the Echocardiography laboratory 
to have a non-invasive, 3-dimensional echocardiography of your heart. This procedure will 
be performed by a certified echocardiography technician/researcher and accompanied by 
Dr. Liu.  
• The imaging of your heart will be non-invasive (no needles, no blood) using a Doppler 
ultrasound technique, which is very similar to the probe used to measure your neck and leg 
blood flow during Visit 3 at Syracuse University. An ultrasound probe will be placed on 
your chest near the left side of your chest. The technician will take 1-2 images of your 
heart.  
• We will also measure ankle-brachial index (ABI), which measures your artery function. 
This is a non-invasive test that will compare the blood pressure at your ankles with the 
blood pressure at your arm. This procedure indicates of how good your circulation is 
throughout your body. 
• This visit to the echocardiography lab will take approximately 30 minutes, however, the 
total duration of the visit to Upstate University Hospital will take ~1 hour with parking, 
arrival and imaging. 
 
A University Hospital (UH) medical record will not be created for you as a participant in this 
study. If you already have a medical record at UH, we will not add the tests being done for this 
study to your UH medical record. A copy of your test results will be kept in Dr. Liu's study 
records; therefore, if you want a copy of the test results, please contact Dr. Liu at 
Liuk@upstate.edu or (315) 464-9335. 
  
RISKS & DISCOMFORTS: 
 
• There are some risks associated with portions of this study. 
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• We will use a small amount of gel to help us measure your brain blood flow. There is minimal 
risk of gel getting into your eye when we measure brain blood flow due to the small amount of 
gel used in this technique.  Nonetheless, we will remind you to remain still as we take these 
measures to ensure that the gel does not come into contact with your eye. The gel is water-
based and is designed for eye exams so in the event some comes in contact with your eye the 
discomfort should be minimal and temporary and can be rinsed out easily.  We will escort you 
quickly to a sink to rinse out your eye if discomfort occurs.  
• You may experience discomfort from the finger stick to test your blood lipids, cardiac 
function, inflammation, hematocrit and hemoglobin. This will only be done two or three times 
and no more than that. We will use different fingers each time to reduce discomfort. If desired 
we can also place ice on the finger prior to the finger stick to reduce discomfort from the pinch. 
• There is a small risk of infection associated with the finger stick. However, we will reduce this 
risk by ensuring that equipment is clean and sterile and the finger stick technician will wear lab 
coat, gloves, will clean the finger with alcohol swabs and will clean the area with a disinfectant 
wipe afterwards.     
• You will be asked to come to Visit 1 (≥12 hours fast) and 3 (≥12hours fasted) following a fast.  
It is possible that you may experience some gastrointestinal discomfort by the end of testing 
from feelings of hunger or experience symptoms of low blood sugar such as, feeling faint or 
dizzy.  Although this is not anticipated, as many people do not consume food for large breaks 
during the day, we will provide a light snack at the completion of testing (granola bar) if you 
are hungry. It is important that we have participants arrive fasted because food consumption 
can greatly affect vascular function based on the timing and content of the meal.   
• There are risks associated with exercise.   
• There is a small risk of losing consciousness following intense exercise. We will 
minimize this risk by having you “cool-down” following the cardiorespiratory fitness test 
at visit 2.  This will prevent the blood from staying down in your legs and will reduce the 
risk of light-headedness or dizziness after exercise.  Additionally, we will ask you 
communicate directly with us if you feel any light-headedness so that we can take 
appropriate precautions.  
• Any type of exercise may, in rare instances, lead to heart attack, stroke or death; 
however, this is unusual, especially in adults free of known cardiovascular disease, free 
of any signs or symptoms of cardiovascular disease, and with few major risk factors of 
cardiovascular disease.  Thus, risks associated with exercise are low in healthy, middle-
aged adults.  Our multi-stage screening process will help us ensure that exercise is 
appropriate and safe for you.  The multi-stage screening process will let us identify any 
pre-existing conditions or abnormalities that might limit exercise. By design, our 
exclusion criteria and extensive health screening prior to the exercise visits (visit 2 and 3) 
will remove you from participating if you are a high-risk individual.   
• Based on our criteria however, you may be a moderate-risk individuals (i.e. you have >2 
cardiovascular risk factors).  The odds are, if you have high blood pressure you will fall 
into this moderate-risk group.  As mentioned previously, we will require you to obtain 
clearance from your physician to participate in the exercise portion of the study if you are 
in this moderate-risk group (>2 cardiovascular risk factors).  If you are unable to obtain 
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clearance from your physician you will not be allowed to participate in the exercise visits.  
• It should be noted that exercise is widely recommeneded by health organizations as a 
lifestyle modification to reduce the negative effects of cardiovascular disease, even in 
moderate-risk populations with high blood pressure.  Our multi-stage screening process 
and physican clearance steps will ensure that you will only engage in exercise if it is 
appropriate and safe for you, thus these risks should be minimal should you be cleared for 
the exercise portions of the study. 
• Communicating with the researcher throughout the protocol will reduce risks.  
• It is possible that we may find out something about your health that you did not know 
about. In the event we discover any significant medical abnormalities during the course 
of your participation in this study, we will inform you and your primary care physician, if 
you wish. If you do not have a primary physician, an appropriate referral will be made. 
• If at any point, you are uncomfortable or feel pain anywhere, please tell us immediately.   
 
BENEFITS: 
 
• There is no direct benefit to you for participating in this research study; however, the 
information learned may help others in the future.  
 
• You will receive information on your blood pressure, cholesterol level, body 
composition, aerobic fitness, cognitive function, heart structure and function. However,  
These tests are not being used to diagnose a problem (NOT for medical/clinical 
purposes). These tests are being performed for research purposes only.  If you have 
high blood pressure, high cholesterol, high blood glucose, depression, or blood in your 
urine we will inform you to go the university health center or your health care provider.  
If an abnormality is detected on the 3D echocardiography, low ABI is detected or an 
abnormal heart rhythm is observed, you will be referred to the cardiologist, lead 
physician on this study, Dr. Kan Liu.  
 
VOLUNTARY PARTICIPATION: 
 
Your participation in this study is entirely voluntary and you may refuse to participate or 
discontinue participation at any time without penalty or loss of benefits to which you would 
normally be entitled. Your decision about whether or not to participate in the study will not 
affect your relationship with Syracuse University or SUNY Upstate Medical University.  
 
STUDY WITHDRAWAL: 
 
• At any time, you may remove yourself from the study without giving any reason.  
• If you are a student, withdrawing from the study will not affect your grade in courses in any way.  
• Exercise is not appropriate for all individuals based on their health status.  This study has 
a multi-stage process where we may exclude you from participating in the exercise portions 
of the study. Throughout this process, you may be excluded from the study based on 
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answers to the eligibility survey, the questionnaires administered in the screening visit, if 
you have low kidney function (determined from the urine test), very low cognitive function 
(determined from the basic cognitive function test on visit 1), high depressive 
symptomology (determined from a questionnaire), and very high cholesterol or blood sugar 
(determined from blood tests).  We may also exclude you if…  
o We find that you regularly experience any signs or symptoms that suggest you may 
have a medical condition and your health care provider is not aware that you are 
experiencing these symptoms.  We will exclude you from the study and ask that 
you contact your health care provider.   
o You have recently sustained a concussion.   
o You have high blood pressure (systolic pressure >140, diastolic pressure >90 
mmHg) and are not undergoing medical treatment for it. We will exclude you and 
ask that you follow up with your health care provider.   
o You have an abnormal blood pressure response to exercise during visit 2.   
o You have >2 cardiovascular risk factors and your physician does not give you, or 
you do not obtain, clearance to exercise.   
• If you are experiencing any signs or symptoms of a serious/significant health condition (i.e. 
severe chest pain, leg pain, dizziness, feelings of heart palpitations) we will contact 
emergency medical services immediately and you will not be able to participate in the 
study. 
The researchers may take you out of the study at any time with or without your agreement.  This 
may happen if:  
• It is in your best medical interest to stop your participation 
• You are not able to follow the study instructions 
• The study is canceled   
 
ALTERNATIVES: 
 
If you decide not to participate in this research study, you will not have any of the above 
procedures done for research purposes.      
 
NEW INFORMATION: 
 
You will be informed in a timely manner if new information that could affect your willingness to 
continue participation in this study becomes available. 
 
COSTS/PAYMENTS: 
 
• There will be no costs to you for participating in this study. 
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• You will receive monetary compensation for your time.  You will receive $5 for completing 
the health screening visit, $5 for completing the physical activity and at-home blood pressure 
monitoring, $5 for completing the cardiorespiratory fitness test, and $5 for completing the final 
exercise visit along with at-home blood pressure monitoring and $5 and parking fees and $5 for 
completion of the echocardiogram. If you remove yourself, or are excluded, from the study 
prior to completing all visits, you will only be compensated for the visits/procedures that were 
completed.  If you withdraw or are excluded from the study at visit 2 or 3, your compensation 
will be pro-rated depending on what stage of the visit you had completed.  
 
QUESTIONS: 
 
If you have any questions about the research, or in the event of a research-related injury, please 
contact Kan Liu, MD at (315) 464-9335, Jacqueline Augustine at (860) 508-8996, Kevin 
Heffernan, PhD at (315) 443-9801. If you have any questions about your rights as a research 
subject, please contact the SUNY Upstate Medical University Institutional Review Board Office 
at (315) 464-4317 or the Syracuse University Institutional Review Board Office at (315) 443-
3013 
 
IN CASE OF INJURY: 
 
In the event of illness or physical injury resulting from taking part in this research study, medical 
treatment will be provided at University Hospital. You will be responsible for any costs not paid 
by your insurance company. No other compensation is offered by SUNY Upstate Medical 
University or Syracuse University. SUNY Upstate Medical University and Syracuse University 
have no plans to give you money if you are injured. You have not waived any of your legal rights 
by signing this form. 
  
CONFIDENTIALITY OF RECORDS AND AUTHORIZATION TO USE/SHARE 
PROTECTED HEALTH INFORMATION FOR RESEARCH:  
 
If you agree to participate in this research, identifiable health information about you will be used 
and shared with others involved in this research. For you to be in this research we need your 
permission to collect and share this information. Federal law protects your right to privacy 
concerning this information.  
 
When you sign this consent form at the end, it means that you have read this section and 
authorize the use and/or sharing of your protected health information as explained below. Your 
signature also means you have received a copy of Upstate’s Notice of Privacy Practices. The 
Notice of Privacy Practices should be given to each subject at the time consent for participation 
in the study is obtained. 
 
Individually identifiable health information under the federal privacy law is considered to be any 
information from your medical record, or obtained from this study, that can be associated with 
you, and relates to your past, present, or future physical or mental health or condition. This is 
referred to as protected health information. 
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Your protected health information will be kept confidential. Your identity will not be revealed in 
any publication or presentation of the results of this research. 
Why is it necessary to use/share your protected health information with others? 
The main reason to use and share your health information is to conduct the research as described 
in this consent form. Your information may also be shared with people and organizations that 
make sure the research is being done correctly, and to report unexpected or bad side effects. 
 
In addition, we may be required by law to release protected health information about you; for 
example, if a judge requires such release in a lawsuit, or if you tell us of your intent to harm 
yourself or others. 
 
What protected health information about you will be used or shared with others as part of this 
research? 
We may use and share the results of tests, questionnaires, and interviews. We may also use and 
share information from your medical and research records. We will only collect information that 
is needed for the research. 
 
Who will be authorized to use and/or share your protected health information? 
The researchers, their staff and the staff of Upstate Medical University and Syracuse University 
participating in the research will use your protected health information for this research study. In 
addition, the Upstate Institutional Review Board (IRB) and the Syracuse University IRB, 
committees responsible for protecting the rights of research subjects, and other Upstate Medical 
University, Syracuse University, or University Hospital staff who supervise the way the research 
is done may have access to your protected health information.  
 
The researchers and their staff will determine if your protected health information will be used or 
shared with others outside of Upstate Medical University and Syracuse University for purposes 
directly related to the conduct of the research.  
 
 
With whom would the protected health information be shared? 
Your protected health information may be shared with:  
• Federal agencies that supervise the way the research is conducted, such as the 
Department of Health and Human Services’ Office for Human Research Protections, or 
other governmental offices in the US or other countries, as required by law.   
 
All reasonable efforts will be used to protect the confidentiality of your protected health 
information. However, not all individuals or groups have to comply with the Federal privacy 
law. Therefore, once your protected health information is disclosed (leaves Upstate Medical 
University), the Federal privacy law may not protect it.   
 
For how long will your protected health information be used or shared with others? 
There is no scheduled date at which this information will be destroyed or no longer used. This is 
because information that is collected for research purposes continues to be used and analyzed for 
many years and it is not possible to determine when this will be complete. 
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Can you withdraw your authorization to collect/use/share your protected health information? 
You always have the right to withdraw your permission (revoke authorization) for us to use and 
share your health information, by putting your request in writing to the investigator in charge of 
the study.  This means that no further private health information will be collected. Once 
authorization is revoked, you may no longer participate in this research activity, but standard 
medical care and any other benefits to which you are entitled will not be affected. Revoking your 
authorization only affects uses and sharing of information obtained after your written request has 
been received, but not information obtained prior to that time.  
 
Even after you withdraw your permission, Upstate Medical University and Syracuse University 
may continue to use and share information needed for the integrity of the study; for example, 
information about an unexpected or bad side effect you experienced related to the study.  
 
Can you have access to your health information? 
 
At the end of the study, you have the right to see and copy health information about you in 
accordance with the SUNY Upstate Medical University policies; however, your access may be 
limited while the study is in progress.  
 
CONSENT TO PARTICIPATE IN RESEARCH & AUTHORIZATION TO USE AND 
SHARE PERSONAL HEALTH INFORMATION: 
 
• I have read this information and this study has been explained to me.  
• It has been written in a language that I understand.   
• All my questions about the study have been answered to my satisfaction.   
 
I hereby give my consent to participate in this research study and agree that my personal health 
information can be collected, used and shared by the researchers and staff for the research study 
described in this form. I will receive a signed copy of this consent form.  
 
______________________________________    _______________ 
Signature of subject           Date 
 
___________________________________________   _______________ 
Signature of Person Obtaining Consent/Authorization   Date 
 
_________________________________________   
Name of Person Obtaining Consent/Authorization 
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Human Performance Lab Health Screening Form                       Date__________  
 
Age _______  
Gender ______                       
 
Please answer the following questions as honestly as you can. Your patterns of responses will determine 
whether you may participate in the study. 
Known Diseases (Medical Conditions) 
1. List the medications and dietary supplements you take on a regular basis. (Include 
prescription and non-prescription, aspirin vitamins/minerals, nutrition supplements 
[Ensure, Boost, etc.])  
______________________________________________________________________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
________________________________________________________________________ 
Please underline or highlight or bold your answers to indicate “Yes” or “No” to the 
questions below: 
 
2. Has your health care provider ever told you have diabetes?  No  Yes 
3. Do you have acute or terminal illness (if so, please explain below)? No   Yes 
4.   Have you ever had a stroke, heart attack or heart trouble?   No   Yes 
5.  Has your health care provider ever told you that you have a heart murmur?   
No  Yes  
6.  Have you had a head injury in the past 3 months?                                              No   Yes 
7.   Do you have asthma /take asthma medication?      No  Yes 
8.   Has your health care provider ever told you that you have  
      kidney or liver disease?          No  Yes 
9.  Has your health care provider ever told you that you have  
      chronic pulmonary or respiratory disease?                                                   No  Yes 
     10.  Has your health care provider ever told you that you have  
            peripheral artery disease?          No  Yes 
     11.  Has your health care provider ever told you that you have  
            high blood pressure?             No   Yes 
     12.  Has your health care provider ever told you that you have  
     high cholesterol?                                         No       Yes 
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     13.  Do you smoke cigarettes on a daily basis?                         No  Yes  
      If yes to #13, how many packs per day _________________ 
      If yes to #13, how long have you been smoking _________________ 
 
 
     14.  Have you lost or gained weight in the previous 6 months?   No   Yes 
If yes, how much weight? _______  
     15.  Has a first degree relative (e.g. father, mother, sister, brother, or child)  
        suffered from a heart attack or diagnosed cardiovascular disease?  No   Yes 
 
Relative Age Did they pass away? 
   
   
 
 
16. Do you often have pains in your heart, chest, neck, jaw, arms or other areas    No Yes 
 especially during exercise?         
17. Do you regularly get pains in you calves or lower legs during exercise 
 which are not due to soreness or stiffness?    No Yes 
18. Do you experience swelling or accumulation of fluid in or around your ankles? No
 Yes 
19. Do you often feel faint or have spells of severe dizziness during exercise? No Yes 
20. Do you often get the feeling that your heart is beating faster, racing, 
  or skipping beats, either at rest or during exercise?    No Yes 
21. If you answered YES to question(s) 17-21, does your health care provider  
       know that you have this/these symptom(s)?              No       Yes  
 
22. If you answered YES to question(s) 16-20, are you currently experiencing this/these  
      symptom(s) RIGHT NOW?                             No        Yes 
 
23.  With which hand do you write?                                                                              Left       Right 
 
24. How do you define your race/ethnicity? ___________________________________ 
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25.   What is the highest grade/level of schooling/education completed? 
 
       8th Grade            Some HS              HS              some college          college            graduate school 
 
26.  Have you ever lost consciousness before during any daily activity?  No  Yes 
 If you answered YES to question 31, please explain below. 
 
 
27.  On a scale of 1-5 (1= not anxious at all; 5= very anxious) how anxious do you feel during a 
typical Doctor’s office visit?  1 2 3 4 5 
 
Please underline or highlight or bold your answers to indicate “Yes” or “No” to the 
questions below: 
28.  Additional:   
Allergies Fibromyalgia Polio Flu 
Anemia Attention Deficit 
Hyperactivity Disorder 
Reflux or Ulcers Seizures 
 
Anxiety Glaucoma Liver Disease Concussion 
Arthritis Lupus Bone Disease Eczema 
Asthma Meningitis Leg/foot Ulcers Epilepsy 
Cataracts Chronic Lyme Disease Diverticulitis  Headaches/Migraine 
Chronic 
Bronchitis 
Gout Infection Urinary Tract Infection 
Lung Disease Thyroid 
(underactive/overactive) 
Cold Kidney Stones 
  
 
Blood pressure history 
 
3. Have you ever been told you have high blood pressure (i.e. hypertension)?  No Yes 
 
4. Have you ever been diagnosed with high blood pressure by your physician?  No Yes 
 
If yes, how long have you been living with high blood pressure? _____________ 
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5. Are you currently taking prescription medication to treat/control your blood pressure?No
 Yes 
 
If yes, what kind of medication are you taking? ___________ 
 
What dose? ____________ 
 
Approximately how long have you been taking this medication? ____________ 
 
Has your medication or your dose changed in the past 4-6 weeks?  No Yes 
 
6. Have you had trouble medically controlling your blood pressure (i.e. been on multiple 
medications)?           
  No Yes 
Marathon History  
Please underline or highlight or bold your answers to indicate “Yes” or “No” to the questions 
below: 
 
1. Have you ever completed a Marathon?      No  Yes 
2. Are you currently training for a marathon race?     No  Yes  
a. If Yes, When is the marathon race?______________ 
 
3. How many marathons have you completed in the past 1 year? _________ 
4. How many marathons have you complete in the past 3 years?__________ 
5. How many marathons have you completed in the past 5 years?_________ 
6. If you have completed any marathons in the past 5 years, please list the names of the 
races, year completed, and your finishing time 
_______________________________________________________________ 
 
_______________________________________________________________ 
 
7. How many marathons have you completed in the past 20 years? _______ 
 
8. How many marathons have you completed in your lifetime? __________ 
 
 
9. On Average how many miles/week do you run? (circle one)       
 
<10      10-25        25-35       35-45      >45 
 
10. On average how fast do you normally run? (circle one)  
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<5-6mph (>10 min/mile)          6-8mph (7:30-10:00 min/mile)        >8mph (<7:30 
min/mile) 
 
11. On average how many times a week do you run? (circle one) 
 
0       1-2      3-5     5-7 
 
12. How many times a week do you perform extensive strength training sessions? 
 
0       1-2      3-5     5-7 
 
13. Do regularly compete in road races or running competitions?  No  Yes 
 
Regular Exercise History 
 
1. Do you currently exercise on a regular basis?      No Yes 
 
2. Please rate your exercise level on a scale of 1 to 5 (5 indicating very strenuous) for each age 
range to your present age: 
 
15-20  _______     21-30  _______    31- 40  _______   41-50  _______    50 & older  
_______ 
 
3. Were you a high school and/or college athlete? 
 
If yes, please specify:  
___________________________________________________________ 
 
4. Approximately how much time per week do you engage in exercise?    
Minutes/day:  ______________   Days/week:  _______________ 
 
5. Are you currently involved in regular endurance (cardiovascular) exercise?  No Yes 
 
If yes, specify the type of exercise(s): 
_______________________________________________ 
 
Days/week: ___________        Minutes/day: ___________ 
 
Rate your perception of the exertion during your endurance/cardiovascular exercise 
(circle the number): 
 
(1) Light                    (2) Fairly Light                   (3) Somewhat Hard                  (4) Hard 
 
6. Are you currently involved in regular strength building (weight lifting) exercise? 
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If yes, specify the type of exercise(s): 
_______________________________________________ 
 
Days/week: ___________        Minutes/day: ___________ 
 
Rate your perception of the exertion during your strength building exercise (circle the 
number): 
 
(1) Light                    (2) Fairly Light                   (3) Somewhat Hard                  (4) Hard 
 
7. How long have you been exercising regularly?     _________ months       ________ years 
 
8. Do you participate in any sport, or recreational activities? 
 
If yes, please specify the sports/activities 
____________________________________________________________ 
 
____________________________________________________________ 
Menstrual Status (answer these questions only if you are a female) 
 
1. Do you currently experience a regular menstrual cycle (i.e. period)?  No Yes 
If no, approximately how many years ago did you have a 
regular menstrual cycle (10-12 a year)?_________ 
 
If yes, approximately how many periods in a year do you have? _______  
 
Approximately how many days between periods? _______ 
 
What was the approximate date of your last menstrual period?______________ 
 
2. Has the time between your menstrual cycles changed at all recently?   No Yes 
Has the length differed by >7 days?      No Yes 
 
Has the length between cycles been >60 days (2 months)?    No Yes 
 
3. Have you ever experienced menstrual irregularity?    No Yes 
 
Please describe (i.e. number of skipped menses, or prolonged menses): 
_____________________  
 
Approximately how long did this occur? Are you experiencing this 
currently?________________ 
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4. Are you currently amenorrheic?       No Yes 
 
5. Have you gone through menopause (defined as no menstrual cycle/period for more than 12 
months without any other possible causes)?      
 No Yes 
 
6. Do you currently experience any of the following? Circle all that apply  No Yes 
 
7. Hot flashes 8. Irregular menstrual cycles 9. Night sweats 10. Sleep problems 
11. Mood changes 12. Frequent urination 13. Urinary tract infections 
14. Uncomfortable 
genital dryness 
 
15. Do you use oral contraceptives?        No Yes 
If yes, for how long have you been using? ____________ 
 
Which kind? ____________________  
 
What dose?______  
 
Do you take the withdrawal/Placebo pills?___________      
 
16. Do you use Depo-Provera for birth control?      No Yes 
If yes, for how long have you used this method?_________ 
 
17. Do you use hormone replacement therapy?     No Yes 
If yes, for how long have you been using? ____________ 
 
Which kind? ____________________  
 
What dose?______  
 
18. If you are not currently taking a form of contraception of hormone replacement, have you 
ever been on any contraception and if so for how many years?     
 No          Yes 
a. How long ago did you discontinue use of contraception or hormone replacement? 
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7-Day Exercise Training Log  
**Please make sure to wear your Heart Rate monitor that was given to you for the next 7 days 
DURING your training sessions**  
Day 1 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 2 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 3 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 4 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 5 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 6 Date:____________________  
What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? _____________  
Day 7 Date:____________________  
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What time did you workout? ______________ What was your workout? _________________ 
How long did you work out for?____________ If you ran how many miles did you run? _____ 
What was your average pace? ____________  
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives.  The questions will ask you about the time you spent being 
physically active in the last 7 days.  Please answer each question even if you do not 
consider yourself to be an active person.  Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe 
much harder than normal.  Think only about those physical activities that you did for at 
least 10 minutes at a time. 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
No vigorous physical activities  Skip to question 3 
 
2. How much time did you usually spend doing vigorous physical activities on one of those 
days? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate 
activities refer to activities that take moderate physical effort and make you breathe 
somewhat harder than normal.  Think only about those physical activities that you did 
for at least 10 minutes at a time. 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles tennis?  
Do not include walking. 
 
_____ days per week 
   No moderate physical activities  Skip to question 5 
 
4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
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_____ hours per day 
_____ minutes per day 
 
  Don’t know/Not sure  
 
Think about the time you spent walking in the last 7 days.  This includes at work and at 
home, walking to travel from place to place, and any other walking that you might do 
solely for recreation, sport, exercise, or leisure. 
5. During the last 7 days, on how many days did you walk for at least 10 minutes 
at a time?   
_____ days per week  
   No walking     Skip to question 7 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day  
 
  Don’t know/Not sure  
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time.  This 
may include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to 
watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week day? 
 
_____ hours per day  
_____ minutes per day  
 
  Don’t know/Not sure  
This is the end of the questionnaire, thank you for participating. 
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PITTSBURGH SLEEP QUALITY INDEX 
INSTRUCTIONS: 
The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the past 
month. 
Please answer all questions. 
 
1. During the past month, what time have you usually gone to bed at night? 
BED TIME ___________ 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each 
night? 
NUMBER OF MINUTES ___________ 
3. During the past month, what time have you usually gotten up in the morning? 
GETTING UP TIME ___________ 
4. During the past month, how many hours of actual sleep did you get at night? (This may be 
different than the number of hours you spent in bed.) 
HOURS OF SLEEP PER NIGHT ___________ 
For each of the remaining questions, check the one best response. Please answer all 
questions. 
5. During the past month, how often have you had trouble sleeping because you . . . 
a) Cannot get to sleep within 30 minutes 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
b) Wake up in the middle of the night or early morning 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
c) Have to get up to use the bathroom 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
 
d) Cannot breathe comfortably 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
e) Cough or snore loudly 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
f) Feel too cold 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
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g) Feel too hot 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
h) Had bad dreams 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
i) Have pain 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
j) Other reason(s), please describe__________________________________________ 
__________________________________________________________________________ 
How often during the past month have you had trouble sleeping because of this? 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
6. During the past month, how would you rate your sleep quality overall? 
Very good ___________ 
Fairly good ___________ 
Fairly bad ___________ 
Very bad ___________ 
7. During the past month, how often have you taken medicine to help you sleep (prescribed or 
"over the counter")? 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
8. During the past month, how often have you had trouble staying awake while driving, eating 
meals, or engaging in social activity? 
 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____  times a week_____ 
 
 
9. During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? 
 
No problem at all __________ 
Only a very slight problem __________ 
Somewhat of a problem __________ 
A very big problem __________ 
10. Do you have a bed partner or room mate? 
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No bed partner or room mate __________ 
Partner/room mate in other room __________ 
Partner in same room, but not same bed __________ 
Partner in same bed __________ 
If you have a room mate or bed partner, ask him/her how often in the past month you 
have had . . . 
 
a) Loud snoring 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
b) Long pauses between breaths while asleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
 
c) Legs twitching or jerking while you sleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
d) Episodes of disorientation or confusion during sleep 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____  a week_____   times a week_____ 
 
e) Other restlessness while you sleep; please describe__________________________________ 
___________________________________________________________________________ 
Not during the  Less than   Once or twice   Three or more 
past month_____  once a week_____ a week_____   times a week_____ 
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CES-D Depression Inventory 
 
INSTRUCTIONS: For each statement, please circle the number in the column 
that best describes how you have been feeling in the past week. 
 
 
  Rarely or none 
of the time  
(less than 1 day) 
 
Some or a little 
of the time  
(1-2days) 
 
Occasionally or a 
moderate amount 
of the time 
(3-4 days) 
Most or all 
of the time 
(5-7 days) 
 
1. I was bothered by things that usually don’t bother me. 0 1 2 3 
2. I did not feel like eating; my appetite was poor. 0 1 2 3 
3. 
I felt that I could not shake 
off the blues, even with the 
help from family or friends. 
0 1 2 3 
4. I felt that I was just as good as other people. 3 2 1 0 
5. I had trouble keeping my mind on what I was doing. 0 1 2 3 
6. I felt depressed. 0 1 2 3 
7. I felt that everything I did was an effort. 0 1 2 3 
8. I felt hopeful about the future. 3 2 1 0 
9. I thought my life had been a failure. 0 1 2 3 
10. I felt fearful. 0 1 2 3 
11. My sleep was restless. 0 1 2 3 
12. I was happy. 3 2 1 0 
13. I talked less than usual. 0 1 2 3 
14. I felt lonely. 0 1 2 3 
15. People were unfriendly. 0 1 2 3 
16. I enjoyed life. 3 2 1 0 
17. I had crying spells. 0 1 2 3 
18. I felt sad. 0 1 2 3 
19. I felt that people dislike me. 0 1 2 3 
20. I could not get “going”. 0 1 2 3 
 
 
Anyone with suicidal urges should seek immediate consultation with a qualified psychiatrist or psychologist. 
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Activity Monitor Log 
Please wear the physical activity monitor taped to the middle part of your thigh. Please wear this 
monitor during all waking and sleeping hours. Remove the monitor before any water activity 
(i.e. swimming, bathing, showering) and document the time and duration that it was off of 
your body.  
EXAMPLE DAILY LOG  
Monday  
Woke up at: 6:30AM  
Went to bed at: 10:30PM  
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
 
6:45-7:00AM - shower  
  
 
-  
5:30-5:40PM - shower after exercise  
  
-  
  
-  -  
-  
  
-  
-  
   
-  
   
 
Monday  
Woke up at:  
Went to bed at:  
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
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Tuesday  
Woke up at:  
Went to bed at:  
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
   
    
     
  
      
Wednesday  
Woke up at:  
Went to bed at:  
Thursday  
Woke up at:  
Went to bed at:  
 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
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Friday  
Woke up at:  
Went to bed at:  
Saturday  
Woke up at:  
Went to bed at:  
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
   
      
  
     
    
       
Sunday  
Woke up at:  
 
 
 
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
      
     
  
    
     
       
  
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
   
    
     
  
        
173 
 
 
Went to bed at:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Please indicate time interval when monitor was not worn (i.e. "8:05-8:25AM - shower)  
    
    
  
  
      
Other notes:  
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The Keep Your 
Heart Running 
Study 
The Exercise Science Department at Syracuse 
University is recruiting participants for a 
research study 
To examine sex differences in the effect of endurance exercise 
(such as a marathon) on heart and blood vessel health. 
You are eligible if you are 35-50 years old: 
• Regularly participate in marathon races 
• Are healthy recreationally-active adult 
• Do not smoke, do not have diabetes, kidney disease, or cardiovascular disease 
What do you have to do? 
• Visit 1: Health Screening to determine eligibility and receive body fat testing, body 
composition testing, 7-day physical activity, heart rate monitoring (1 hour) 
• Visit 2: Perform a maximal exercise test on a treadmill to determine fitness level (1 
hour) 
• Visit 3: Perform an easy 30 minute walk/run on the treadmill (1 hour) 
• Visit 4: Receive a non-invasive three dimensional echocardiography image of your heart 
at SUNY Upstate Medical University (1 hour) 
You may receive up to $25 compensation for completing the full study 
 
All research will take place on the main campus of Syracuse University with one visit to the 6th 
floor of SUNY Upstate Medical University (on site, no cost for parking), Human Performance 
Laboratory, 820 Comstock Avenue, Women’s Building, SUNY Upstate Medical University, 750 E. 
Adams St, Echocardiography Lab 
For more information, please contact us: Jaimse@syr.edu or 315-443-4540 
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Facebook Page Recruitment 
We are requesting a study Facebook page aimed at expanding our recruitment efforts in order to 
reach more potential participants.  We plan to use the Facebook page to post information about 
our study and use Facebook’s business outreach features where we would pay a small fee to 
increase our page’s exposure (in order to increase webpage traffic).  The attached screenshots of 
the Facebook page represent our current working page, which will not get published (i.e. go 
public) until approval has been received. We still plan to use our flyers/SU news posts, this is 
meant to supplement our current recruiting efforts.  
 
 
 
 
 
 
176 
 
 
 
Study Design Schematic 
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Two-Dimensional Echocardiography: LV Structure and Function 
BSA, Body Surface Area; LV, Left Ventricle Mass; LVMI, Left Ventricle Mass Index; EDV, End Diastolic Volume; ESV, End 
Systolic Volume; SV, Stroke Volume; Q, Cardiac Output; EF, Ejection Fraction; IVS, Interventricular Septum; LVDd, Left Ventricle 
Diameter in Diastole; PWD, Posterior Wall Diameter; LVDs, Left Ventricle Diameter in Systole; RWT, Relative Wall Thickness. 
Significance Level at p<0.05. SxT interaction, Sex x Training Interaction. 
 
 
 
 
 
 
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
Marathoners 
(n=24) 
Male 
Controls 
(n=24) 
Sex 
Effect 
Training 
Effect 
SxT 
Interaction 
LV Structure         
   LVM (g)  120±20 118±25 176±51 158±32 0.00 0.24 0.50 
   LVMI (g/m2) 74±15 67±21 86±3 83±17 0.00 0.24 0.58 
   LVM/EDV  59±12 55±17 61±20 66±11 0.12 0.59 0.27 
   EDV (ml)  94±17 94±18 121±31 119±24 0.00 0.74 0.99 
   ESV (ml)  39±7 48±15 47±13 42±13 0.00 0.26 0.73 
   SV (ml)  57±11 62±17 74±21 73±15 0.00 0.83 0.46 
   SV/BSA (L/m2) 38±7 32±10 37±9 37±9 0.75 0.07 0.09 
   Q (L/min) 3.1±0.8 4.0±1.1 3.8±0.9 4.3±1.2 0.05 0.23 0.35 
   Q/BSA (L/min/m2)  1.8±0.4 2.3±0.6 1.9±0.5 2.2±0.5 0.40 0.50 0.20 
   IVS (cm)  0.82±0.10 0.80±0.09 0.94±0.13 0.90±0.08 0.00 0.11 0.67 
   PWD (cm)  0.82±0.10 0.80±0.09 0.95±0.14 0.89±0.09 0.00 0.19 0.49 
   LVDd (cm)  4.50±0.37 4.53±0.37 4.97±0.54 4.98±0.44 0.00 0.99 0.88 
   LVDs (cm)  3.05±0.30 3.00±0.24 3.35±0.38 3.35±0.38 0.00 0.71 0.71 
   RWT   0.37±0.06 0.36±0.04 0.38±0.06 0.36±0.04 0.34 0.15 0.69 
LV Function         
   EF (%)  62.9±7.4 64.4±5.4 62.6±6.0 61±6.3 0.17 0.80 0.39 
   Fractional Shortening (%) 33.4±6.8 34.1±3.9 35.3±10.8 33.0±4.4 0.79 0.38 0.45 
   2D Peak Global Strain (%) -21.3±2.3 -25.9±24.4 -20.1±2.7 -19.4±2.1 0.18 0.50 0.36 
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Average Non-Exercise 24-hour Ambulatory Hemodynamics 
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathoners 
(n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Training 
Effect 
GxT 
Interaction 
SBP (mmHg) 113±10 116±10 122±6 120±6 0.00 0.28 0.07 
MAP (mmHg) 89±7 92±9 97±5 97±5 0.00 0.31 0.11 
DBP (mmHg) 69±7 72±9 77±5 77±6 0.00 0.40 0.23 
PP (mmHg) 44±7 44±5 44±5 44±4 0.98 0.56 0.21 
HR (bpm) 62±7 69±9 57±6 64±6 0.00 0.00 0.78 
aSBP (mmHg) 120±8 121±11 135±10 128±6 0.00 0.12 0.06 
aDBP (mmHg) 71±6 72±8 79±5 78±6 0.00 0.72 0.39 
aPP (mmHg) 49±9 48±7 52±4 53±3 0.00 0.13 0.14 
PWV (m/s)  6.0±0.5  6.1±0.5  6.3±0.4 6.2±0.4 0.02 0.93 0.15 
Pb (mmHg) 13.6±2.3 14.3±1.8 13.2±1.5 13.2±1.5 0.07 0.11 0.12 
Pf (mmHg) 21.04±3.1 21.6±2.1 21.6±2.8 21.4±1.8 0.75 0.37 0.19 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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Average Non-Exercise Control 24-hour Ambulatory Day Hemodynamics  
 
Variable    
Female 
Marathoner
s (n=28) 
Female 
Controls 
(n=25) 
Male 
marathone
rs (n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Trainin
g Effect 
GxT 
Interactio
n 
SBP (mmHg) 117±9 121±11 127±7 125±7 0.00 0.48 0.04 
MAP (mmHg) 93±7 96±10 103±6 101±6 0.00 0.49 0.07 
DBP (mmHg) 73±7 75±9 82±6 81±7 0.00 0.54 0.19 
PP (mmHg) 44±7 5±5 45±6 43±5 0.73 0.80 0.18 
HR (bpm) 65±7 72±9 60±6 66±7 0.00 0.00 0.90 
aSBP (mmHg) 121±10 122±12 137±12 130±7 0.00 0.18 0.08 
aDBP (mmHg) 75±7 76±9 84±6 83±7 0.00 0.91 0.54 
aPP (mmHg) 46±6 45±4 54±4 56±5 0.00 0.28 0.06 
PWV (m/s)  6.0±0.5 6.2±0.5 6.2±1.4 6.4±0.5 0.33 0.43 0.96 
Pb (mmHg) 12.8±2.7 13.6±2.04 12.7±1.5 12.4±1.8 0.10 0.20 0.06 
Pf (mmHg) 20.6±3.5 21.3±2.3 21.4±2.7 20.8±2.3 0.78 0.53 0.07 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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Average Non-Exercise Control 24-hour Ambulatory Night Hemodynamics  
 
Variable    
Female 
Marathone
rs (n=28) 
Female 
Controls 
(n=25) 
Male 
marathone
rs (n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Trainin
g Effect 
GxT 
Interacti
on 
SBP (mmHg) 106±10 108±11 112±7 111±5 0.02 0.45 0.15 
MAP (mmHg) 83±9 84±9 88±5 88±5 0.01 0.69 0.31 
DBP (mmHg) 64±8 64±9 69±4 68±6 0.00 0.95 0.58 
PP (mmHg) 43±6 44±6 43±5 43±4 0.74 0.36 0.15 
HR (bpm) 56±7 64±9 53±7 60±8 0.03 0.00 0.84 
aSBP (mmHg) 120±9 117±8 133±10 127±6 0.00 0.02 0.44 
aDBP (mmHg) 68±6 69±9 76±8 73±8 0.00 0.49 0.42 
aPP (mmHg) 52±6 48±5 57±5 55±4 0.08 0.03 0.50 
PWV (m/s)  5.8±0.5 6.0±0.4 6.2±0.4 6.1±0.4 0.06 0.77 0.27 
Pb (mmHg) 15.5±7.3 15.9±2.7 13.7±2.1 14.3±1.8 0.07 0.49 0.99 
Pf (mmHg) 21.6±3.0 22.1±2.9 21.2±2.9 21.8±2.3 0.84 0.08 0.44 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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Average Post-exercise 24-hour Ambulatory Hemodynamics 
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathoners 
(n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Training 
Effect 
GxT 
Interaction 
SBP (mmHg) 112±8 115±11 120±7 120±6 0.00 0.25 0.25 
MAP (mmHg)  89±7 91±10 96±5 96±6 0.00 0.22 0.56 
DBP (mmHg) 70±7 71±9 75±5 77±7 0.00 0.26 0.96 
PP (mmHg)  43±7 44±5 45±5 43±4 0.60 0.79 0.07 
HR (bpm)  62±6 69±7 57±7 64±8 0.00 0.00 0.98 
aSBP (mmHg)  120±8 120±12 135±12 130±7 0.01 0.30 0.40 
aDBP (mmHg)  73±7 71±7 79±6 80±8 0.00 0.83 0.32 
aPP (mmHg)  32±5 34±4 33±4 32±4 0.28 0.38 0.02 
PWV (m/s)   6.0±0.5 6.1±0.6 6.3±0.6 6.2±0.4 0.12 0.93 0.73 
Pb (mmHg)  13.3±2.4 14.4±1.8 13.3±1.7 12.7±2.1 0.04 0.35 0.01 
Pf (mmHg)  20.7±3.1 21.5±2.2 21.9±2.9 21.1±1.9 0.48 0.68 0.06 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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Average Post-Exercise Ambulatory Day Hemodynamics 
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathoners 
(n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Training 
Effect 
GxT 
Interaction 
SBP (mmHg) 117±8 121±12 125±7 124±6 0.00 0.45 0.14 
MAP (mmHg) 93±7 96±10 101±6 100±6 0.00 0.52 0.31 
DBP (mmHg) 74±7 75±9 81±7 80±7 0.00 0.64 0.63 
PP (mmHg) 44±7 45±5 45±5 44±5 0.80 0.61 0.11 
HR (bpm)  66±6 73±8 61±7 69±8 0.00 0.00 0.81 
aSBP (mmHg) 120±12 121±12 135±11 130±7 0.00 0.35 0.25 
aDBP (mmHg) 78±8 74±8 83±7 83±7 0.00 0.31 0.43 
aPP (mmHg) 43±5 47±4 52±4 47±5 0.45 0.76 0.22 
PWV (m/s)   6.2±0.5 6.2±0.6 6.4±0.5 6.3±9.4 0.14 0.64 0.81 
Pb (mmHg)  12.6±2.2* 13.5±1.8 12.7±1.6 11.8±2.3 0.07 0.64 0.01 
Pf (mmHg)  20.4±3.2 21.1±2.3 21.6±2.8 20.6±2.4 0.45 0.91 0.05 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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Average Post-exercise 24-hour Night Hemodynamics  
 
Variable    
Female 
Marathoners 
(n=28) 
Female 
Controls 
(n=25) 
Male 
marathoners 
(n=24) 
Male 
controls 
(n=24) 
Gender 
Effect 
Training 
Effect 
GxT 
Interaction 
SBP (mmHg) 106±9 108±10 111±7 113±7 0.00 0.16 0.56 
MAP (mmHg) 83±8 84±9 87±5 89±7 0.00 0.16 0.83 
DBP (mmHg) 64±8 64±9 67±5 70±7 0.00 0.21 0.33 
PP (mmHg) 42±6 44±6 45±5 43±2 0.36 0.62  0.35 
HR (bpm) 56±7 62±8 51±7 58±10 0.01 0.00 0.92 
aSBP (mmHg) 118±11 117±11 135±14 132±13 0.03 0.49 0.81 
aDBP (mmHg) 70±6 67±8 74±8 75±9 0.00 0.70 0.33 
aPP (mmHg) 48±5 50±6 60±6 57±3 0.00 0.06 0.06 
PWV (m/s)  5.9±0.4 5.9±0.6 6.2±0.6 6.0±0.5 0.17 0.60 0.50 
Pb (mmHg) 13.9±2.4 15.9±3.0 14.2±2.7 14.1±1.6 0.17 0.05 0.02 
Pf (mmHg) 20.8±2.8 22.1±3.1 21.9±3.4 21.8±1.9 0.44 0.19 0.13 
SBP, systolic blood pressure; MAP, Mean arterial pressure; DBP, Diastolic blood pressure; PP, Pulse pressure; HR, heart rate; aSBP, 
aortic systolic blood pressure; aDBP, aortic diastolic blood pressure; aPP, aortic pulse pressure; PWV, pulse wave velocity; Pb, 
backward wave pressure; Pf, forward wave pressure.  
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